<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Gowling WLG Resources RSS Feed</title><link>https://gowlingwlg.com/ecaapi/en-cn/rss/resource?service=Patents</link><description>Gowling WLG Resources RSS Feed</description><item><guid isPermaLink="false">84679c11-aba5-4ca5-b1e8-f39a5a6a5a2a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/restoring-patent-priority-in-canada</link><title>Restoring patent priority in Canada</title><description>Learn how restoration of priority can help patent applicants in Canada protect an earlier filing date.</description><pubDate>Mon, 24 Aug 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5c120633-18b8-4a3b-be44-9c083c2c3aa8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/a-guide-to-ai-inventions-in-singapore-and-canada</link><title>Bridging the AI frontier: A guide to AI inventions in Singapore and Canada</title><description>This article provides a comparative analysis of Singapore (IPOS) and Canada (CIPO) patent landscapes, offering actionable drafting and prosecution strategies for maximising portfolio value in both jurisdictions.</description><pubDate>Mon, 27 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ad2bda1-c1bc-49f7-aab7-989cbdd78191</guid><link>https://gowlingwlg.com/en-cn/insights-resources/client-work/2026/gowling-wlg-successfully-represents-jempak-ulc-in-complex-patent-trial</link><title>Gowling WLG successfully represents Jempak ULC in complex patent trial</title><description>Gowling WLG successfully represented Jempak ULC in a complex patent infringement action before the Federal Court of Canada, resulting in the dismissal of all infringement claims advanced by Gemak Trust.</description><pubDate>Tue, 21 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8d72c88d-8ca5-45f9-b060-735d440f7184</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/pharmascience-v-janssen-supreme-court</link><title>Skill, judgment, and the syringe: &#x3C;em&#x3E;Pharmascience v Janssen&#x3C;/em&#x3E; at the Supreme Court</title><description>The Supreme Court of Canada&#x2019;s first patent decision since 2017 provides new guidance on when methods of medical treatment may be patentable.</description><pubDate>Fri, 17 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4f32f008-25ab-46d4-acf8-8402c9aa949c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/ai-transforming-patent-what-businesses-need-to-know</link><title>How AI is transforming patent practice and what your business needs to know</title><description>AI is fundamentally changing how companies invent, file, and protect their intellectual property. The efficiency gains are substantial, but so are the risks.</description><pubDate>Tue, 07 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">30dd4909-bd48-46b9-b845-0b219699d7bc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/patentability-and-the-supreme-court</link><title>Patentability and the Supreme Court: Conundrums surrounding methods of medical treatment</title><description>A highly anticipated Supreme Court of Canada decision could bring new clarity to how Canadian patent law treats methods of medical treatment.</description><pubDate>Thu, 02 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8413bc3d-712d-4d74-85a9-b674ca6575c3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/how-foreign-companies-face-canadian-patent-liability</link><title>Borders not an escape: How foreign companies face Canadian patent liability</title><description>Can a company working outside of Canada infringe a Canadian patent? The answer may surprise you.</description><pubDate>Thu, 02 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7ec849e0-f000-493e-81d3-dd20e5b36b20</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2026/china-2026-trademark-law-revision</link><title>China&#x27;s 2026 Trademark Law revision - 10 changes reshaping brand protection</title><description>China&#x27;s trademark reforms mark a decisive move towards stronger enforcement and real commercial use. For businesses with China exposure, the implications are significant. Read our latest insight to see how to prepare before the changes take effect.</description><pubDate>Wed, 01 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c7efa8e2-f1a5-4597-9e9c-5db1ed9ade41</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/from-neurodata-to-the-no-fakes-act</link><title>From neurodata to the NO FAKES Act: Recognising human contributions in the algorithmic age</title><description>The Nurture Originals, Foster Art, and Keep Entertainment Safe Act of 2026 (the so-called NO FAKES Act) creates a federal intellectual property right in an individual&#x27;s voice and visual likeness. The new development signals that the idea of treating personal human data as a protectable asset is gaining legislative worldwide traction.</description><pubDate>Tue, 02 Jun 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">45deb591-1899-46dd-998f-c2067bb9568b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/new-pmac-model-clauses</link><title>New PMAC model clauses: position your IP agreements for the UPC era</title><description>The UPC&#x2019;s Patent Mediation and Arbitration Centre has published model ADR clauses, completing its framework. The development shows why drafting now matters for enforcement, leverage and outcomes under the UPC for patent&#x2011;critical SEP and FRAND agreements. Find out more.</description><pubDate>Tue, 05 May 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9d09a15f-6caa-4931-b902-0853c1da0123</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/protecting-pharmaceutical-and-medical-device-patents-in-saudi-arabia</link><title>Protecting pharmaceutical and medical device patents in Saudi Arabia: the two-step process every innovator must know</title><description>Saudi Arabia&#x2019;s fast-growing pharma market under Vision 2030 creates real opportunity, but patents alone won&#x2019;t stop generics. Rights holders must also register products and notify the Saudi Food and Drug Authority. Get the protection strategy right before launch.</description><pubDate>Tue, 21 Apr 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">81f30dd0-0812-4d81-83dd-6cffe0037806</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/changing-life-sciences-patent-landscape</link><title>Changing Life Sciences&#x27; patent landscape: It&#x27;s time to talk about efficient licensing</title><description>Life sciences has transformed and the patent landscape is transforming with it. The question the industry must confront is whether the licensing models inherited from an earlier era can still deliver life-saving innovation to patients efficiently, or if something new is required?</description><pubDate>Wed, 25 Mar 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a7ccbae9-9a61-4ece-9bf3-432b7b5ec761</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/legal-side-ip-backed-lending</link><title>Smoke detectors and domino effects: The legal side of IP-backed lending</title><description>IP-backed deals require a different kind of legal architecture than traditional asset-based lending&#x2014;one that reflects the unique characteristics of intangible collateral.</description><pubDate>Tue, 17 Mar 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7155e508-8117-4b2f-9f3a-03aaa1c0866f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2026/fifa-world-cup-trademark-copyright-and-enforcement-considerations</link><title>The 2026 FIFA World Cup&#x26;trade;: Trademark, copyright and enforcement considerations</title><description>This overview explains how Canada&#x2019;s existing IP framework will govern use of FIFA World Cup-related marks, content and marketing, and the practical steps businesses can take to avoid missteps before the tournament begins.</description><pubDate>Tue, 17 Mar 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61c3e65c-9672-4119-85bc-a42ca782b694</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2026/ip-protection-canadian-firms-in-sa</link><title>IP protection for Canadian firms working in South America&#x27;s burgeoning mining sector</title><description>We explore the key considerations for Canadian mining companies to secure, safeguard and manage their IP rights effectively.</description><pubDate>Fri, 06 Feb 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3bfe55d8-a5da-46ae-b830-dafb50891763</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/how-to-assess-patentable-subject-matter-eligibility</link><title>How to assess patentable subject matter eligibility? &#x3C;em&#x3E;Dusome&#x3C;/em&#x3E; continues a trend, SCC to follow</title><description>On the heels of the Supreme Court of Canada&#x2019;s (&#x201C;SCC&#x201D;) hearing in Pharmascience Inc. v. Janssen Inc., et al. regarding subject matter eligibility of methods of medical treatment, the Federal Court issued a subject matter eligibility decision in Dusome v. Canada (Attorney General).</description><pubDate>Tue, 09 Dec 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">600aeb01-6a0a-4982-91a0-a881938e9570</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/uk-asa-rules-unqualified-sustainable-fashion-google-ads-misleading</link><title>UK ASA rules unqualified &#x22;sustainable&#x22; fashion Google ads misleading: what brands must do now</title><description>Are your sustainability claims putting your brand at risk? Find out how recent ASA rulings on &#x22;sustainable&#x22; fashion ads highlight the need for clear, evidence-based messaging, and what all brands should do next.</description><pubDate>Mon, 08 Dec 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d67f081d-9fce-4e99-99e9-6574154a117f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2025/upc-case-win-for-molecular-instruments</link><title>Life Sciences team helps secure success for Molecular Instruments in its patent litigation case in the Unified Patent Court</title><description>Our Life Sciences UPC Litigation team is proud to announce that, together with teams at patent attorney firm Boult and Dutch lawyers at De Brauw Blackstone Westbroek, they have secured a victory for US company Molecular Instruments in a patent litigation case before the Unified Patent Court (UPC), Local Division of the Hague.</description><pubDate>Thu, 04 Dec 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e8dda82d-f745-4f0f-bc8f-5257269f4377</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/chinese-version-of-your-brand</link><title>Do you really need a Chinese version of your brand? Not always&#x2014;and here&#x27;s the smarter alternative IP move</title><description>Do you need to use a Chinese name in branding? Do you need to secure a Chinese brand name in IP? The real question is whether you control your Chinese name.</description><pubDate>Thu, 27 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4aa5ba66-110e-4780-aa6b-7e1e9b3ef680</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/recovering-from-canadas-patent-office-delays</link><title>Recovering from Canada&#x2019;s Patent Office delays with the Patent Term Adjustment Process</title><description>As delays continue with Canada&#x2019;s Patent Office, patentees should consider if Canada&#x2019;s recently introduced Patent Term Adjustment (PTA) system can provide some recovery of otherwise lost patent term. With the Patent Office&#x2019;s service standards now significantly extended, a greater number of patents may qualify for PTA than was the case when PTA was first proposed.</description><pubDate>Wed, 26 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">85cce640-633b-4526-b290-77a93b2d013f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/budget-2025-a-measured-step-up-for-ip-and-innovation</link><title>Budget 2025: A measured step up for intellectual property and innovation</title><description>Budget 2025 introduces new tax incentives, expanded R&#x26;D supports, and major investments in AI and IP programs to strengthen Canada&#x2019;s innovation ecosystem. Overall, the budget aims to make it easier for businesses, especially those developing intellectual property, to innovate, grow, and keep their IP in Canada.</description><pubDate>Wed, 26 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f086c6bb-ff30-4e92-93f0-79f52e416efe</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/retailers-and-brands-face-a-deluge-of-new-challenges-as-cma-intensifies-action-on-drip-pricing</link><title>Retailers and brands face a deluge of new challenges, as CMA intensifies action on drip pricing</title><description>Consumer law dominates compliance in 2025 as the Competition and Markets Authority gains new powers under the Digital Markets Competition and Consumers Act. Actions target fake reviews, price transparency, drip pricing, enforcement against eight businesses, and guidance for 100 others.</description><pubDate>Thu, 20 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ecee06f-f71c-4ca2-a557-6724f462e273</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/femtech-in-canada-guide-to-patents-trademarks-and-ip-strategy</link><title>Femtech in Canada: A practical guide to patents, trademarks and IP strategy</title><description>Femtech&#x2014;technology and innovation focused on women&#x2019;s health&#x2014;has rapidly grown from a niche sector into a central pillar of the modern healthcare economy. As the market expands, strategic intellectual property protection is essential, with patents and trademarks creating defensible moats that safeguard innovation, build consumer trust, and support long-term commercial success.</description><pubDate>Tue, 18 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fc1832d4-d289-4e43-bca8-36d322f2b935</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/stability-ai-defeats-getty-images-in-landmark-copyright-case</link><title>Stability AI defeats Getty Images in landmark copyright case</title><description>Stability AI largely wins Getty Images case, clarifying UK law on AI and copyright. Getty drops main claims but urges government support for content creators. The judgment addresses secondary infringement and AI&#x2019;s legal context.</description><pubDate>Wed, 05 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3dcbb433-a30b-419e-a50f-c7d3454566bb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/hidden-costs-chinese-ip-strategy-wrong</link><title>The hidden costs of getting your Chinese IP strategy wrong</title><description>Here are five of the most common blind spots and how you can avoid them while there&#x2019;s still time.</description><pubDate>Wed, 29 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d0414f76-0fde-40c4-9555-04f3ef6f4f9d</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/uk-court-of-appeal-clarifies-redaction-test-in-optis-v-apple-frand-licensing-dispute</link><title>UK Court of Appeal clarifies redaction test in Optis v Apple FRAND licensing dispute</title><description>The Court of Appeal&#x2019;s latest decision in Optis v Apple clarifies when UK courts will redact confidential information in judgments.</description><pubDate>Thu, 23 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f5781957-cf93-48f5-83d4-10191b02d6bc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/canada-patent-maintenance-fee</link><title>An overview of Canada&#x2019;s patent maintenance fee requirement</title><description>This article provides an overview of a patentee&#x2019;s obligations for Canadian patents and patent applications.</description><pubDate>Wed, 22 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b9e0d681-e67d-4040-84f4-2d6966e2a3d0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/federal-court-of-appeal-clarifies-patent-deadlines</link><title>Federal Court of Appeal clarifies: Everyone involved in patents must take care with deadlines</title><description>Everyone involved in looking after a patent asset has an important role to play in making sure deadlines are met.</description><pubDate>Tue, 07 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8fcef619-d091-4b38-9eb2-dc03840f1329</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/neurodata-in-the-algorithmic-age</link><title>The data beneath the skull: Neurodata in the algorithmic age</title><description>In today&#x27;s algorithmic age, neurodata is no longer just a medical curiosity&#x2014;it has become a critical resource powering personalized medicine, adaptive technologies, and even targeted advertising.</description><pubDate>Wed, 24 Sep 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">24de14c2-584b-4541-9c70-d491952cbfcc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/crispr-patent-landscape</link><title>Fragmented and shifting CRISPR patent landscape: Global proceedings and the patent pool solution</title><description>In this article we summarize the current state of the CRISPR patent landscape, including major disputes and proceedings in key jurisdictions, and more.</description><pubDate>Wed, 24 Sep 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f8b66cdf-2084-4382-ad1d-7ae1564927af</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/your-step-by-step-guide-to-the-uks-important-design-law-consultation</link><title>Your step by step guide to the UK&#x27;s important design law consultation</title><description>The UK government is consulting on reforms to modernise design law, creating a framework tailored for the digital age to better support UK innovation and creativity.</description><pubDate>Thu, 04 Sep 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c57f47ce-ff36-4ebd-9289-6eeb417a736e</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/ai-impact-ip-rights-enforcement</link><title>AI&#x27;s impact on intellectual property rights and enforcement</title><description>AI is both a source of new creative tools and a disruptive force challenging long-standing business models and requiring that we develop new legal standards and norms.</description><pubDate>Thu, 28 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f7b7a39a-4435-4b1e-af7d-2c338058174f</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/safeguarding-trademarks-brands-globalized-market</link><title>Safeguarding trademarks and brands in a globalized market</title><description>As companies push to expand their market reach, safeguarding trademarks and branding becomes a legal necessity and a strategic imperative.</description><pubDate>Mon, 25 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b826b25d-5ee3-4ec0-bb56-459c9066abfb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/ip-ownership-of-the-human-cell-atlas</link><title>Could IP ownership of the Human Cell Atlas turn into a legal headache for researchers?</title><description>Let&#x2019;s unpack the legal implications of this ambitious international project.</description><pubDate>Fri, 15 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ff3deb65-faa6-4c2e-ae13-d078b4d791d3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/cultural-heritage-sustainability-ip-assets</link><title>Cultural heritage and sustainability as intellectual property assets</title><description>The protection and sustainable use of cultural heritage are not only matters of preservation but also of innovation and economic opportunity which has become both an asset and a responsibility.</description><pubDate>Fri, 15 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f18f9925-fe7a-40ae-82d2-0cf61e0b36dc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/can-us-differences-in-patent-prosecution</link><title>Canada and the U.S.: Differences in patent prosecution</title><description>The patent prosecution processes in Canada and the United States have evolved in distinct ways, resulting in notable procedural and substantive differences.</description><pubDate>Tue, 12 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d49e43dc-cc0d-4dc2-b589-69b440721400</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/why-computer-software-is-too-vague-for-trademark-protection-and-why-it-matters</link><title>Why Computer Software is too vague for trademark protection - and why it matters</title><description>In the EU, vague trademark claims like &#x201C;computer software&#x201D; persist despite the Court of Justice of the European Union rulings requiring clarity. Unlike NFTs, software lacks specificity, risking unjust monopolies. Courts now limit such claims, urging applicants to be precise to ensure fair competition.</description><pubDate>Tue, 05 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d12c035a-2ca7-43ce-beb5-e024fa5fc797</guid><link>https://gowlingwlg.com/en-CN/insights-resources/white-papers/2025/annual-patent-case-law-review</link><title>Annual patent case law review</title><description>Our annual patent case law review took place at the start of July 2025. As always, a lot of ground was covered, including in-depth and interactive breakout sessions.</description><pubDate>Thu, 10 Jul 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c064f433-401b-4988-86ba-98505a207139</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/navigating-virtual-patent-marking-in-china</link><title>Navigating virtual patent marking in China: Key compliance insights</title><description>Virtual patent marking in China is complex due to the lack of explicit regulations. Companies must comply with general patent laws, detailing patent categories and numbers in Chinese to ensure proper protection and showcasing of intellectual property.</description><pubDate>Tue, 27 May 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5446c849-ac1b-4317-8b86-7c17844f4e04</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/eu-courts-can-overreach-in-foreign-patent-disputes</link><title>EU courts can overreach in foreign patent disputes: the arm is very long and not confined to infringement</title><description>The Court of Justice of the European Union (CJEU) has ruled in BSH v Electrolux case that courts of EU Member States may hear claims for infringement of foreign patents when seised by domicile. We explore the scope of the reasoning and inconsistencies in the court&#x27;s position.</description><pubDate>Mon, 19 May 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">67a3f663-4f95-4239-a7f1-4360f907c2cb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/ip-assets-guide-to-maximizing-your-portfolio-value</link><title>IP assets: A guide to maximizing your portfolio&#x27;s value</title><description>Intellectual property can be a central asset for your business, but are you maximizing its value? Read on for a guide to understanding the types of IP available in Canada, how your business can best utilize its IP portfolio, and best practices for maximizing IP as a business asset.</description><pubDate>Tue, 06 May 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ef063a2d-545d-4e4a-b2c9-46dc5ec21c28</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/from-ad-law-to-influencers</link><title>From ad law to influencers</title><description>This year&#x27;s INTA Annual Meeting is once again almost upon us. The event is now global benchmark on the IP industry calendar. This year&#x27;s no different with more than 10,000 delegates set to descend on the San Diego Convention Center, for five days of meetings, presentations and networking.</description><pubDate>Tue, 08 Apr 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3e3d4a13-092f-4ddf-9542-be48d2c2146d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/can-you-benefit-from-more-ip-protection</link><title>Can you benefit from more than one form of IP protection?</title><description>In this article, we will discuss three different forms of intellectual property protection in Canada: patents, trademarks and industrial designs.</description><pubDate>Thu, 03 Apr 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">74e4135d-a744-4d7b-9457-f015eaed5814</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/ip-complaints-trade-fairs-china</link><title>How to make intellectual property complaints at trade fairs in China</title><description>Given China&#x27;s vast market size and manufacturing capabilities, large-scale trade fairs are held regularly. Among them, the Canton Fair is one of the largest and most comprehensive in the world.</description><pubDate>Wed, 05 Mar 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">43605e81-4a62-46a1-a8f7-ab55fc45b2f4</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/what-does-the-upcs-dusseldorf-courts-long-arm-mean-for-global-patent-disputes</link><title>What does the UPC&#x27;s long arm mean for global patent disputes?</title><description>We explore the Fujifilm v Kodak case, as the UPC D&#xFC;sseldorf court&#x27;s recent decision to rule on a UK patent, despite the UK not being part of the UPC system, highlights the court&#x27;s jurisdictional reach and its implications for global patent disputes.</description><pubDate>Mon, 24 Feb 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">92cd9fb2-83c5-4abb-9774-ddf437721c96</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/beware-overreach-by-eu-courts-in-foreign-patent-disputes</link><title>Beware overreach by EU courts in foreign patent disputes</title><description>Why should companies be wary of overreach by EU courts in foreign patent disputes? We explore the BSH v Electrolux and Fujifilm v Kodak cases that raise critical questions about the jurisdiction of courts of EU Member States and the UPC.</description><pubDate>Thu, 30 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8398eaf1-0f48-4f0d-a242-5f7563e745a1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/updates-to-canadian-patent-office-practices-in-2025</link><title>Updates to Canadian patent office practices in 2025</title><description>On January 1, 2025, amendments to Canada&#x2019;s Patent Rules came into force, the amendments to Canada&#x2019;s Patent Rules provide a framework for Patent Term Adjustment (PTA).</description><pubDate>Fri, 24 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">27ca84b9-669c-477c-a38f-3cacbf291c6a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2025/beyond-the-standard-patent-term</link><title>Beyond the standard patent term: Canada&#x27;s new patent term adjustment framework</title><description>Beginning January 1, 2025, patent term adjustment is available to protect patent owners from diminished patent terms in Canada.</description><pubDate>Thu, 09 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0210b8d6-0364-471d-b73a-b2c5cae6c59a</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2025/canadian-patent-law-2024-in-review</link><title>Canadian patent law: 2024 in review</title><description>Prepare for the year ahead with our 2024 summary of notable Canadian patent law developments.</description><pubDate>Wed, 08 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">927e6ac1-9fab-4670-866c-109e381b29f2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/transparency-in-litigation-part-three</link><title>Transparency in litigation - transparency before the court of France (part 3)</title><description>In the final article of our three-part series on transparency in litigation, we take a look at transparency issues from the perspective of the courts of France.</description><pubDate>Thu, 25 Jul 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9140b0f7-875a-4201-979e-c1e81e668669</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2024/transparency-in-litigation-part-two</link><title>Transparency in litigation - the courts of England &#x26; Wales (part 2)</title><description>In part two of our series on transparency in litigation, we take a look at the litigation documents that non-parties can obtain in the courts of England and Wales, and the principles underlying document requests.</description><pubDate>Thu, 18 Jul 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0a5db28a-191e-43e3-a118-b9a1a2e95a9a</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2024/transparency-in-litigation</link><title>Transparency in litigation - The Unified Patent Court, the courts of England &#x26; Wales and the French courts (part 1)</title><description>In our three-part series &#x27;Transparency in Litigation&#x27; we take a look at the documents that non-parties can obtain in the Unified Patent Court (part one), the courts of England &#x26; Wales (part two) and the French courts, with a deep dive into the principles underlying requests for documents (part three). Read the first article here.</description><pubDate>Fri, 12 Jul 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7e8d0437-a86f-43c6-923c-d88c7b3a4cd8</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2024/canadas-proposed-patent-term-adjustment-framework</link><title>Canada&#x27;s proposed Patent Term Adjustment framework excludes cases of unreasonable delay by the Patent Office</title><description>Canada&#x27;s Patent Term Adjustment framework, set to take effect in January 2025, promises to address unreasonable delays. However, the proposed regulations may fall short, potentially excluding many patents from receiving adequate term adjustments. Learn more about the implications for patentees and how to voice your concerns.</description><pubDate>Wed, 12 Jun 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">03586957-7cfc-4135-afb0-306e6fda05fa</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/claims-for-patent-infringement-in-alberta</link><title>Alberta patent infringement claims: Two-year and not a six-year limitation period - Seriously? Comments on the recent &#x3C;em&#x3E;JL Energy Transportation&#x3C;/em&#x3E; decision</title><description>Claims for patent infringement in Alberta have only a two-year and not a six-year limitation period as set out in the Patent Act. Seriously? Comments on the recent Alberta Court of Kings Bench decision in JL Energy Transportation Inc. v. Alliance Pipeline Limited Partnership</description><pubDate>Tue, 07 May 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c44e9465-ac98-47b2-b40c-b9b0c820803a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/protecting-canadian-innovation-cleantech-sector</link><title>Protecting Canadian innovation in the Cleantech sector</title><description>Emerging technologies to mitigate environmental impact and even remediate harm that has already occurred, known colloquially as &#x22;cleantech&#x22;, represent a potentially explosive growth opportunity for Canadian innovation.</description><pubDate>Wed, 17 Apr 2024 12:16:00 Z</pubDate></item><item><guid isPermaLink="false">97beb504-500b-4ed0-99f0-559f243a7563</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/trade-secret-tactics-10-strategies-counsel</link><title>Trade secret tactics: 10 strategies for in-house counsel</title><description>Trade secrets play a crucial role in the innovation ecosystem. With the fast pace of innovation often rendering recent technology quickly redundant or even obsolete, relying on patent protection as a sole basis for IP protection may not be appropriate or cost-effective.</description><pubDate>Tue, 26 Mar 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">94622cf9-cf74-4c3d-a046-e8230d639acc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/the-whole-truth-and-nothing-but-the-truth</link><title>The whole truth and nothing but the truth: failing to provide the Judge authorising a saisie with all the relevant information may have serious consequences</title><description>In France, and now before the UPC, a saisie is vital for infringement proof, but strictly regulated. Find out more on how the French Supreme Court laid down obligations that the applicant is required to comply with.</description><pubDate>Wed, 13 Mar 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2124af50-7f52-4f38-b0fe-87f02cb6f0c6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/white-papers/2024/26th-annual-patent-case-law-review</link><title>26th Annual Patent Case Law Review</title><description>We recently held our 26th Annual Patent Case Law Review where our IP lawyers explored key topics, including ongoing developments in the SEP/FRAND case law, a review of UPC cases and what to watch out for in 2024. Explore our Annual Review to find out more.</description><pubDate>Wed, 28 Feb 2024 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">870552e3-3a7a-4661-8084-fea9cf8fc905</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/patentability-of-methods-of-medical-treatment</link><title>Federal Court of Appeal addresses patentability of methods of medical treatment in Canada</title><description>Methods of medical treatment are considered to be an exception to patentable subject matter in Canada. However, it is acknowledged that the exception has no explicit statutory basis, and the supporting jurisprudence is both unclear and contradictory.</description><pubDate>Fri, 23 Feb 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7fbc0f61-11a0-4c20-b9bd-a1be3c60b72a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/cjeu-assessed-compliance-with-eu-law</link><title>Enforcing a provisional measure? Beware the revoked title! CJEU assessed compliance with EU law of strict liability on the basis of a revoked title</title><description>Patent holders, enforcing a provisional measure may expose you to compensate the opposing party in the event of your title getting revoked. It is therefore essential to assess its validity beforehand. Our latest article looks at the decision issued on this matter by the Court of Justice of the European Union on 11 January 2024, its impact in France and Germany, and how this issue is dealt with in Canada, the UK, and China.</description><pubDate>Mon, 12 Feb 2024 11:36:00 Z</pubDate></item><item><guid isPermaLink="false">dba816a0-5042-4bec-82ed-f35d2301ca68</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/patentability-of-ai</link><title>Patentability of AI: Emotional Perception vs the UK IPO</title><description>Recent High Court ruling challenges patent eligibility for AI inventions in the UK. The UK Intellectual Property Office (IPO) is appealing the decision and we take a look at the issues under appeal and the possible consequences for the patentability of AI inventions in the UK.</description><pubDate>Mon, 12 Feb 2024 08:41:00 Z</pubDate></item><item><guid isPermaLink="false">1a46ace0-758c-4f18-a9da-98bedaa2094c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/new-costs-cap-under-the-shorter-trial-scheme</link><title>Will the new costs cap under the Shorter Trial Scheme bring a rise in mid-tier patent litigation?</title><description>For patent and registered design right cases in England and Wales, a new costs cap has been introduced under the Shorter Trials Scheme procedure in the High Court&#x27;s Patents Court. What does the change mean and how will it impact cost recovery? Here we provide a summary of the key points to note and the wider implications of this change in terms of the options for resolving disputes through the courts.</description><pubDate>Wed, 31 Jan 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4e81b151-01c7-4b23-addd-2c7bc9e2b16b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/qatar-patent-applications</link><title>Qatar joins Bahrain and Kuwait as third national patent office to refer patent applications to GCCPO</title><description>In 2023, Qatar became the third country to begin referring the filing and examination of national patent applications to the GCCPO. We provide a summary of what this change means.</description><pubDate>Wed, 24 Jan 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2e5b5cf6-47c7-446a-9964-f9b1bbe2956e</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2024/new-official-fees-for-uae-patent-applications</link><title>New official fees for UAE patent applications effective from January 2024</title><description>A new Ministerial Decision no. 112 of 2023 was issued by the UAE Cabinet in November 2023, which introduces changes to the official fees for UAE patent applications, utility models and industrial design applications, amending the official fees associated with Federal law no. 11 of 2021. The Decision was published in the UAE&#x2019;s Official Gazette on November 15, 2023 and these changes came into effect on January 15, 2024. In this article, we examine those changes and how they affect patent applications filed in the UAE.</description><pubDate>Mon, 22 Jan 2024 08:32:00 Z</pubDate></item><item><guid isPermaLink="false">b4896e33-d00c-4f63-a6f5-84e368615509</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2024/canadian-patent-law-2023-year-in-review</link><title>Canadian patent law: 2023 year in review</title><description>Canadian courts issued many patent-related decisions in 2023. This article summarizes a number of the more notable court decisions.</description><pubDate>Tue, 16 Jan 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">971ddd34-0385-4525-933a-aae9ba0d8878</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2024/patent-applications-must-identify-human-inventors</link><title>Supreme Court rules that patent applications must identify human inventors</title><description>UK Supreme Court rules in Thaler case: a patent application must identify a human inventor. The judgment leaves open for later cases the possibility of patents for inventions made by humans involving the use of AI. Our legal experts explore this topic in our latest insight.</description><pubDate>Wed, 03 Jan 2024 10:54:00 Z</pubDate></item><item><guid isPermaLink="false">2d9340d9-b186-4d04-bf2b-1c0138ca5d7e</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2023/upc-and-the-definition-of-same-parties</link><title>The party season is upon us but what does a party look like to the Unified Patent Court?</title><description>The Unified Patent Court&#x27;s (UPC&#x27;s) decision in a recent case has raised a significant point in relation to the definition of &#x27;same parties&#x27; in the context of parallel revocation and infringement claims. Our IP experts do a deep dive and consider what it means for future claims brought before the UPC.</description><pubDate>Wed, 20 Dec 2023 08:26:00 Z</pubDate></item><item><guid isPermaLink="false">d4ccafe5-7301-4811-b8aa-69f948aa4f7c</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2023/rational-reaction-to-emotional-perception</link><title>Rational reaction to Emotional Perception?</title><description>The UK Intellectual Property Office (IPO) has changed its patenting guidelines for AI inventions. Two recent announcements from the IPO have shed some light on the issue, but questions remain. We take a look at what the IPO said and what it will do.</description><pubDate>Mon, 04 Dec 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ea825db5-8827-49f9-a76f-8a94cf3a20d0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/get-ready-for-patents-for-ai</link><title>Get ready for patents for AI: UK court says Artificial Neural Networks are patentable</title><description>Can you get a patent for AI? The UK High Court has recently issued its first judgment on this topic, Emotional Perception AI v Comptroller-General of Patents [2023] EWHC 2948 (Ch) and has said &#x27;yes&#x27;. In this article, we discuss the eligibility, implications and key takeaways.</description><pubDate>Mon, 27 Nov 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1b19a2a0-7a35-44c4-ad2e-4837f7d97e03</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/trade-secrets-non-competes-ndas</link><title>How not to kill trade secrets with non-competes and NDAs: A global survey</title><description>As one method of safeguarding trade secrets and shielding them from misappropriation, companies often use non-competes and non-disclosure agreements (NDAs). The problem, however, is that such agreements may not always be legally enforceable, thus falling short of delivering the intended protection.</description><pubDate>Fri, 10 Nov 2023 13:50:00 Z</pubDate></item><item><guid isPermaLink="false">cd9de36d-8472-4802-b42d-79130cdd445c</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2023/new-trade-secrets-directive-in-germany</link><title>Trade Secrets Directive - effective business framework</title><description>The Act relating to safeguarding trade secrets (GeschGehG) entered into force on 26 April 2019 and fundamentally changed the protection of trade secrets in Germany. Find out key details about the Act and its wider impact in our article.</description><pubDate>Tue, 24 Oct 2023 14:01:00 Z</pubDate></item><item><guid isPermaLink="false">2d0aa896-96f9-4f3f-862c-52f046b45d7e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/guides/2023/the-legal-500-ip-country-comparative-guide-2023</link><title>The essential guide to intellectual property laws and regulations: understanding IP across multiple jurisdictions</title><description>It is important to understand intellectual property on an international level in order for businesses to protect their brands globally. Take a look at our insights in the latest edition of The Legal 500: Intellectual Property Country Comparative Guide.</description><pubDate>Tue, 24 Oct 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">69c73497-ad60-450b-b162-4e58979a9d1d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/recording-assignments-with-the-epo</link><title>Recording assignments with the EPO &#x2013; time called on using electronic signatures</title><description>The European Patent Office has confirmed its return to requiring handwritten signatures for the assignment of legal documents. Our intellectual property lawyers discuss the background to the decision and what organisations need to consider when making future applications to the EPO.</description><pubDate>Thu, 12 Oct 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d90bcc61-4369-449b-bbf8-6c59de18c56a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/distinction-confidential-information-know-how</link><title>Confidential information, know-how and trade secrets: The importance of definition in valuation</title><description>What is know-how? What is a trade secret? Is all know-how a trade secret? Is all know-how confidential? How does this fit into the larger proprietary information framework that we refer to as intellectual property?</description><pubDate>Tue, 12 Sep 2023 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">2e0c023d-8e9b-4d96-aede-ddf6530d47ca</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/how-reula-will-impact-ip-law-in-the-uk</link><title>REULA&#x27;s end of supremacy of EU law will impact IP law in the UK from 2024, explains High Court</title><description>The Retained EU Law (Revocation and Reform) Act 2023 (REULA) is now on the statute books. As has been reported widely, it revokes, at the end of 2023, a long list of retained direct and subordinate legislation derived from EU legislation. This will impact intellectual property law in the UK as the UK separates further from the EU.</description><pubDate>Mon, 04 Sep 2023 11:13:00 Z</pubDate></item><item><guid isPermaLink="false">8e6dd9a7-5908-462c-a1dc-c1df9545748a</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2023/prior-art-and-patentability-canada</link><title>Prior art and patentability: Canada</title><description>This Note provides information useful for patent counsel with responsibility for a global patent portfolio to help them understand the legal analytical framework in Canada for determining the potential patentability of an invention, which a patent applicant may seek to cover.</description><pubDate>Tue, 22 Aug 2023 19:37:00 Z</pubDate></item><item><guid isPermaLink="false">1f6c2940-038a-497a-82a2-ff7263dc21a0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/federal-court-of-appeal-subject-matter-eligibility</link><title>Canadian Federal Court of Appeal on subject matter eligibility: Try, try again</title><description>Last summer, the Federal Court proposed a new framework when considering an appeal that arose from the Canadian Intellectual Property Office (CIPO)&#x27;s rejection of two Canadian patent applications for being directed at ineligible subject matter.</description><pubDate>Thu, 10 Aug 2023 21:29:00 Z</pubDate></item><item><guid isPermaLink="false">e562e750-1d82-4f19-b7e3-1dc5deb66449</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/significant-cipo-trademark-fee-increase</link><title>Significant CIPO trademark fee increase effective January 1, 2024: the time is right to file new applications!</title><description>Effective January 1, 2024, CIPO will increase most trademark fees across the board by 25 per cent, including trademark application fees per class.</description><pubDate>Thu, 06 Jul 2023 14:51:00 Z</pubDate></item><item><guid isPermaLink="false">23381152-bc35-4539-8332-958847c61358</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/canadian-patent-fees-to-significantly-increase</link><title>Canadian patent fees to significantly increase in 2024: how to avoid the increase and save money</title><description>Under recent legislative amendments to the Canadian Patent Rules, the tariff of official fees payable to the Canadian Patent Office in respect of patent applications and issued patents will increase starting January 1, 2024.</description><pubDate>Thu, 06 Jul 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7ec68e1c-dc7f-4f86-a95a-d0ad9183f53b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2023/unified-patent-court-system-in-europe</link><title>Lifecycle of a smart idea | Are you prepared for the new unified patent court system in Europe?</title><description>Our panellists examine the position of current and future patents in Europe, consider new options, and provide detailed, practical answers to important questions.</description><pubDate>Fri, 02 Jun 2023 15:18:00 Z</pubDate></item><item><guid isPermaLink="false">f5bf2384-3dc1-4dce-94c6-e4ebad3ef4c8</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2023/the-pmprb-controversy-and-suspense</link><title>The PMPRB: Controversy and suspense</title><description>The Patented Medicines Prices Review Board (PMPRB) has seemingly courted controversy over the last 6 years. Through its pricing decisions and proposed regulatory amendments, the PMPRB took steps to expand its jurisdiction beyond its statutory domain.</description><pubDate>Tue, 25 Apr 2023 16:11:00 Z</pubDate></item><item><guid isPermaLink="false">c20c0060-d738-443c-a884-a39b6e18e9ec</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/strategically-using-chinese-utility-models</link><title>Strategically using Chinese utility models</title><description>Despite recent headlines emphasizing &#x22;nearshoring&#x22; and long-term demographic issues, China remains a manufacturing powerhouse and a large market. In view of this, non-Chinese companies commonly partner with Chinese companies to manufacture products for worldwide distribution and to gain access to the Chinese market.</description><pubDate>Tue, 25 Apr 2023 16:09:00 Z</pubDate></item><item><guid isPermaLink="false">c85d476b-22bb-494f-96ae-88dbb7df58e8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/reports/2023/are-you-prepared-for-the-unitary-patent-system</link><title>The Unitary Patent System - Expectations, challenges, preparation</title><description>In 2015, Gowling WLG conducted an online survey of patent attorneys and solicitors in private practice and in-house roles, seeking their views on the introduction of the Unified Patent Court (UPC) and Unitary Patent (UP). The results then showed a strong degree of pessimism as to the necessity of the system and whether it would be a success.</description><pubDate>Mon, 24 Apr 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">439fe93f-afe3-400d-9c4a-4c24ca186bdb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2023/patent-infringement-remedies-around-the-world</link><title>Lifecycle of a smart idea | Remedies for patent infringement around the world</title><description>Our international panel of intellectual property (IP) professionals have hosted an informative session focusing on the remedies available for patent infringement in Canada, the US, the UK, France, China, as well as under the new Unified Patent Court.</description><pubDate>Wed, 05 Apr 2023 13:26:00 Z</pubDate></item><item><guid isPermaLink="false">e18cc69c-6986-4c88-8fa5-33521326149d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2023/managing-software-and-ai-inventions-as-ip</link><title>Managing software and AI inventions as IP</title><description>Although AI has been around for some time, the rapid development and widespread application of AI technology over the last 10 years has resulted in a global AI &#x27;patent boom&#x27;.</description><pubDate>Tue, 04 Apr 2023 07:55:00 Z</pubDate></item><item><guid isPermaLink="false">a2e7dc29-f02d-43a7-84c9-0c282686c39f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/opting-out-of-the-upc</link><title>Opting out of the Unified Patent Court? Our guide for patent owners</title><description>In this article, our IP experts outline the opt-out option for owners of European Patents (EPs), Supplementary Protection Certificates (SPCs) and patent applications, how opt-outs work, the implications and how to opt back in at a later date.</description><pubDate>Wed, 15 Mar 2023 08:17:00 Z</pubDate></item><item><guid isPermaLink="false">21ffbc36-04e0-45be-a8ac-83ca03c21b8e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/what-will-litigation-in-front-of-the-upc-look-like</link><title>What will litigation in front of the Unified Patent Court look like?</title><description>In this article, our IP lawyers summarise the key procedures and tools available in the UPC and set out a comparison with the rules and procedures in Germany, France and the UK.</description><pubDate>Wed, 15 Mar 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4d525fce-82a5-4ea8-8b69-43eff60585a0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2023/court-of-appeal-win-for-interdigital</link><title>Intellectual property team secures another Court of Appeal win for InterDigital in Lenovo dispute</title><description>The Intellectual Property team has secured another Court of Appeal win in 2023 for InterDigital, one of the world&#x27;s largest mobile and video technology research and development companies, in its litigation against Lenovo.</description><pubDate>Thu, 16 Feb 2023 09:24:00 Z</pubDate></item><item><guid isPermaLink="false">c8460c03-3ae6-4131-aac8-820fe1937c1b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2022/influencers-in-toronto</link><title>Influencers in Toronto</title><description>In this series, you will meet a number of practitioners in our Toronto office who have helped their clients overcome a variety of complex legal obstacles.</description><pubDate>Thu, 09 Feb 2023 18:59:00 Z</pubDate></item><item><guid isPermaLink="false">aee0185d-8588-42b1-a598-507d28f009c9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/white-papers/2023/annual-patent-review-paper-2022</link><title>Annual patent review paper 2022: A Slightly Slippery Slope</title><description>Our annual review of UK patent judgments in 2022 comprehensively reviews the patent decisions of the courts of England and Wales, with comment and opinion on the big issues arising.</description><pubDate>Wed, 08 Feb 2023 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">e8aff526-5906-47e8-b995-53a6e7c039e8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2023/uk-court-of-appeal-win-for-interdigital</link><title>Intellectual Property team secures UK Court of Appeal win for InterDigital</title><description>The Intellectual Property team has secured another win for InterDigital, one of the world&#x27;s largest mobile and video technology research and development companies, in its litigation against Lenovo. The UK Court of Appeal has upheld the lower court decision which held that Lenovo is infringing a valid and essential InterDigital cellular patent.</description><pubDate>Fri, 03 Feb 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2ee8334c-f6b9-451d-a2cc-9271db027c3d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/uk-and-uae-approach-to-patent-enforcement</link><title>Enforcing UAE patent rights: A comparative overview of the UK and UAE approach</title><description>In this article we look at some of the procedural differences between patent litigation in the UK and the UAE. First, we remind readers of the process for obtaining patent rights and utility models in the UAE.</description><pubDate>Mon, 30 Jan 2023 08:44:00 Z</pubDate></item><item><guid isPermaLink="false">1adeaef6-fd0c-4d9b-ad6f-85bf5b80a959</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2023/canadian-patent-law-2022-year-in-review</link><title>Canadian patent law: 2022 year in review</title><description>Canadian Courts issued many patent-related decisions in 2022. This article summarizes a number of the more notable court decisions, as well as other patent-related developments from 2022.</description><pubDate>Thu, 12 Jan 2023 17:15:00 Z</pubDate></item><item><guid isPermaLink="false">3efff9fb-9848-4c72-a7ce-769ed5243309</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/gcc-patent-office-to-handle-new-applications</link><title>The GCC Patent Office to handle new applications from January 2023</title><description>In the latest Official Gazette issued by the GCC Patent Office, it was confirmed that from 1st January 2023 the GCC Patent Office will begin to handle national patent applications on behalf of the requesting GCC country. So far, two countries have confirmed to be referring their national applications from January 2023 to the GCC Patent Office to handle formality and substantive examination.</description><pubDate>Tue, 20 Dec 2022 09:14:00 Z</pubDate></item><item><guid isPermaLink="false">ab8edc47-3ac7-4188-9964-a2a4e4801540</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/changes-to-canadian-patent-rules</link><title>Recent changes to the Canadian &#x3C;em&#x3E;Patent Rules&#x3C;/em&#x3E; and considerations for applicants</title><description>The new Patent Rules have now come into force, and will apply to all applications for which a request for examination was made on or after October 3, 2022.</description><pubDate>Thu, 24 Nov 2022 18:59:00 Z</pubDate></item><item><guid isPermaLink="false">077ba475-634d-4ca6-ae01-6fbc6ccaff23</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/scc-upholds-usd644-million-award-for-patent-infringement</link><title>Supreme Court of Canada upholds $644-million award for patent infringement; provides fresh guidance for conducting an accounting of profits</title><description>In an 8 to 1 decision (2022 SCC 43), the Supreme Court of Canada has upheld the largest monetary award ever by a Canadian court for patent infringement: $644 million in favour of Dow Chemical for Nova Chemicals&#x27; infringement of Dow&#x27;s patent. In so doing, the Supreme Court provided fresh guidance and a preferred framework for conducting an accounting of profits.</description><pubDate>Fri, 18 Nov 2022 20:30:00 Z</pubDate></item><item><guid isPermaLink="false">759e3803-8338-44bc-ab49-b4b29ea25707</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/key-trademark-considerations-m-a-transactions</link><title>Trademarks and brands: Key considerations for M&#x26;A transactions</title><description>It is crucial that a buyer or seller of a company does not overlook trademarks and brands in business acquisitions, or any red flags that might get revealed. Luckily, there are solutions to overcome such complexities.</description><pubDate>Fri, 18 Nov 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aabf5b35-01e6-4d68-b6a8-54ae907e380c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/international-licensors-licensees-business-china</link><title>Legal considerations for international licensors and licensees conducting business in China</title><description>Foreign licensors and licensees need to be aware of the key consequences of doing business in China. Taking proper account of these will also help them weigh up whether to follow through with litigation or to go down the route of arbitration in the event of a dispute.</description><pubDate>Thu, 17 Nov 2022 13:31:00 Z</pubDate></item><item><guid isPermaLink="false">e78490e3-c7da-4a77-ae2a-2c9f1ce5cd9f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/key-to-success-technology-transfer-tips-ip-manager</link><title>The key to success: Technology transfer tips for university and research IP managers</title><description>The role of the technology transfer office is crucial for getting products to market. Implementing well thought-out strategies will allow these to flourish in your organisation.</description><pubDate>Tue, 15 Nov 2022 14:38:00 Z</pubDate></item><item><guid isPermaLink="false">637e9ee9-b289-4535-8ce2-39630b8dbc4f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/guides/2022/protecting-your-inventions-in-china-patent-guide</link><title>Protecting your inventions in China: The China Patent Law Guide</title><description>Our China Patent Law Guide serves as an easy-to-read, searchable and continuously updated resource for IP practitioners who must learn to negotiate this legal landscape strategically.</description><pubDate>Thu, 10 Nov 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6a93963f-02da-4467-9aa6-5c161fed0dbe</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2022/crocs-successfully-asserts-industrial-design</link><title>Crocs successfully asserts industrial design, awarded infringer&#x27;s profits</title><description>Crocs has successfully asserted an industrial design that covers its MAMMOTH line of clogs, establishing infringement by Double Diamond&#x27;s knock-off Fleece Dawgs products.</description><pubDate>Thu, 27 Oct 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">befe3712-2c2c-4b91-b2eb-f6094f4551b9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/how-far-can-the-upc-reach</link><title>Just how far can the UPC reach?</title><description>The UPC has recently suggested an amendment to the UPC Rules of Procedure. In this insight, our IP team discusses these changes and their implications.</description><pubDate>Fri, 21 Oct 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8930a02d-0d4a-4364-8faf-d09856b674bc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2022/miovision-acquires-rapid-flow-technologies</link><title>Miovision acquires Rapid Flow Technologies</title><description>On October 11, 2022, Miovision Technologies Inc. announced that it had acquired Pittsburgh-based Rapid Flow Technologies.</description><pubDate>Tue, 11 Oct 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b8d0265b-cd24-4176-927b-a87ff28922ea</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/false-patent-marking-in-china</link><title>False patent marking in China &#x2013; How the courts are determining damages</title><description>In China, false patent marking is becoming more prevalent, so it is interesting that in June 2022, the Chinese Supreme People&#x27;s Court heard an appeal case that shed light on how damages should be determined in such cases. In this article, we explore the outcome of that case and how the approach to determining damages differs to that for patent infringement cases.</description><pubDate>Thu, 29 Sep 2022 10:34:00 Z</pubDate></item><item><guid isPermaLink="false">aa3cf212-bbaf-4dc2-8e27-832c1be97f55</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/the-cost-challenge</link><title>The Cost Challenge: How can UK courts remain competitive for patent litigation in a new era?</title><description>Gordon Harris&#x27; insightful article &#x27;The Cost Challenge: How can UK courts remain competitive for patent litigation in a new era&#x27; explores the success of costs reforms instigated in the last 30 years in England and Wales.</description><pubDate>Tue, 13 Sep 2022 13:11:00 Z</pubDate></item><item><guid isPermaLink="false">85c48bcb-7ff2-46a0-b25f-4fe91cb05d7b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/market-it-or-lose-it-a-cautionary-tale</link><title>Market it or lose it: A cautionary tale for innovators</title><description>In AbbVie Corporation v Canada (Health), 2022 FC 1209, Justice Fothergill of the Federal Court upheld the Minister of Health&#x27;s finding that innovator pharmaceutical companies must actively market their drugs in Canada in order to benefit from Canada&#x27;s patent linkage regime.</description><pubDate>Tue, 30 Aug 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5327db39-c471-4ed0-95cb-773430fec09f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/patent-ownership-when-your-r-d-staff-depart</link><title>Patent ownership when your R&#x26;D staff depart</title><description>The success of IP transactions is rooted in the IP asset in play. But what if your company suddenly discovers it no longer actually owns the right, despite it being created by employees?</description><pubDate>Tue, 02 Aug 2022 14:38:00 Z</pubDate></item><item><guid isPermaLink="false">be731487-11b7-4f80-a27f-29565a2f65a5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/be-proactive-about-ip-ownership</link><title>Be proactive about IP ownership</title><description>For patented or patentable inventions, it is best practice to execute an agreement for a patent assignment that compensates the employee for the invention separately from their usual employment compensation.</description><pubDate>Tue, 02 Aug 2022 14:36:00 Z</pubDate></item><item><guid isPermaLink="false">f0441588-2136-4be5-9a1f-899e26501fb5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2022/going-global-with-your-patents-for-smes</link><title>Going global with your patents: Risks and opportunities for Canadian SMEs</title><description>Patent rights are the lifeblood of the global innovation economy and one of the most valuable corporate assets a growing business can have. With the right strategy, IP assets can be levered to secure finance for company growth, as well as attract and solidify partnerships.</description><pubDate>Wed, 20 Jul 2022 14:37:00 Z</pubDate></item><item><guid isPermaLink="false">aceff640-d48b-4918-ac5e-74b8fc7be602</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/how-does-the-upc-work</link><title>How does the Unified Patent Court work?</title><description>Our IP team sets out everything you need to know about the UPC, its structure and how it works.</description><pubDate>Mon, 18 Jul 2022 12:49:00 Z</pubDate></item><item><guid isPermaLink="false">d56fef2c-00d8-48eb-ad8b-579d4bc991d1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/new-export-control-provisions-for-uae-patents</link><title>UAE Patent Regulations introduce new &#x27;export control&#x27; type provisions for UAE patent applications with security and military applications</title><description>What do the new restrictions to the Implementing Regulations for the UAE Patent Law mean for companies and research organisations operating in the military defence or national security sectors? We discuss the new provisions for UAE patents with security or military application.</description><pubDate>Thu, 30 Jun 2022 13:21:00 Z</pubDate></item><item><guid isPermaLink="false">30f91ad1-33e9-4654-a835-152e4b136ce5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/a-small-screen-patent-infringement-case</link><title>A small-screen patent infringement case with a large royalty payment on the line</title><description>In Rovi v Videotron, 2022 FC 874, Rovi alleged infringement by Videotron of four patents with respect to interactive television program guides. Rovi sought an accounting of Videotron&#x27;s profits or, in the alternative, damages in the form of a royalty.</description><pubDate>Wed, 29 Jun 2022 16:43:00 Z</pubDate></item><item><guid isPermaLink="false">93790faf-6470-4a3b-b966-db39fa518ea9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/eligibility-test-computer-implemented-inventions</link><title>Practically Permissible? Canadian Federal Court adopts new subject matter eligibility test in the context of computer-implemented inventions</title><description>For the third time in a little over a decade, the Canadian Federal Court has disagreed with how the Canadian Intellectual Property Office determines eligibility of computer-implemented inventions.</description><pubDate>Mon, 20 Jun 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7295a317-3fdc-4d44-bd6d-105a3205cde0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/middle-east-based-patent-filers-are-you-prepared</link><title>Middle East-based patent filers - the Unified Patent Court will open doors early 2023, are you prepared?</title><description>In this article we summarise everything Middle East-based European patent holders need to know about the major changes to the European patent system.</description><pubDate>Wed, 01 Jun 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8c1b84de-cfe3-41dc-9263-5dd58eb2acc1</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/patents-as-legal-firepower-evolusion-concepts</link><title>Patents as Legal Firepower: Evolusion Concepts, Inc. v HOC Events, Inc., 2022 WL 128577</title><description>Firearms with detachable magazines allow the user to quickly replace the magazine when it is depleted without disassembling the firearm action. In many shooting sports where scores are based on a combination of speed and accuracy, the ability to quickly replace an empty magazine can have a significant impact on a competitor&#x27;s ranking.</description><pubDate>Thu, 28 Apr 2022 15:43:00 Z</pubDate></item><item><guid isPermaLink="false">c9483e0c-552d-40d4-8d98-710be0ce8a3d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/map-of-the-unified-patent-court-upc</link><title>Map of the Unified Patent Court (UPC)</title><description>The introduction of a Unitary Patent system provides protection across all participating EU member states, use our interactive map to understand the current status of each jurisdiction.</description><pubDate>Thu, 21 Apr 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9929fe24-b1ff-44ea-9034-fdb6ad78b6ed</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/guide-to-the-unified-patent-court-upc</link><title>Guide to the Unified Patent Court (UPC)</title><description>Anyone who deals with patents in the European market needs to understand how the Unified Patent Court (UPC) system will work and prepare for its arrival. Visit our UPC and Unitary Patent hub for an easy-to-follow guide and FAQs.</description><pubDate>Wed, 20 Apr 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d72ab2fe-0eee-4df7-b173-72b6d611b32b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/ip-transactions-in-china-and-canada</link><title>IP transactions in life sciences: data transfer, sharing and exclusivity in China and Canada</title><description>Data and technology transfer play a vital role in many IP transactions, especially in life sciences. That said, very little time is usually spent on the details of operational provisions in this area, as well as on territorial legal/regulatory provisions concerning data sharing among regulatory authorities.</description><pubDate>Fri, 25 Mar 2022 17:33:00 Z</pubDate></item><item><guid isPermaLink="false">ca66a038-f24a-4e1c-83bd-f74a4eaed385</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/accelerate-patent-prosecution-in-asean-region</link><title>How to accelerate patent prosecution in the Asean region</title><description>How can businesses accelerate patent prosecution in the ASEAN Region? In this article, our Singapore IP experts discuss the main international, regional, and national acceleration programmes in Association of Southeast Asian Nations (ASEAN) countries</description><pubDate>Thu, 24 Mar 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0ccdfffb-fc2e-4231-a79a-b936ceaad387</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/technology-transfer-leads-to-innovation-success</link><title>Why technology transfer leads to innovation success</title><description>For numerous innovations we use today, the journey began in the research labs of universities or research organisations. In fact, the science and knowledge generated in publicly funded research labs has been the foundation of many revolutionary innovations on the market today.</description><pubDate>Thu, 17 Mar 2022 12:49:00 Z</pubDate></item><item><guid isPermaLink="false">00a58eff-319b-466e-93a2-d155873aac8d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/exhaustion-of-patent-and-trademark-rights</link><title>Exhaustion of patent and trademark rights in Canada</title><description>If your business is involved in or interested in the movement into Canada of goods protected by an intellectual property right, then you need to understand what the law on &#x27;exhaustion&#x27; of the relevant right is in Canada.</description><pubDate>Wed, 09 Mar 2022 14:54:00 Z</pubDate></item><item><guid isPermaLink="false">50b15b00-b4cb-4258-b84d-8d171b324d99</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/exhaustion-of-patent-and-trademarks-in-france</link><title>Exhaustion of patent and trademark rights in France</title><description>What is the law on &#x27;exhaustion&#x27; of intellectual property in France and the EU? Our global IP experts explore the development of the regime governing exhaustion in the country for patents and trademarks, and what this means for businesses.</description><pubDate>Wed, 09 Mar 2022 14:52:00 Z</pubDate></item><item><guid isPermaLink="false">5a7689a4-a4e4-4b6d-8ce6-727a356593a3</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/exhaustion-of-patent-trademark-rights-in-the-uk</link><title>Exhaustion of patent and trademark rights in the United Kingdom</title><description>Our global IP experts explore the UK&#x27;s &#x27;exhaustion&#x27; regime for patents and trademarks, how this governs the import of genuine IP-protected goods, and what it means for businesses.</description><pubDate>Wed, 09 Mar 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4248d321-5fec-41b1-a6af-ad73b82c001f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/canadian-patent-law-2021-year-in-review</link><title>Canadian patent law: 2021 year in review</title><description>Last year was a busy one for the Federal Courts and included a number of developments in Canadian patent law. This article summarizes notable court decisions on patent law and practice in Canada from 2021.</description><pubDate>Wed, 02 Mar 2022 14:20:00 Z</pubDate></item><item><guid isPermaLink="false">31facd6e-06c9-46b4-8c50-d00db567e7c6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/podcasts/2022/protecting-cleantech-inventions-in-canada</link><title>Protecting cleantech inventions in Canada</title><description>How do you commercialize an idea in Canada&#x27;s cleantech sector? Step one: protect it.</description><pubDate>Wed, 16 Feb 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0a7f34a8-3774-4eec-b074-40b98eb380c9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/white-papers/2022/annual-review-of-uk-patent-judgments-2021</link><title>Annual review of UK patent judgments &#x2013; 2021</title><description>Read our complete guide to the key patent case law emerging from the courts in the UK in 2021, in which partner Gordon Harris takes you through a blockbuster year of patent case law, noting trends and points to watch out for.</description><pubDate>Fri, 11 Feb 2022 11:08:00 Z</pubDate></item><item><guid isPermaLink="false">9686d33f-16e2-4b6d-adf3-98bc9f35eae2</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/protecting-innovation-in-fintech</link><title>How to protect innovation in FinTech - The role of trade secrets</title><description>We take a look at a recent example of an innovator&#x27;s rights in FinTech apparently being under threat by a departing employee, before discussing how to protect your trade secrets.</description><pubDate>Wed, 09 Feb 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c7f8db40-5ff5-4c74-ab81-d2395e8d7d86</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/patent-infringement-summary-trend-continues</link><title>Patent infringement summary judgment trend continues</title><description>The Federal Court&#x27;s decision in Kobold v NCS, 2021 FC 1437 presents a few firsts. Most importantly, it is the first time the Federal Court has been asked to interpret and apply the new &#x27;prior use&#x27; defence in section 56 of the Patent Act.</description><pubDate>Tue, 08 Feb 2022 14:48:00 Z</pubDate></item><item><guid isPermaLink="false">9c2b8ebd-d6d5-463d-b6b5-5427e28c36f0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/what-to-expect-in-2022-pending-patent-decisions</link><title>What to expect in 2022: pending patent decisions and upcoming trials/appeals in the federal courts</title><description>Just one month into 2022, the Federal Courts have nearly cleared the docket of pending patent decisions. The Rovi Guides decisions are still pending from the Federal Court, and the Court of Appeal has one patent decision pending.</description><pubDate>Tue, 08 Feb 2022 14:42:00 Z</pubDate></item><item><guid isPermaLink="false">ce265dfc-bce1-4adf-8fbd-338ab10beed8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/new-uae-patent-law-what-do-you-need-to-know</link><title>New UAE Patent Law: What do you need to know?</title><description>The UAE has issued Federal Law no. 11 of 2021 concerning the regulation and protection of Industrial Property Rights. In this article, we review the key changes in the Law and their implications.</description><pubDate>Thu, 03 Feb 2022 08:53:00 Z</pubDate></item><item><guid isPermaLink="false">e869e1ff-c63c-4c1b-a25b-76f199b8145b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/gcc-patent-office-new-working-model-confirmed</link><title>Implementing Regulations confirm the GCC patent office&#x27;s new working model</title><description>The Implementing Regulations for the GCC Patent Office&#x27;s new working model were issued in November 2021. We take you through the key takeaways for the new Regulations.</description><pubDate>Tue, 01 Feb 2022 10:20:00 Z</pubDate></item><item><guid isPermaLink="false">baf9e12d-ae20-42e9-88b9-a5f724e326fa</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2022/licensing-for-global-companies-in-china</link><title>Licensing considerations for global companies in China</title><description>A common strategy to deal with patent infringement claims is to negotiate to obtain a patent licence. However, there are particular issues other than the common issues one may experience in other jurisdictions, this article raises some red flag issues for global companies signing licensing agreements in China.</description><pubDate>Fri, 28 Jan 2022 20:53:00 Z</pubDate></item><item><guid isPermaLink="false">0e920527-4e8b-45da-86bc-156183d2f3a6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/case-of-xenobots-part-i-patenting-living-machines</link><title>The curious case of xenobots part 1 &#x2013; Patenting of living machines</title><description>Since the 1970s when genetically-engineered bacterium capable of breaking down crude oil was held to be patentable subject-matter, much attention has been paid to the patenting of living inventions.</description><pubDate>Wed, 26 Jan 2022 13:51:00 Z</pubDate></item><item><guid isPermaLink="false">12475dc8-12aa-4d4b-81cc-6788d0ac41a5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/invega-sustenna-patent-is-infringed</link><title>Summary Trial under the &#x3C;em&#x3E;PM(NOC) Regulations&#x3C;/em&#x3E;: Janssen&#x27;s INVEGA SUSTENNA patent is infringed</title><description>This new decision is the first summary trial decision in a pharma case under the Patented Medicines (Notice of Compliance) Regulations.</description><pubDate>Mon, 24 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ebfbd72c-756a-456f-8077-570405fe0d06</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/upcoming-changes-to-the-european-patent-system</link><title>Upcoming changes to the European patent system: The Unitary Patent and Unified Patent Court</title><description>The European patent system is undergoing major changes that will impact all patent filers in Europe.&#xA0; After years of legal and political hurdles, the long-awaited Unitary Patent and Unified Patent Court should soon see the light of day, and possibly by the end of 2022.</description><pubDate>Tue, 18 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b8fa5ce4-1bf2-4bc2-8481-af39bbaca2a9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2022/google-wins-patent-infringement-for-google-ads</link><title>Google wins patent infringement litigation aimed at Google ads</title><description>The Federal Court of Canada has dismissed a long-running patent infringement case against Google Canada Corporation, Google LLC and Alphabet Inc.</description><pubDate>Thu, 13 Jan 2022 20:56:00 Z</pubDate></item><item><guid isPermaLink="false">812b72a4-7d5b-4ca3-b78e-abd44cb8e601</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/enforcement-related-consideration-patent-valuation</link><title>Enforcement-related considerations for patent valuation: The perspective from Canada</title><description>Organisations acquire patent rights in a number of different ways and for a number of different reasons.</description><pubDate>Thu, 13 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1da81553-aece-46df-ab11-f2607fe0d354</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2022/talan-to-acquire-createch</link><title>Talan to acquire Createch in cross-border transaction</title><description>On January 13, 2022, Talan announced that it had entered into an agreement to acquire Createch, with the acquisition expected to close in Q1.</description><pubDate>Thu, 13 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c3edcb1a-3b7a-4cb6-988b-244474b04853</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2022/epo-rejects-patent-application-in-dabus-case</link><title>EPO rejects patent application identifying AI system DABUS as inventor</title><description>In the latest on the DABUS case, the European Patent Office has confirmed the decision of the Receiving Section that a patent application cannot succeed where the designated inventor is not a person, but an AI machine.</description><pubDate>Fri, 07 Jan 2022 09:34:00 Z</pubDate></item><item><guid isPermaLink="false">91c931b5-5fb4-4a95-bf39-7c875eadb158</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/upcoming-changes-to-the-canadian-patent-rules</link><title>Upcoming changes to the Canadian &#x3C;em&#x3E;Patent Rules&#x3C;/em&#x3E;</title><description>As Canada moves to implement a patent term adjustment regime as required by the Canada-United States-Mexico Agreement, there will be changes to the Canadian Patent Rules in an attempt to streamline the examination process with a view to avoiding unnecessary delays.</description><pubDate>Thu, 16 Dec 2021 15:09:00 Z</pubDate></item><item><guid isPermaLink="false">90547118-5dcb-4612-90a1-eeb3f9d9acda</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/cleantech-protection-of-intellectual-property</link><title>Cleantech and the protection of intellectual property</title><description>Roch Ripley, a Gowling WLG partner who leads the firm&#x27;s Intellectual Property Group in Vancouver, recently connected with Jeanette Jackson, CEO of the cleantech ecosystem accelerator Foresight, for an engaging and illuminating podcast on this very subject.</description><pubDate>Wed, 15 Dec 2021 21:01:00 Z</pubDate></item><item><guid isPermaLink="false">60dec7ed-93b7-4931-a2d8-2fd965ecc103</guid><link>https://gowlingwlg.com/en-CN/insights-resources/reports/2021/patent-litigation-trends-the-future-of-biologics</link><title>Patent litigation trends: the future of biologics?</title><description>As the biologics market continues to expand, patent litigation is also increasing. Our report examines what we&#x27;re likely to see in the next few years in this industry and how litigators can prepare for the increase of innovation in next generation therapies.</description><pubDate>Mon, 06 Dec 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8fa63d9b-6a12-4380-b222-540b53eb1945</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/exhaustion-of-intellectual-property-rights</link><title>Exhaustion of intellectual property rights in Singapore</title><description>In Singapore, the question of whether an intellectual property right (such as a registered trademark or a patent) can be enforced by way of an infringement action against the sale of genuine goods placed on the market in another country and then parallel imported into Singapore, is governed by an area of law called &#x27;exhaustion&#x27;.</description><pubDate>Thu, 18 Nov 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">645e05f8-3594-466b-a9f6-295cac02177a</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/exhaustion-in-the-uk-ip-law-under-review</link><title>Exhaustion in the UK: IP law under review</title><description>How might UK law on exhaustion of IP rights change soon? And what does this mean for parallel imports into post #Brexit Britain? Our IP team detail the key points to note.</description><pubDate>Fri, 12 Nov 2021 13:42:00 Z</pubDate></item><item><guid isPermaLink="false">c1057bef-4a85-478d-b936-537cfd214145</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/role-of-ip-strategy-in-drug-development</link><title>From discovery to market: The role of IP strategy in drug development</title><description>With vaccine brand names still very much top-of-mind for Canadians, Gowling WLG&#x27;s own Brian Kingwell and Dr. Sonia Ziesche took part in a recent online panel discussion surrounding drug development and intellectual property.</description><pubDate>Mon, 08 Nov 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b36fb33a-88df-49f4-b274-6ad9ebbb1364</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/exclusions-in-russian-patent-law</link><title>How to successfully navigate exclusions in Russian patent law</title><description>The question of what constitutes an invention does not have a universally accepted definition, but according to the Russian Patent Office, there are a number of objects that are excluded from patentability. To succeed in their application, candidates are advised to avoid terms that unambiguously exclude inventions from consideration as patents.</description><pubDate>Fri, 05 Nov 2021 16:45:00 Z</pubDate></item><item><guid isPermaLink="false">f27e0dc0-e690-49ac-8866-89225b72f85c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/strategies-to-protect-your-intellectual-property</link><title>Strategies to protect your Intellectual Property</title><description>Nelson Godfrey, partner and head of the IP litigation department of Gowling WLG&#x27;s Vancouver office, took part in a recent online panel discussion on how companies can survive and thrive when it comes to safeguarding IP.</description><pubDate>Tue, 02 Nov 2021 18:48:00 Z</pubDate></item><item><guid isPermaLink="false">d760094a-13e8-4679-9bc2-1838e776decc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/eurasian-patent-organisation-register</link><title>How to register on the Eurasian Patent Organisation&#x27;s new Pharmaceutical Register</title><description>The Eurasian Patent Organisation (EAPO) launched its Pharmaceutical Register in March 2021, and it can be accessed on the EAPO&#x27;s website in Russian and partially in English. However, those wishing to register need to be aware of the particular requirements before filing a request.</description><pubDate>Tue, 02 Nov 2021 16:23:00 Z</pubDate></item><item><guid isPermaLink="false">f245fa18-f682-434f-9136-1b2c4d5a8fa0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/how-to-protect-ideas-in-the-life-sciences-sector</link><title>How to protect ideas in the booming life sciences sector</title><description>The life sciences sector is booming! Most sectors of the economy are now becoming knowledge-based industries, and in those industries &#x2013; the competition is for ideas. But how do firms protect ideas and innovations, and shield them from being stolen?</description><pubDate>Thu, 28 Oct 2021 14:13:00 Z</pubDate></item><item><guid isPermaLink="false">461bb5d1-e952-42f0-9008-d1ecbfdd7191</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/optis-v-apple-form-of-order-published</link><title>Apple falls short of committing to take court-determined FRAND licence in &#x3C;em&#x3E;Optis v Apple&#x3C;/em&#x3E;... for now</title><description>The Court reiterated that it had made it clear that Apple was expected to &#x27;give a simple and unconstrained undertaking to accept whatever licence was ruled to be FRAND&#x27; following a trial planned in June/July 2022.</description><pubDate>Mon, 25 Oct 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1d8520de-5ef4-4c92-be41-0811bfb0813b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/optis-v-apple-decision-to-be-appealed</link><title>UK Court&#x27;s &#x27;willingness&#x27; decision in Optis v Apple to be appealed</title><description>Only a week after the judgment the UK Court sat again to hear Apple&#x27;s request for permission to appeal</description><pubDate>Fri, 08 Oct 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e65f023a-1693-40c1-93cd-5099ad6f53a0</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/sep-licensing-wars-put-up-or-shut-up</link><title>SEP Licensing Wars: Put up or shut up</title><description>UK Court says implementers must either commit to taking a court-determined FRAND licence once a patent trial has been won or face an injunction in Optis v. Apple.</description><pubDate>Fri, 01 Oct 2021 08:37:00 Z</pubDate></item><item><guid isPermaLink="false">5aaba54e-c831-47a7-a1da-b5c9a6e19d76</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/updated-ai-invention-denied-patent-in-dabus-case</link><title>UPDATED: Court of Appeal - AI generated inventions denied UK Patent in DABUS case</title><description>The Court of Appeal held that a patent cannot be granted if the inventor is not a person and the law would need to be changed in order for purely machine-created inventions to be patentable.</description><pubDate>Thu, 23 Sep 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d36ebec2-a9a4-45e5-b149-1a712ff141ee</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/exhaustion-of-ip-rights-in-the-uk-past-future</link><title>Exhaustion of IP rights in the UK &#x2013; the past and the future</title><description>The UK Government is considering the shape of the UK&#x27;s future regime for the &#x27;exhaustion&#x27; of intellectual property rights. The regime settled upon will govern future rules on parallel imports of genuine goods into the UK.</description><pubDate>Mon, 20 Sep 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c781f37b-0095-4550-9ede-47023d9cded0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/patent-faqs-for-canadian-smes</link><title>Patent FAQs for Canadian SMEs</title><description>What are the frequently asked questions (FAQ) among Canadian Small Medium Enterprises (SMEs) looking to protect their inventions? Download the PDF to find out.</description><pubDate>Tue, 14 Sep 2021 15:33:00 Z</pubDate></item><item><guid isPermaLink="false">a9b6b238-b224-4305-af72-70b2774b887e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/china-joint-patent-infringement-hearings</link><title>Joint patent infringement and validity hearings in China</title><description>In July 2021, in Guangdong Province (Foshan City), a joint hearing took place to determine patent validity and patent infringement. This was the first time such a joint hearing had been held in Guangdong Province: Does it signal a fundamental change in China&#x27;s bifurcated patent system? And is it bad news for plaintiffs, good news for defendants? Or too early to tell?</description><pubDate>Thu, 09 Sep 2021 10:55:00 Z</pubDate></item><item><guid isPermaLink="false">f90d08dc-8be7-4ef6-a468-393adcbd1b06</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/influencers-in-toronto-spotlight-on-natalie-rk</link><title>Influencers in Toronto: Spotlight on Natalie Rizkalla-Kamel</title><description>Natalie Rizkalla-Kamel shares her story about how she became an IP lawyer and the importance of building a relationship with her clients to become a &#x22;trusted adviser.&#x22;</description><pubDate>Wed, 01 Sep 2021 20:25:00 Z</pubDate></item><item><guid isPermaLink="false">7b258971-bb6f-4b7e-b28e-2b04ab8a9732</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/federal-court-appeal-bauer-patent-lawsuit</link><title>Federal Court of Appeal upholds CCM&#x27;s defence of Bauer&#x27;s patent infringement lawsuit</title><description>In a unanimous decision, the panel dismissed Bauer&#x27;s appeal on the basis that there was no reviewable error in the obviousness analysis.</description><pubDate>Thu, 19 Aug 2021 18:06:00 Z</pubDate></item><item><guid isPermaLink="false">0b6428b0-2381-4733-ba9e-8acb1c8b38ff</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/the-new-gcc-patent-filing-system</link><title>The new GCC patent filing system and what to expect</title><description>In January 2021 the GCC Patent Office (GCCPO) announced the suspension of the GCC patent filing system.</description><pubDate>Mon, 16 Aug 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9461b2ce-9506-417d-be00-b2552bd2b745</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/the-great-divide-patent-law-and-antitrust</link><title>The great divide? The interaction of patent law and antitrust in the pharmaceutical markets</title><description>In his article &#x27;The Great Divide? The interaction of patent law and antitrust in the pharmaceutical markets&#x27;, first published in the BIO-Science Law Review, IP partner Gordon Harris looks at the position and concludes that the patent system is capable of policing itself.</description><pubDate>Thu, 12 Aug 2021 10:04:00 Z</pubDate></item><item><guid isPermaLink="false">e19a9cf1-a06c-43f6-9467-d4f79bef1ee9</guid><link>https://gowlingwlg.com/en-cn/insights-resources/client-work/2021/fca-dismisses-bauer-patent-infringement-lawsuit</link><title>Federal Court of Appeal upholds CCM&#x27;s defence of Bauer&#x27;s patent infringement lawsuit</title><description>On August 12, 2021, the Federal Court of Appeal dismissed Bauer&#x27;s appeal, which sought to overturn the May 2020 dismissal of Bauer&#x27;s patent infringement lawsuit against CCM on the basis that the asserted patent was invalid.</description><pubDate>Thu, 12 Aug 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">94c8c817-571b-4163-9ed1-9f3a01ab8ba3</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/protecting-trade-secrets-in-china</link><title>Trade secret protection in China in the era of civil code</title><description>The Supreme People&#x27;s Court of China handed down the second-instance judgment for the dispute between the plaintiffs Jiaxing Zhonghua Chemical Co., Ltd. et al. and the defendants Wanglong Group Co., Ltd. et al. over the infringement of technical secrets involving the chemical Vanillin. We provide an overview of the case.</description><pubDate>Wed, 11 Aug 2021 09:14:00 Z</pubDate></item><item><guid isPermaLink="false">5dcc5b46-55ad-4b1c-9d48-5622490da842</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/fca-upholds-compound-interest-cefaclor-appeal</link><title>FCA upholds award of compound interest in &#x3C;em&#x3E;Cefaclor&#x3C;/em&#x3E; damages appeal</title><description>In the latest Cefaclor decision, the Federal Court of Appeal of Canada has upheld the award of compound interest as damages for the time value of money lost, where there is trial evidence to support the award.</description><pubDate>Tue, 27 Jul 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a55285ec-eeb8-4c0b-bafe-6d022b64eef7</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/helpful-tips-about-expert-witnesses-patent-cases</link><title>Helpful tips about expert witnesses in patent cases (no matter where the IP dispute is tried)</title><description>In patent cases, expert witnesses are almost always called upon to render expert opinions concerning claim construction and the issues of infringement and invalidity.</description><pubDate>Mon, 26 Jul 2021 15:21:00 Z</pubDate></item><item><guid isPermaLink="false">f338c801-e535-40cc-a6f5-291b3ada9f50</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/proposed-amendments-canadian-patent-rules</link><title>Proposed amendments to Canadian Patent Rules introduce &#x22;excess&#x22; claim fees and limit number of office actions</title><description>Proposed amendments to the Patent Rules, if implemented would introduce excess claim fees above 20 claims and limit the number of office actions to three. The proposed amendments are open for comment until August 2, 2021 and are slated to come into force on January 1, 2022 (with a 30 day transitional period).</description><pubDate>Fri, 09 Jul 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b86cec0d-85f3-4753-a419-29a00bbf2338</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/amendments-russian-regulations-generic-drugs</link><title>New amendments to Russian regulations pave way for generic drugs</title><description>Two new amendments to existing regulations have come into force, which could have a significant impact on the Russian pharmaceutical sector. The initiative behind these was the belief that original drug manufacturers pursue a patent renewal strategy by filing applications and obtaining patents for various forms and derivatives of known compounds, which in turn prevent the eventual production of corresponding generic drugs.</description><pubDate>Mon, 05 Jul 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5ea00a23-3d38-43de-b2b1-97df0bf09a2d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/russia-fast-tracks-patent-applications-covid-19</link><title>Russia fast-tracks patent applications in the war against COVID-19</title><description>As part of its efforts to address the COVID-19 pandemic, since April 2020 the Russia Patent and Trademark Office (Rospatent) has introduced faster prosecution for patent applications for viruses and concomitant diseases, such as pneumonia.</description><pubDate>Mon, 28 Jun 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">14b42aea-5fc7-4500-b683-4dfc4b5c51c0</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/schrodinger-s-seed-drill</link><title>Schr&#xF6;dinger&#x27;s Seed Drill - A short review of Prior Use cases in the UK</title><description>If the alleged disclosure takes place in the open, but there is no allegation that it was actually observed, just what actually constitutes a level of disclosure sufficient to invalidate a patent?</description><pubDate>Thu, 10 Jun 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">282835b5-06b2-4fcb-9dcc-9956edb1448d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/influencers-in-toronto-spotlight-on-omar-nassif</link><title>Influencers in Toronto: Spotlight on Omar Nassif</title><description>Omar discusses the collaborative approach he takes with his clients in order to understand how to protect and maximize their inventions.</description><pubDate>Mon, 07 Jun 2021 21:44:00 Z</pubDate></item><item><guid isPermaLink="false">505d513b-3798-4db4-9b61-e1237ff813d0</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/patent-protection-microorganism-russia</link><title>How to obtain patent protection for microorganism strains in Russia</title><description>The term &#x27;microorganism&#x27; includes yeast, bacteria, higher fungi, bacteriophages, unicellular algae, viruses and protozoa, among others. The cell lines of plants and animals are also defined as microorganisms.</description><pubDate>Wed, 02 Jun 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7488cd7b-fcc3-4bef-8fa1-585d2a844a98</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/russia-first-to-file-state-secret-check-explained</link><title>Russia&#x27;s first-to-file and state-secret check requirement explained</title><description>It is essential to understand the unique traits of the IP laws of the country in which an invention was created before seeking the legal protection of an invention in another country.</description><pubDate>Thu, 27 May 2021 22:04:00 Z</pubDate></item><item><guid isPermaLink="false">e90adc0e-48ec-4964-a04d-29a22f0cab6a</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/canadian-industrial-design-marking-three-things</link><title>Canadian industrial design marking: Three things you are probably doing wrong</title><description>Despite guidance from the Canadian Intellectual Property Office (CIPO), it seems that very few owners of registered Canadian industrial designs actually mark their products with the industrial design symbol. If you are thinking to yourself &#x22;there is an industrial design marking?&#x22; then you are probably not alone in missing out on the benefits afforded by this symbol.</description><pubDate>Wed, 19 May 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">54a13da1-b37f-41f2-93de-e022fcbc2150</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2021/estee-lauder-increases-ownership-in-deciem</link><title>The Est&#xE9;e Lauder Companies increases ownership in DECIEM in US$1 billion transaction</title><description>On February 23, 2021, The Est&#xE9;e Lauder Companies Inc. (NYSE: EL) (&#x22;ELC&#x22;) announced that it had entered into an agreement to increase its investment in DECIEM Beauty Group Inc. (&#x22;DECIEM&#x22;).</description><pubDate>Tue, 18 May 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">52649393-c6b1-4069-9b58-5055ec4053c5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/introduction-of-utility-models-in-china</link><title>Introduction of Utility Models in China</title><description>Beijing-based Patent Agent, Jason Yang introduces a special type of patent protection in China known as a Utility Model.</description><pubDate>Fri, 07 May 2021 18:20:00 Z</pubDate></item><item><guid isPermaLink="false">325f0a9b-7d72-4bf1-bcc0-d6a95f3abca2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/belarus-joins-hague-system-protecting-rights-cis</link><title>Belarus joins the Hague system and other new possibilities for protecting industrial design rights in the CIS</title><description>On April 19, 2021 Belarus joined the Hague System for the International Registration of Industrial Designs, expanding the system&#x27;s coverage further into the Commonwealth of Independent States (CIS). As of July 19, 2021, it will be possible to designate Belarus on an international design application and to benefit from the advantages of Hague System mechanisms for protecting industrial designs.</description><pubDate>Wed, 28 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1b168e2c-be22-468d-9787-3a6ca655b8da</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/ip-best-practices-for-canadian-scale-ups</link><title>IP best practices for Canadian scale-ups looking to raise capital</title><description>No matter what the next phases of growth looks like for you company, you need to raise capital &#x2014; fast. IP strategy gives you the edge you need to do just that, opening the door to a universe of government funding programs tailored specifically for SMEs.</description><pubDate>Mon, 26 Apr 2021 17:45:00 Z</pubDate></item><item><guid isPermaLink="false">9072842b-0292-4d95-a8c7-a32b2c8c7664</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/understanding-ip-value-history-of-insulin</link><title>Understanding the true value of your IP assets: A brief history of insulin</title><description>On the occasion of a World IP Day that is taking place in the midst of a global pandemic, and during the life saving rollout of entirely new vaccine technologies, it is worth commemorating the role that innovation has long played in improving human health.</description><pubDate>Mon, 26 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8ff5bd12-d170-4979-af71-86887576a512</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/the-essential-a-z-of-ip</link><title>The essential A-Z of IP</title><description>We&#x27;re here to help SMEs cut through the legal jargon, with a summary of some of the key terms you need to know to ensure the success of your brand when it comes to intellectual property law.</description><pubDate>Thu, 22 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d968d47c-da1c-4f07-8ecb-f0ed7754f1eb</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/investment-in-innovation-look-at-bc-budget-2021</link><title>Investment in Innovation: A Look at BC&#x27;s Budget 2021</title><description>On April 20, 2020, the Government of British Columbia tabled the 2021-2022 provincial budget (&#x22;Budget 2021&#x22;). Budget 2021 focuses on recovery from the economic harm inflicted on BC by the COVID-19 pandemic, and includes $3.25 billion in COVID-19 recovery spending.</description><pubDate>Thu, 22 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a482af6f-4017-4c4d-be32-00b3ef1db0d1</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/government-panel-of-experts-russia-ip-cases</link><title>Government approved panel of experts for intellectual property cases being proposed for Russia</title><description>At the end of March 2021, the Ministry of Justice of the Russian Federation put forward a proposal to introduce an approved panel of experts to be responsible for forensic examinations in intellectual property matters. &#xA0;According to the draft Order of the Ministry of Justice of Russia N 237 a new panel of experts for the &#x22;Investigation of intellectual property&#x22; matters would be officially recognized.</description><pubDate>Tue, 20 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">781d28b9-7135-4b5c-a7ae-1ab6b5b6f220</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/patenting-during-a-pandemic</link><title>Patenting during a pandemic</title><description>Few of us would have imagined that a vaccine to a new virus could be developed in a year. But, 12 months from the first known cases of COVID-19, two vaccines are already being administered within our communities.</description><pubDate>Tue, 20 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6915773e-9fcd-4461-810a-d66fddb800bc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/patent-protection-process-for-canadian-smes</link><title>Patent 101: A guide to the patent protection process for Canadian SMEs</title><description>In this video, Jeff Coles discusses the patent protection process for Canadian SMEs, as part of the Patent 101 video series.</description><pubDate>Mon, 19 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">371c904f-ae45-4bc6-ac4a-cc973b4516bb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/patent-faqs-for-canadian-smes</link><title>Patent 101: Patent FAQs for Canadian SMEs</title><description>In this video, Jennifer Jannuska discusses frequently asked questions about patents for Canadian small and medium enterprises, as part of the Patent 101 video series.</description><pubDate>Mon, 19 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">052ff47d-2841-4428-a41a-0b4af52c1e1e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/top-tips-canadian-smes-patents</link><title>Patent 101: Top 3 things Canadian SMEs need to know about patents</title><description>In this video, Anthony Dearden discusses the top things Canadian small and medium enterprises need to know about patents, as part of the Patent 101 video series.</description><pubDate>Mon, 19 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">269dce79-48ba-4280-aa27-3bd5aacb0f6c</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/setting-up-global-anti-counterfeiting-program</link><title>Setting up a global anti-counterfeiting program for the first time</title><description>When setting up a global anti-counterfeiting program for the first time, there are several aspects to consider.</description><pubDate>Wed, 31 Mar 2021 12:42:00 Z</pubDate></item><item><guid isPermaLink="false">5d4dd7ae-f684-4fb4-8174-0ab4c2150549</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/patent-for-detecting-marijuana-grow-ops-invalid</link><title>Patent for detecting marijuana grow-ops found not infringed and invalid</title><description>In dTechs EPM Ltd. v British Columbia Hydro and Power Authority and Awesense Wireless Inc., 2021 FC 190, Justice Fothergill addressed allegations of patent infringement concerning Canadian Patent No. 2,549,087 (the 087 Patent), which relates generally to monitoring usage of electrical utilities to detect potential instances of atypical consumption or theft, such as theft of electricity related to the indoor cultivation of marijuana.</description><pubDate>Fri, 26 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">26a0c550-7bce-43dc-8966-a5b716921d9e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/renewals-under-new-canadian-trademarks-act</link><title>A guide to Canadian trademark renewals under the new Canadian Trademarks Act</title><description>In this video, Susannah Rolston offers quick and helpful tips you should consider before renewing your trademark under the revised Canadian Trademarks Act.</description><pubDate>Fri, 19 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f340ea27-2b96-460d-8860-3c009ce3ad3c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/pending-patent-decisions-federal-courts-2021</link><title>What to expect in 2021: Pending patent decisions from the Federal Courts</title><description>The end of 2020 and start of 2021 have been busy with Federal Court judges writing, and the patent bar reading, several interesting patent decisions. That trend may continue in 2021. There are several pending decisions from patent trials and patent appeals heard in 2020, or early 2021. This article provides a snapshot of those trials and appeals, and what issues we can expect to be addressed by the decisions.</description><pubDate>Wed, 17 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b51f9519-2121-4c43-897d-14eb7eedb339</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/evolving-approach-to-costs-in-the-federal-court</link><title>Show me the money: The evolving approach to costs in the Federal Court</title><description>The costs of litigation in Canada follow the general principle that the loser pays, meaning the successful party is able to recover some of the fees required to bring or defend the action. While a simple concept, the approach is complex and continually evolving. In this article, the evolving approach to costs in the Federal Court is examined.</description><pubDate>Mon, 15 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">89b28e6a-7fdd-4961-a2fb-6f1d1da790f0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/takeda-wins-canadian-vyvanse-patent-appeal</link><title>Takeda successfully defends Canadian VYVANSE&#xAE; patent on appeal</title><description>The Federal Court of Appeal has dismissed two appeals brought by Apotex in respect of the validity of certain claims of Takeda&#x27;s (as Shire) Canadian Patent No. 2,527,646 which cover, inter alia, lisdexamfetamine (LDX), the active ingredient in Takeda&#x27;s ADHD medication VYVANSE&#xAE;.</description><pubDate>Fri, 12 Mar 2021 22:52:00 Z</pubDate></item><item><guid isPermaLink="false">4fe1e21d-3fe8-4596-bdfd-ba67a7d1004a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/focus-genetic-construct-drug-patent</link><title>Focusing on the genetic construct when applying for a drug patent could be key to obtaining protection</title><description>Russia has a lively pharmaceutical market, in which it is possible to obtain comprehensive patent protection for products and methods that are aimed at treating and diagnosing specific diseases. However, development in the sector relies on manufacturers being confident that their patents will provide adequate and reliable protection, which requires comprehensive patent protection for both the drug and for items in related fields. When drafting an application, it is therefore crucial to focus on aspects, such as genetic constructs.</description><pubDate>Thu, 11 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ebe9931-1b70-4dba-a015-24c939a99473</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2021/appeals-dismissed-for-vyvanse-patent</link><title>Federal Court of Appeal dismisses appeals brought by Apotex in respect of Takeda&#x27;s Canadian VYVANSE&#xAE; patent</title><description>On March 11, 2021, the Federal Court of Appeal dismissed two appeals brought by Apotex in respect of the validity of certain claims of Takeda&#x27;s (as Shire) Canadian Patent No. 2,527,646 (the &#x22;646 Patent&#x22;) which covers, inter alia, lisdexamfetamine (LDX), the active ingredient in Takeda&#x27;s ADHD medication VYVANSE&#xAE;.</description><pubDate>Thu, 11 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2c45b8c4-a20a-4cfd-ad8b-d8e70146a6b2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/statute-of-monopolies-action-dismissed</link><title>Statute of Monopolies action dismissed via summary judgment</title><description>The Ontario Superior Court of Justice has dismissed a claim brought by Apotex for treble damages and an accounting of the innovative defendants&#x27; profits brought under the Statute of Monopolies, the Trademarks Act, and at common law.</description><pubDate>Wed, 10 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7d27e535-88fb-4eb5-9011-60068fa30a23</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/federal-court-of-appeal-analysis-advantages</link><title>Federal Court of Appeal reaffirms that advantages can be considered in obviousness analysis</title><description>The Federal Court of Appeal recently dismissed an appeal from Janssen v Apotex, 2019 FC 1355 (Phelan J.) in Apotex v Janssen, 2021 FCA 45.</description><pubDate>Wed, 10 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ddea8414-5e62-4705-8b55-4af3bb1040ce</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/eurasian-patent-office-launches-pharma-register</link><title>The Eurasian Patent Office launches its pharmaceutical register</title><description>On March 1, 2021, the Eurasian Patent Office launched the EAPO Pharmaceutical Register. The Register lists Eurasian patents that relate to the active pharmaceutical ingredients of the drugs according to their International Non-proprietary Names (INN).</description><pubDate>Mon, 08 Mar 2021 14:02:00 Z</pubDate></item><item><guid isPermaLink="false">0fa2eb6c-1dd6-4d3a-beae-54ab02ed6064</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2021/apotex-claim-dismissed</link><title>Ontario Superior Court of Justice dismisses Statute of Monopolies action via summary judgment</title><description>On March 8, 2021, the Ontario Superior Court of Justice dismissed a claim brought by Apotex for treble damages and an accounting of the innovative defendants&#x27; profits brought under the Statute of Monopolies, the Trademarks Act, and at common law.</description><pubDate>Mon, 08 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">589a6f16-d622-48f7-aae0-b7fa164dffbc</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2021/chambers-patent-litigation-2021-guide-france</link><title>Chambers Patent Litigation 2021 Guide &#x2013; France</title><description>C&#xE9;line Bey and Cl&#xE9;mence Lap&#xF4;tre have written the French Chapter of the 2021 Chambers Patent Litigation guide.</description><pubDate>Thu, 25 Feb 2021 12:53:00 Z</pubDate></item><item><guid isPermaLink="false">73fcb2bf-baf8-484d-a0cb-8438ba076aa9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/prosecuting-industrial-designs-in-china</link><title>Prosecuting industrial designs in China: An overview</title><description>In this video, Jason Yang, a patent agent in Gowling WLG&#x27;s Beijing office, describes how to file industrial designs effectively in China and highlights the latest developments in Chinese patent law.</description><pubDate>Tue, 09 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">19590a0c-63ce-406f-86b5-590b4e7c1c19</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/a-review-of-uk-patent-cases-in-2020</link><title>A review of UK patent cases in 2020</title><description>Gordon Harris gives his annual review and summary of 2020&#x27;s important patent cases.</description><pubDate>Thu, 04 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">35979bbb-0bdf-4e50-89cb-9400ddac1cde</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/second-medical-use-patents-verifying-validity</link><title>Second medical use patents part 2 - Verifying validity</title><description>What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something in-between?</description><pubDate>Mon, 01 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">39245029-4526-422f-9ec1-24fe4fc5c5ac</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/brexit-and-trade-secrets-6-key-things-to-know</link><title>Brexit and trade secrets: 6 key things to know</title><description>On 31 December 2020, the Brexit transition period comes to an end, and significant changes to the law in the UK will take effect.</description><pubDate>Thu, 28 Jan 2021 10:38:00 Z</pubDate></item><item><guid isPermaLink="false">aa9c2555-b79c-45d9-a184-2f215e7e5d39</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/brexit-and-copyright-6-key-things-to-know</link><title>Brexit and copyright: Six key things to know</title><description>On 31 December 2020, the Brexit transition period comes to an end, and significant changes to the law in the UK will take effect. For copyright and neighbouring areas of the law, there are some important soundbites for businesses to be aware of &#x2013; some of which you may already have heard about, while others may be news outside the UK (even for experienced copyright lawyers).</description><pubDate>Thu, 28 Jan 2021 10:38:00 Z</pubDate></item><item><guid isPermaLink="false">9d8bb56f-169a-4813-af7a-58b363990eea</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/brexit-and-patents-key-things-to-know</link><title>Brexit and patents: 10 key things to know</title><description>On 31 December 2020, the Brexit transition period comes to an end and significant changes to the law in the UK will take effect.</description><pubDate>Thu, 28 Jan 2021 10:35:00 Z</pubDate></item><item><guid isPermaLink="false">211dd0ba-ec11-4fae-bb5c-186babc7f9ef</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/2020-annual-review-of-uk-patent-judgments</link><title>Annual review of UK patent judgments - 2020</title><description>&#x27;Swings and Roundabouts&#x27;, Gordon Harris&#x27; comprehensive annual review of patent case law, is your complete guide to the most important, industry-influencing UK patent judgments in 2020.</description><pubDate>Wed, 27 Jan 2021 12:46:00 Z</pubDate></item><item><guid isPermaLink="false">385bbc47-3b8d-4ab1-874d-a1c31b37c7b2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/patent-infringement-against-oil-sands-dismissed</link><title>Non-practising entity&#x27;s allegations of patent infringement against oil sands producer /operator dismissed</title><description>On January 26, 2021, Justice Manson of the Federal Court of Canada dismissed a patent infringement action brought by an individual, non-practising entity, Maoz Betser-Zilevitch against PetroChina Canada Ltd.</description><pubDate>Wed, 27 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">135a3285-12d3-42ec-b317-d64fe4b49251</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/russia-blocking-websites-and-social-networks</link><title>Russia introduces new grounds for blocking websites and social networks</title><description>On&#xA0; January 10, 2021, the Federal law N 482-FZ came in force granting Roskomnadzor, the federal oversight service for communications, IT, and mass media, the right to block Internet resources premised upon improper censorship and/or on grounds of discrimination against Russian users or mass media.</description><pubDate>Tue, 26 Jan 2021 18:46:00 Z</pubDate></item><item><guid isPermaLink="false">7ae26f73-6a01-47a0-92e6-d86ce7e4f1e7</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2021/understanding-infringement-and-enforcement</link><title>Second medical use patent series: Understanding infringement and enforcement</title><description>As the scientific community continues to tackle some of the world&#x27;s most challenging diseases, research and innovation has led to the discovery of new uses for previously known medicines. Patents that cover these new uses are often called &#x22;second medical use&#x22; patents.</description><pubDate>Fri, 22 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2bb399dc-b3d6-4935-b89b-012ec74a5617</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/top-5-trademark-considerations-for-cleantech</link><title>Top 5 trademark considerations every CleanTech entrepreneur should know</title><description>The growth in global demand for clean technology is creating a more competitive market where the competition for brand recognition has never been fiercer.</description><pubDate>Thu, 21 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">60750e67-fba3-44d9-b4da-96fc3178830a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/podcasts/2021/the-patent-bar-and-beyond</link><title>The patent bar and beyond: In conversation with Sir Robin Jacob</title><description>In the latest podcast in our &#x27;In Conversation with Gowling WLG&#x27; series, global intellectual property partner Gordon Harris speaks to the Right Honourable Professor Sir Robin Jacob &#x2013; a veritable legend of the IP world.</description><pubDate>Wed, 20 Jan 2021 13:20:00 Z</pubDate></item><item><guid isPermaLink="false">444eeb85-e8b6-4a32-b711-53d8b08393d8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/the-new-rules-of-canadian-patent-litigation</link><title>The new rules of Canadian patent litigation: Federal Court of Appeal affirms the viability of summary judgments in patent actions, upholds interpretation of file wrapper estoppel</title><description>On Jan. 20, 2021, the Federal Court of Appeal dismissed the appeal in CanMar Foods Ltd. v. TA Foods Ltd 2021 FCA 7. This precedent setting appeal stems from the underlying decision of Justice Manson which itself was recognized as the Canadian Patent Impact Case of the Year by Managing Intellectual Property (MIP) Americas Awards 2020.</description><pubDate>Wed, 20 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8f1113ae-5f18-41af-9f3d-b0ce8b33d661</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2021/canadian-patent-law-2020-year-in-review</link><title>Canadian patent law: &#x3C;br&#x3E;2020 year in review</title><description>There were various developments in Canadian patent law in 2020. This article summaries a number of notable court decisions on patent law and practice in Canada.</description><pubDate>Thu, 14 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">128b9bf5-519b-4b5e-9d63-cebefe0f9b6e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2021/influencers-in-toronto-spotlight-on-selena-kim</link><title>Influencers in Toronto: Spotlight on Selena Kim</title><description>Selena shares her inspiring story about how perseverance has played a key role in her success as a lawyer.</description><pubDate>Mon, 11 Jan 2021 20:52:00 Z</pubDate></item><item><guid isPermaLink="false">2ab7faed-6202-4104-b48e-a3ccd5c6f4b6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/podcasts/2020/in-conversation-with-lord-neuberger</link><title>The UK Supreme Court, patent infringement, and the challenges of judging IP cases: In conversation with Lord Neuberger</title><description>What is it really like to be the UK Supreme Court&#x27;s leading decision maker, acting on some of the most important intellectual property decisions of recent times? In the latest podcast in our &#x27;In Conversation with Gowling WLG&#x27; series, global IP partner Ron Dimock speaks to the Right Honourable Lord Neuberger of Abbotsbury, former President of the United Kingdom Supreme Court.</description><pubDate>Tue, 15 Dec 2020 14:14:00 Z</pubDate></item><item><guid isPermaLink="false">1b1f1f53-9bfe-4dea-9287-d204c9f00225</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/what-rospatent-has-in-store-for-2021</link><title>What Rospatent has in store for 2021 &#x2013; head of Rospatent speaks out</title><description>The Association of European Businesses held a briefing in Russia, in which the head of the Russia Patent and Trademark Office (Rospatent) &#x2013; Grigory Ivliev &#x2013; outlined what Rospatent is doing in the IP field to improve the investment climate in Russia.</description><pubDate>Fri, 11 Dec 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9356b66a-d1c0-4ba5-9ce5-a8d7a3d5dd58</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/patenting-antibody-based-biologics-in-canada</link><title>Patenting antibody-based biologics in Canada</title><description>A summary of a number of important considerations when drafting claims for patent applications intended to be filed in Canada.</description><pubDate>Mon, 30 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61dd744a-56cd-4e1e-a0d5-0169412f4ab6</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/patent-term-extension-in-canada</link><title>Patent term extension in Canada: An overview of certificates of supplemental protection</title><description>An overview of certificates of supplemental protection regarding patent term extension in Canada.</description><pubDate>Fri, 27 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">160c429d-b27c-4108-bad6-4ebac9b3b118</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/patents-to-protect-antibody-based-drugs-russia</link><title>Using patents to best protect antibody-based drugs in Russia</title><description>Antibody-based drugs are among the widest selling in the world. They are being used to treat a expanding range of conditions and their significance and value in treating cancer continues to grow. Accordingly, this makes them an indispensable component of the pharmaceutical industry and it also means that their protection through invention patents is absolutely essential.</description><pubDate>Thu, 26 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cdbc874d-c9ba-4c8c-98d7-44147e2587cb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/working-with-known-materials-in-the-life-science</link><title>Working with known materials in life sciences: Key patent considerations</title><description>Life science companies who are in the early stages of research often ask &#x27;how will I know if I have something patentable&#x27;.</description><pubDate>Wed, 11 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">98da9499-3cc9-4c3f-97bf-e645b79d55f9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/cipo-clarifies-eligibility-analysis</link><title>Presumed essential: CIPO clarifies its approach toward eligibility analysis following Federal Court decision</title><description>The Choueifaty decision found fault with a &#x22;problem-solution&#x22; approach to claim construction that had been applied by the Canadian Intellectual Property Office (&#x22;CIPO&#x22;). Pursuant to the Choueifaty decision, which will not be appealed, CIPO has now promulgated a Practice Notice that provides administrative guidance on claims construction and patentable subject-matter.</description><pubDate>Wed, 11 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8900e16d-025a-4b20-baf1-08e3b6ce59e7</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/patenting-cleantech-in-europe-global-market-canada</link><title>Patenting cleantech in Europe: A global market for Canada&#x27;s clean technology</title><description>The case for patent protection of cleantech can sometimes be more easily made than for other technologies.&#xA0; For example, intellectual property embodied purely in intangible software can sometimes face stiffer resistance from a patent office for being too abstract, resulting in protracted and more costly prosecution.&#xA0; With national policy paving the way for heavy investment in environmentally clean technologies, cleantech&#x27;s capital-intensive innovations often demand robust IP protection, especially in the form of patents, as a means of safeguarding the ability to leverage the IP over the long term for increased revenue generation.</description><pubDate>Wed, 11 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1d213144-dad9-4b3b-a4fd-8d8baa40897a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/what-does-brexit-mean-for-intellectual-property</link><title>What does Brexit mean for intellectual property?</title><description>On 31 December 2020, the intellectual property regime in the UK (and Europe) will undergo transition as a consequence of the UK&#x27;s exit from the EU (Brexit).</description><pubDate>Mon, 09 Nov 2020 14:36:00 Z</pubDate></item><item><guid isPermaLink="false">64abc244-87d3-43ea-afdd-80ce9a7c4257</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/simplify-patent-security-clearance-for-inventions</link><title>How to simplify patent security clearance for inventions</title><description>When an invention is made in Russia, the filing of counterpart patent applications in other countries is temporarily restricted for national security reasons.</description><pubDate>Wed, 28 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">dd1a1340-ca91-4480-8d8a-eeb9a073cfe2</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/new-possibilities-to-protect-designs-in-eurasia</link><title>New possibilities to protect designs in Eurasia</title><description>In September 2019 a conference on adopting the Protocol on the Protection of Industrial Designs in Eurasia was held in Nur-Sultan (formerly Astana), the capital of Kazakhstan. The member states of the Eurasian Patent Convention (EAPC) &#x2013; Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Russia, Tajikistan and Turkmenistan &#x2013; discussed the possibility of introducing a unitary Eurasian industrial design regime. As a result of the meeting, Armenia, Azerbaijan, Kazakhstan, Kyrgyzstan and Russia signed the protocol.</description><pubDate>Thu, 22 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">53566e38-721b-4ad8-a88f-1a50a9c1ec50</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2020/five-tips-for-choosing-an-ip-professional</link><title>Five tips for choosing an IP professional</title><description>In this video, Neil Henderson advises that choosing a patent agent or attorney is an important decision, that cost is not the only factor, and to not underestimate the importance of &#x27;personality&#x27; in the decision.</description><pubDate>Thu, 22 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">eb24cecd-70f8-4b02-a81c-96877d1c17a6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/toilette-station-spatiale</link><title>Is the new toilet on the International Space Station patentable?</title><description>In this article, we look at the patentability of the new space toilet system. Obviously, for a technology to be patentable in Canada, it must be new, inventive and useful. There is no doubt that the new system will be particularly useful to the ISS!</description><pubDate>Wed, 21 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ec5ab3aa-ffab-42c3-894c-9188b97451d7</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/patent-infringement-in-multiple-jurisdictions</link><title>Worried about being sued for patent infringement in multiple jurisdictions?</title><description>Three ways to gain control is you are worried about being sued for patent infringement in multiple jurisdictions.</description><pubDate>Thu, 15 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f71c9087-2c4f-4e09-8417-50639eebb2d6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/ip-audits-what-s-in-your-ip-portfolio</link><title>IP audits: What&#x27;s in your IP portfolio?</title><description>Fundamental to the development of a robust IP strategy is a thorough understanding of the business&#x27; IP portfolio, which may include patents, trademarks, copyrights, trade secrets, domain names, and industrial designs. An IP audit provides just such an insight.</description><pubDate>Wed, 14 Oct 2020 20:42:00 Z</pubDate></item><item><guid isPermaLink="false">bdd45489-8e19-4522-941c-6b69de9df832</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/644-million-award-for-patent-infringement-upheld</link><title>$644-million award for patent infringement upheld on appeal; Accounting of profits remedy removes &#x22;economic incentive to infringe&#x22;</title><description>In 2020 FCA 141, the Federal Court of Appeal has upheld the Federal Court&#x27;s earlier judgment awarding Dow Chemical $644 million, the largest monetary award by a Canadian Court in history for patent infringement.</description><pubDate>Wed, 07 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cee750f3-452e-46a2-bf0e-dcb5f382ff19</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/rospatent-s-ban-on-misleading-trademark-transfers</link><title>Keeping the right side of Rospatent&#x27;s ban on misleading trademark transfers</title><description>Trademarks are a valuable corporate asset and, as with any asset, one way to make money from it is to sell it. It therefore follows that the transfer of trademark rights is fairly common.</description><pubDate>Wed, 30 Sep 2020 21:22:00 Z</pubDate></item><item><guid isPermaLink="false">86d27cce-a1bc-4ed2-b565-1e79c0425b50</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/electronic-signature-considerations-for-patent-pra</link><title>Electronic signature considerations for patent practice</title><description>In the wake of the COVID-19 pandemic, many people are working from home, making it more difficult than usual to get handwritten signatures. In this article, we provide answers to some frequently asked questions regarding the use of electronic signatures on assignment documents for patents and patent applications.</description><pubDate>Mon, 21 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">98d319dc-9200-4297-bcc5-368d99ae45f9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/overview-doctrine-equivalence-china</link><title>A practical overview of the doctrine of equivalence in China</title><description>Equivalence infringement, or the doctrine of equivalence, was officially introduced into Chinese patent law legislation in 2009, through the implementation of the Chinese Supreme Court&#x27;s judicial interpretation, which stated the following: Equivalent features shall mean features which use identical means to achieve identical functions and realise identical effects, and which can be contemplated by people skilled in the art without creative effort.</description><pubDate>Thu, 17 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">62eac6d6-7971-4c63-a71b-a21602ddd244</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2020/design-patent-practice-in-russia</link><title>Design patent practice in Russia</title><description>In this video you will learn more on design patents in Russia. There are three possible filing systems: Direct national filings for Russia; International filings via Hague System Eurasian Design Patents (soon to be launched); and regional protection in Russia and many countries of the former Soviet Union.</description><pubDate>Wed, 16 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ef753e7-5a17-42d2-9ef9-1f019bd6a327</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/getting-the-most-out-of-pharmaceutical-extensions</link><title>Getting the most out of pharmaceutical patent-term extensions in Russia</title><description>The Russia Patent and Trademark Office (Rospatent) has tightened up its approach to allowing patent-term extensions to pharmaceutical and agrochemical patents. However, a strategic and far-sighted approach can still result in excellent protection.</description><pubDate>Thu, 10 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">175f36ae-3850-4af1-8764-aad3fdfbc1fc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/federal-court-finds-problem-with-problem-solution</link><title>Federal Court finds a problem with problem-solution</title><description>In an important decision for patent applicants who are concerned about subject matter eligibility, the Federal Court of Canada held in Yves Choueifaty v. Attorney General of Canada that the problem-solution approach applied by the Canadian Intellectual Property Office (&#x22;CIPO&#x22;) since 2013 to construe patent claims is inconsistent with Canadian law.</description><pubDate>Wed, 09 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b0a6d5c0-e660-43e2-bd54-64facb86ade6</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/cipo-extension-of-designated-days</link><title>CIPO update: An additional extension of designated days to August 31, 2020</title><description>On August 19, the Canadian Intellectual Property Office (CIPO) announced an additional extension of designated days and now&#xA0;all deadlines falling between March 16 and August 28, 2020 have been automatically extended until&#xA0;August 31, 2020.</description><pubDate>Thu, 20 Aug 2020 20:45:00 Z</pubDate></item><item><guid isPermaLink="false">62686f09-06f8-4d4d-a5d7-a707d1a71a64</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/simple-steps-to-expedite-patent-prosecution-russia</link><title>Simple steps to expedite patent prosecution in Russia</title><description>In order to expedite patent prosecution, both offices recognise the Patent Prosecution Highway (PPH) programme, as well as requests for expedited prosecution.</description><pubDate>Wed, 12 Aug 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">65d5e540-c054-4233-a2ea-d1b7ca40330e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/covid-19-impacts-on-ip-activity-in-the-courts</link><title>COVID-19: impacts on IP activity in the courts and UK IPO</title><description>In the UK, COVID-19 is leading to unprecedented adaption by the courts and the UK IPO to audio and video platforms, to enable normal business to continue as far as possible. New rules, guidance and practice seek to maintain access to justice for litigants and the public nature of hearings, including in intellectual property disputes, as Lydia Birch and Kate Hawkins explain.</description><pubDate>Mon, 10 Aug 2020 10:21:00 Z</pubDate></item><item><guid isPermaLink="false">6ace353f-5767-409f-bc0d-f6e9af7246bf</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/strategies-patent-litigation-defendant-view</link><title>Lifecycle of a Smart Idea | The game begins: Strategies for the early stages of patent litigation: The defendant&#x27;s view</title><description>In this seventh episode in our series, &#x27;Lifeycle of a Smart Idea,&#x27; Gowling WLG&#x27;s IP professionals from around the world are going to take a look at patent litigation strategy in the early stages.</description><pubDate>Fri, 07 Aug 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">43249bf6-7722-418e-904a-f36f81eeb356</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/strategies-for-patent-litigation-claimants-view</link><title>Lifecycle of a smart idea | The game begins: Strategies for the early stages of Patent Litigation: The Claimant&#x27;s View</title><description>In the sixth and seventh episodes in our series, &#x27;Lifecycle of a Smart Idea&#x27;, Gowling WLG&#x27;s IP professionals from around the world examine patent litigation strategy in the early stages.</description><pubDate>Mon, 27 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">16222b24-5014-4641-b466-da1cbd105e85</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/doctrine-of-equivalents-in-russian-pharma</link><title>Applying the doctrine of equivalents in Russian pharma</title><description>A patent&#x27;s scope of protection is determined by the specific wording of its claims, which are understood in the context of the patent disclosure. Patent offices and courts therefore construe the words of these claims to determine the breadth or scope of protection.</description><pubDate>Thu, 16 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">83936769-9c40-43e0-b4e4-3d4b3eb46ecf</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/catching-trade-secret-thieves</link><title>Lifecycle of a Smart Idea | Ready or not, here we come: Tips for catching trade secret thieves</title><description>Your patent strategy is optimized and your business is running smoothly - until an employee goes rogue and steals one of your trade secrets. What should you do to mitigate the damage and salvage your secret?</description><pubDate>Wed, 15 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fae2bd96-7534-41b5-9f8b-932d04bc5b02</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/patent-strategies-tech-engineering</link><title>Lifecycle of a Smart Idea | Global patent strategies in the world of tech &#x26; engineering</title><description>Patenting an invention is a complex undertaking across all sectors &#x2013; but there are particular issues that organizations operating in the tech and engineering fields need to contemplate as part of their global patent strategy.</description><pubDate>Thu, 02 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1fa4472a-45a9-407e-b39f-daedcfe62236</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/upheaval-for-patent-law-of-sufficiency-from-the-uk</link><title>Upheaval for patent law of sufficiency from the UK Supreme Court</title><description>The UK Supreme Court (UKSC) has handed down its judgment in patent dispute Regeneron Pharmaceuticals Inc v Kymab Ltd ([2020] UKSC 27 (24 June 2020), making key rulings for the law of &#x27;sufficiency&#x27;.</description><pubDate>Thu, 25 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5b54c3db-93a6-406b-9063-549ed647a950</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/patent-strategy-optimizing-life-sciences-patents</link><title>Lifecycle of a smart idea | Patent strategy: Optimizing life sciences patents</title><description>Third on-demand webinar in our &#x27;Lifecycle of a Smart Idea&#x27; series exploring the scope of patent protection across jurisdictions.</description><pubDate>Tue, 23 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aa0ea6a6-f291-4cc2-8e75-b060cf404a82</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/trade-secrets-international-protection</link><title>Lifecycle of a Smart Idea | Trade Secrets: The what, how and where of international protection</title><description>The second webinar in our &#x27;Lifecycle of a Smart Idea&#x27; series, taking a closer look at protecting trade secrets.</description><pubDate>Mon, 08 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2e28018d-b0eb-4e84-825d-4a17a04cdf6e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/infringement-action-under-pm-noc-regulations</link><title>Infringement Action Under PM(NOC) Regulations Cannot Become Moot</title><description>In a recently released decision (2020 FC 635), Justice O&#x2019;Reilly held that patent infringement actions taken under section 6(1) of the Patent Medicines (Notice of Compliance) Regulations do not become moot if the action is not heard or decided before the patent(s) at issue expires.</description><pubDate>Fri, 05 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">97c2aafc-0c8b-4427-9020-e7c3a4e434d6</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/protection-of-secrets-in-patent-infringement</link><title>Protection of Secrets in Patent Infringement Proceedings</title><description>The need to strengthen procedural protection of trade secrets in patent infringement proceedings has recently taken shape. Speech is silver, but silence is golden.</description><pubDate>Tue, 02 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">92d61e9d-d654-4039-a8e0-bb4543b1de64</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/managing-your-patent-portfolio-during-a-crisis</link><title>Managing your patent portfolio during a crisis</title><description>During the current COVID-19 public health crisis, you may not be able to invest the time and money on a patent portfolio that you normally would. Depending on your risk tolerance, you may be able to trade off risk for cost by being cognizant of and relying on various legal tools and strategies.</description><pubDate>Thu, 28 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4b451020-5ef4-4f9c-84e8-2f9d9b2d5146</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/trademarks-in-russia</link><title>What you need to know about trademarks in Russia</title><description>Whether you already do business in Russia or are just considering entering the market, managing and defending your trademarks rights can be a daunting prospect. To help you navigate this area with confidence, we outline some key aspects of Russia&#x2019;s trademark regime.</description><pubDate>Wed, 20 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d0ae7e52-518c-4a8f-abb6-6236652da265</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2020/fca-dismisses-bauer-hockey-s-patent-infringement</link><title>Federal Court dismisses Bauer Hockey&#x27;s patent infringement action against CCM</title><description>On May 15, 2020, the Federal Court dismissed a patent infringement action brought by Bauer against Sport Maska Inc. dba CCM Hockey and allowed CCM&#x27;s counterclaim of patent invalidity.</description><pubDate>Fri, 15 May 2020 12:00:00 Z</pubDate></item><item><guid isPermaLink="false">e8c0c318-4b26-4ab2-9682-5f10c67a3e54</guid><link>https://gowlingwlg.com/en-CN/insights-resources/on-demand-webinars/2020/to-patent-or-keep-secret</link><title>Lifecycle of a smart idea | To patent or keep secret?</title><description>Given the frenetic pace of today&#x27;s innovation lifecycle, do patents always afford the best protection of proprietary inventions?</description><pubDate>Thu, 14 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">97fc9e8b-8424-44b4-9cb1-9851fbd5c3c1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/ip-protection-notes-in-china-during-covid-19</link><title>Overview on Intellectual Property protection notes in China during the COVID-19 outbreak</title><description>COVID-19 has swept across the globe causing massive disruption to businesses everywhere. While the impact of COVID-19 on other parts of the world continues to increase, China&#x27;s economic activity is now gradually returning to &#x22;business as usual&#x22;. This note will give an overview on the measures taken by the Chinese authorities in relation to IP during the period of COVID-19 outbreak in China and will shed light on what businesses should be aware of in terms of IP protection during this unprecedented time.</description><pubDate>Wed, 13 May 2020 08:40:00 Z</pubDate></item><item><guid isPermaLink="false">64e732b6-3545-4936-9047-0f4b56d3093f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/new-trademark-developments-in-french-law</link><title>Protecting and maximizing trademark rights in France: Five new developments in French law</title><description>An outline of new trademark developments in french law regarding protecting and maximising trademark rights.</description><pubDate>Mon, 04 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">85d67186-c26f-4da5-8053-9960d2468c5b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/covid-19-manage-vr-ar-ip-portfolio</link><title>Managing your VR/AR IP portfolio during the COVID-19 crisis: Strategies and best practices</title><description>For VR/AR companies, spending money on intellectual property is often an investment for the future. In contrast, during the current COVID-19 public health crisis, our attention naturally turns to the present.</description><pubDate>Wed, 29 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">908600f7-277b-4923-91f5-f5bf6d4be87e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/covid-19-the-impact-on-ip-law-practice-in-russia</link><title>COVID-19: The impact on IP law and practice in Russia</title><description>David Aylen and the IP team at Gowling WLG Russia wrote an article about the COVID-19 measures in Russia and their impact on IP enforcement and protection.</description><pubDate>Tue, 28 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c70c6ece-d885-4397-8995-2f8e2b47b7e6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2020/protecting-your-ai-investment-using-patent-applica</link><title>Protecting your AI investment using patent applications</title><description>Wondering how you can leverage intellectual property laws to best protect and commercialise your AI-based inventions? Watch this short IP Explainer from Roch Ripley.</description><pubDate>Sun, 26 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b89ce5e2-a495-4b45-a8f3-1966705ce071</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/federal-court-supports-broad-interpretation-csp</link><title>Better Together &#x2013; Federal Court Supports Broader Interpretation of CSP Regulations Based Upon A Purposive Review of CETA</title><description>The Federal Court has released the first Judicial Review decision addressing the Certificate of Supplementary Protection Regulations, in a case pertaining to a refusal by the Minister of Health to award a CSP to Glaxosmithkline Biologicals for a patent covering its SHINGRIX&#xAE; product.</description><pubDate>Thu, 09 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">186d1479-0ac5-4097-845c-f5a3ef271c15</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/developments-in-arrow-declarations</link><title>English Court of Appeal &#x27;widens the target&#x27; for Arrow declarations (and hands control to defendants)</title><description>Arrow relief continues to develop in the law of the UK, with the Court of Appeal recently refusing to strike out claims for a much broader declaration than has previously been granted.</description><pubDate>Thu, 09 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c3733d9b-dfab-4ed7-a6a1-6b76850c20cf</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/expedited-court-of-appeal-confirms-lucentis-expiry</link><title>Expedited Court of Appeal confirms expiry of Lucentis SPC ahead of time</title><description>Following a highly expedited, video-conferenced hearing, the Court of Appeal has confirmed that Master Data Center and Genentech could not correct the error in payment of the prescribed fee for the SPC for Lucentis, which has therefore expired early.</description><pubDate>Wed, 08 Apr 2020 08:56:00 Z</pubDate></item><item><guid isPermaLink="false">306385dc-9736-4f48-b3ad-9f1ca56d6fb3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/trade-secrets-directive-has-not-changed</link><title>Trade Secrets Directive has not changed substantive English law principles protecting confidential information</title><description>Since the implementation of the Trade Secrets Directive in 2018, there has been a question in the UK about the extent to which the protection for confidential information provided by the common law has been impacted.</description><pubDate>Fri, 03 Apr 2020 13:42:00 Z</pubDate></item><item><guid isPermaLink="false">1bef19fb-3645-48c6-8c7c-583acee75385</guid><link>https://gowlingwlg.com/en-CN/insights-resources/videos/2020/a-message-from-our-global-ip-group</link><title>A message from our Global IP Group</title><description>Our professionals around the world are continuing to work to support you. We are also redefining business casual.</description><pubDate>Mon, 30 Mar 2020 17:57:00 Z</pubDate></item><item><guid isPermaLink="false">6eba90ce-f819-407d-a0f2-48c28ff90de1</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/pay-the-correct-spc-fee-or-risk-expiry</link><title>Pay the correct SPC fee or risk expiry ahead of time!</title><description>Inga Pietsch and Huw Evans explain the need for fully informed and careful compliance with administrative requirements for SPCs, which are national in nature.</description><pubDate>Fri, 27 Mar 2020 10:22:00 Z</pubDate></item><item><guid isPermaLink="false">f0901477-6eda-4f1e-af42-5580b9ba8716</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/covid-19-amendments-to-the-patent-act</link><title>COVID-19 Emergency Response Act: Amendments to the Patent Act</title><description>After lengthy deliberations, the Federal Government has passed an aid bill in response to the COVID-19 pandemic (COVID-19 Emergency Response Act). The legislation received royal assent at roughly 1:30 p.m. on March 25.</description><pubDate>Thu, 26 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7fbf999a-dc99-4493-bd97-c054294044df</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/patent-and-infringement-together-patent-owners</link><title>Patent validity and infringement issues heard together in China for the first time: What patent owners should consider before choosing this route</title><description>For the first time, both the validity of the patent and infringement by the product were heard and decided in the same trial. This combined structure allowed for &#xA0;advantages and disadvantages for both parties, and provided helpful insight for those faced with the choice of validity and infringement combination</description><pubDate>Tue, 24 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">67781ece-1488-4fca-b480-d9a85b10cf02</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/german-constitutional-court-delays-upc</link><title>German Constitutional Court delays UPC</title><description>In Germany, the Federal Constitutional Court (Bundesverfassungsgericht) has held that the statute by which the German Parliament (Bundestag) sought to ratify the UPC Agreement (the &#x27;Act of Approval&#x27;) is void.</description><pubDate>Fri, 20 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9f014d7d-e6e4-4858-96ad-76253545b312</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/update-from-the-canadian-ip-office</link><title>Update from the Canadian Intellectual Property Office</title><description>Amid the spread of COVID-19 and social distancing, the Canadian Intellectual Property Office (CIPO) has announced the relaxation of deadlines, among other precautionary measures, to accommodate potential delays and interruptions in filings.</description><pubDate>Tue, 17 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d4271043-a66b-4ef9-be82-2d7d2a751500</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/canadian-patent-law-2019-year-in-review</link><title>Canadian patent law: 2019 year in review</title><description>There were various developments in Canadian patent law in 2019. Numerous decisions of the Federal Court of Appeal and Federal Court will have a notable impact on patent law in Canada going forward.</description><pubDate>Wed, 26 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">af056957-0892-4981-a7f8-ca040c13b32b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/patent-federal-court-of-appeal-dosage-questions</link><title>Patentability in Canada: Federal Court of Appeal questions the fixed dosage amount vs dosage range distinction</title><description>In Canada, claims to new uses based on the discovery of &#x27;hitherto unrecognized properties&#x27; constitute patentable subject matter.</description><pubDate>Thu, 13 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2927fab0-8ef0-45f5-9778-27e2b005f0c7</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/unity-of-invention-requirements-russia-versus-eur</link><title>Unity of invention requirements: Russia versus Eurasia</title><description>According to Russian and Eurasian patent regulations, an application must relate to one invention or a group of inventions.</description><pubDate>Wed, 12 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1d254376-2414-4e29-8ebe-e9d39307d6bd</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/annual-review-of-uk-patent-cases-2019</link><title>Annual Review of UK Patent Cases - 2019</title><description>Take a look at Gowling WLG&#x27;s annual review of 2019&#x27;s patent cases.</description><pubDate>Tue, 04 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ad58982e-7570-40d7-8265-3f2f5beef58c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/voluntarily-restrictions-on-russian-and-eurasian-p</link><title>Voluntarily restrictions on Russian and Eurasian patents: a useful option for patent holders</title><description>There is no formal procedure for post-grant amendments to Russian patents under the country&#x2019;s Patent Act. However, it is possible to request full or partial renunciation of the granted patent.</description><pubDate>Thu, 30 Jan 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3b8d7cdd-8a9d-49b2-a70e-6e0f6ba63f0b</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2020/amendments-to-the-german-patent-act</link><title>Amendments to the German Patent Act: Introduction and discussion of the draft of a Second Act for simplifying and modernising patent law</title><description>On 14 January 2020, the German Ministry of Justice and Consumer Protection (BMJV) published the draft of a Second Act for simplifying and modernising patent law (hereinafter referred to as: &#x22;Modernisation Draft&#x22;). In this latest Insight, we discuss the most significant amendments.</description><pubDate>Wed, 29 Jan 2020 10:46:00 Z</pubDate></item><item><guid isPermaLink="false">03ccc83c-4db4-4491-beb3-73c05669b226</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/gowling-wlg-lawyers-contribute-russian-expertise</link><title>Gowling WLG lawyers David Aylen and Vladislav Ugryumov contribute Russian IP expertise to The Patent Litigation Law Review (3rd ed.)</title><description>Partners David Aylen and Vladislav Ugryumov of Gowling WLG&#x27;s Moscow office recently contributed their expertise to the third edition of The Patent Litigation Law Review, published late last year.</description><pubDate>Mon, 20 Jan 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f8b39332-b9a0-461e-9b7f-41d0b0f8e36f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2020/vavilov-changes-to-administrative-law-in-canada</link><title>&#x3C;em&#x3E;Vavilov&#x3C;/em&#x3E; : Changes to administrative law in Canada</title><description>In late December 2019, the Supreme Court released its decision in Canada (Minister of Citizenship and Immigration) v Vavilov, 2019 SCC 65.</description><pubDate>Wed, 08 Jan 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7896be06-a82e-4f0f-861c-ed0cbbfce2ba</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/fto-assessments-rights-to-consider</link><title>FTO assessments: what rights holders need to consider</title><description>Patent rights are vigorously protected in Russia - it is therefore advisable that those interested in commercialising a product or process perform vital risk-management analysis in order to gauge their freedom to operate.</description><pubDate>Thu, 19 Dec 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">864d5719-093d-4079-bc93-7f0e556b07ae</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/third-party-rights-to-infringe</link><title>Third Party Rights to Infringe</title><description>Over the last year the Canadian Government has added two new sections to the Patent Act that have created new exceptions to infringement.</description><pubDate>Tue, 26 Nov 2019 18:27:00 Z</pubDate></item><item><guid isPermaLink="false">eae31db5-1e52-413f-b82c-ba52376803ba</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/canadian-v-us-monetary-for-patent-infringement</link><title>Show Me the Money! Canadian v. US Monetary Remedies for Patent Infringement</title><description>In recent years, Canada has become an increasingly attractive jurisdiction for patentees to obtain and enforce their patent rights. In terms of monetary remedies, as compared to the United States, there is often greater flexibility in Canada in crafting compensation for infringement. Despite our smaller market, the size of damages and profits awards can, at times, end up being larger in Canada.</description><pubDate>Mon, 11 Nov 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61bdb2c4-c49a-4357-bc18-a063a3deb158</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/digital-economy-means-for-rospatent</link><title>The future is here: what the Digital Economy Programme means for Rospatent</title><description>Improving electronic interactivity has been a high priority for the Russian Patent and Trademark Office (Rospatent) in recent years, especially since the launch of the Digital Economy Programme in 2018. This long-term initiative aims to revolutionise the country&#x2019;s IT infrastructure, enabling the widespread, efficient and secure receipt, transmission, processing and storage of electronic data by all levels of government bodies by 2024.</description><pubDate>Wed, 06 Nov 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fe489f47-fca8-4bb2-bcfe-cd48fcec9e19</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/gowling-wlg-moscow-co-author-global-patent-book</link><title>Gowling WLG Moscow lawyers Vladislav Ugryumov and Ruben Dzhermakyan co-author global patent book</title><description>Vladislav M. Ugryumov and Ruben V. Dzhermakyan have authored a chapter of the 2019 edition of Global Patent Protection and Enforcement of In Vitro Diagnostic Inventions.</description><pubDate>Wed, 30 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a96eb6f0-671d-4fd4-8916-a18d48a82dd8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/amendments-to-guidelines-for-patent-examination</link><title>A summary of the latest amendments to the Guidelines for Patent Examination in China</title><description>The China National Intellectual Property Administration (CNIPA) Guidelines for Patent Examination set detailed rules and explanations for Chinese patent examiners to determine the patentability of an invention, a utility model or a design.</description><pubDate>Tue, 29 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c4ea666b-0fe1-4935-a006-bc864a1adf0e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/shanks-v-unilever</link><title>Inventing employee wins &#xA3;2 million compensation for outstanding benefit of patents in UK Supreme Court</title><description>The UK Supreme Court has awarded an employee (Mr Shanks), whose inventions led to patents that were of &#x27;outstanding benefit&#x27; to his employer (Unilever), compensation of &#xA3;2&#xA0;million as a &#x27;fair share&#x27; of that benefit.</description><pubDate>Fri, 25 Oct 2019 14:24:00 Z</pubDate></item><item><guid isPermaLink="false">0f8dee9a-48c2-4412-9384-8dd59de33cc4</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/how-much-does-a-canadian-patent-cost</link><title>How much does a &#x3C;br&#x3E;Canadian patent cost?</title><description>Asking how much it costs to get a patent in Canada is a bit like asking how long a piece of string is. The answer, of course, depends on many different factors, but there are a number of general guidelines that can be used to anticipate likely costs that will be incurred over the lifetime of a patent.</description><pubDate>Thu, 24 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">970510ae-5087-4983-b21c-e767bba23ba6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/patenting-artificial-intelligence-inventions</link><title>Patenting Artificial Intelligence Inventions in Canada</title><description>In recent years, the confluence of advancements in computational power and the abundance of rich data sets has led to a surge in the number of practical applications for AI.</description><pubDate>Thu, 24 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">edecda40-246c-4b0c-aad6-69799217ad9a</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/patentees-beware-of-foreign-patent-file-histories</link><title>Patentees Beware: Federal Court rules foreign patent file histories could come back to haunt you</title><description>On Sept. 25, 2019, the Federal Court of Canada released its first decision interpreting the scope of new section 53.1 of the Patent Act. This statutory provision allows for the patent &#x22;file wrapper&#x22; or file history -&#xA0;chiefly comprising correspondence between a patentee and a patent office during prosecution - to be used to rebut a patentee&#x27;s representations about patent claim construction.</description><pubDate>Thu, 26 Sep 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c19723cb-0783-4574-87d8-d1dd5d884033</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2019/precedent-setting-decision-in-patent-infringement</link><title>Federal Court issues precedent-setting decision in patent infringement action</title><description>On Sept. 25, 2019, Justice Manson of the Federal Court of Canada summarily dismissed a patent infringement action brought by CanMar Foods Ltd. against TA Foods Ltd.</description><pubDate>Wed, 25 Sep 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cdc9ef79-7455-4243-a58d-2314d0dd3b65</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/reasons-to-seek-patent-protection-in-canada</link><title>OH CANADA! Reasons to Seek Patent Protection in the True North in 2019</title><description>Canada&#x27;s innovation and tech sectors have flourished in recent years, attracting leading entrepreneurs and major investments from around the world to Canada.</description><pubDate>Thu, 12 Sep 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cb494e42-9059-4afb-b14e-5199112b3cf8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/why-registering-ip-in-china-is-essential</link><title>Why registering IP in China is essential</title><description>Making sure your IP strategy includes China is essential if you are to get a foot in the door of the world&#x2019;s fastest-growing IP market.</description><pubDate>Tue, 03 Sep 2019 08:35:00 Z</pubDate></item><item><guid isPermaLink="false">8d48ecfd-194c-40eb-8c46-af5c9ddfbbb3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/dazed-and-confused-a-closer-look-at-the-amended-p</link><title>Dazed and Confused: A closer look at the Amended Patented Medicines Regulations</title><description>While Friday&#x27;s announcement of amendments to the PMR may not have introduced any surprises, it did highlight the considerable uncertainty facing patentees selling medicines in Canada.</description><pubDate>Thu, 15 Aug 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1f073425-95d9-4e4f-873f-cc6df7310bb8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/pmprb-shakeup-united-states-and-switzerland-no-l</link><title>PMPRB shakeup - United States and Switzerland no longer relevant countries</title><description>The federal government has announced the long-awaited changes to the Patented Medicines Regulations, which are set to come into force on July 1, 2020.</description><pubDate>Fri, 09 Aug 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a04d84e1-a543-4752-b182-3ca48ec4d9aa</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/patent-extension-in-russia</link><title>Patent extension in Russia</title><description>Since 2003 it has been possible to extend the duration or term of a Russian patent for a drug, pesticide or agricultural chemical by up to five years. Upon the patent holder&#x27;s request, an extension to a patent term may be obtained based on the product&#x27;s first marketing authorisation.</description><pubDate>Thu, 08 Aug 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6ee590c1-2e8e-4603-91b8-8a487a91698c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/update-implementation-of-the-patent-law-treaty</link><title>Update: Implementation of the Patent Law Treaty</title><description>The Canadian government has published the final version of the new Patent Rules, which come into force on Oct. 30, 2019.</description><pubDate>Wed, 07 Aug 2019 14:25:00 Z</pubDate></item><item><guid isPermaLink="false">d16544c0-bab7-4598-b0fd-23aff3455e0f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/the-importance-of-ip-rights-in-technology</link><title>The importance of intellectual property rights in technology</title><description>Our intellectual property experts consider the importance of IP rights in technology during disruptive times.</description><pubDate>Thu, 25 Jul 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b6b4c626-e0a6-4309-965d-0af6ef69e6c5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/ip-strategy-learning-from-the-disruptors</link><title>IP Strategy: What management can learn from the disruptors</title><description>Four tips to creating the best IP strategy in the face of disrupted markets.</description><pubDate>Tue, 23 Jul 2019 08:02:00 Z</pubDate></item><item><guid isPermaLink="false">a81a120c-f50c-4946-a3b5-e669ea974a07</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/actavis-v-eli-lilly-impact-on-patent-infringement</link><title>Actavis v Eli Lilly: the impact on patent infringement law in the UK two years on</title><description>Our intellectual property experts discuss the impact that Actavis v Eli Lilly had on patent infringement law in the UK.</description><pubDate>Thu, 18 Jul 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5cc71f77-399a-4639-86ea-1d460a9a0a96</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/publication-of-the-finalized-patent-rules</link><title>Publication of the finalized &#x3C;em&#x3E;Patent Rules&#x3C;/em&#x3E;, and announcement of coming-into-force date</title><description>The coming-into-force date for the new Patent Rules has been announced as October 30, 2019.</description><pubDate>Wed, 10 Jul 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4453b11b-6e8e-41bf-8ee4-025898e1c3b6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/going-overboard-on-overbreadth</link><title>Going Overboard on Overbreadth</title><description>Under the doctrine of overbreadth a patent is invalid if its claims extend beyond the invention.</description><pubDate>Tue, 28 May 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e2458540-bb3b-424b-a0ae-e497a8b517e6</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/jaguar-land-rover-v-landwind-unfair-competition</link><title>Jaguar Land Rover v LandWind: acts of unfair competition and copyright infringement</title><description>The three-year court battle between JLR and Chinese automotive manufacturer Jiangling resulted in a long-awaited victory for JLR and the wider automotive industry.</description><pubDate>Thu, 23 May 2019 13:03:00 Z</pubDate></item><item><guid isPermaLink="false">c2028169-539b-43ff-8566-362c2533b5b0</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/brexit-the-clock-ticks</link><title>Brexit: the clock ticks</title><description>&#x27;Brexit&#x27; poses considerable challenges for intellectual property law and presents uncertainty as to the involvement of the UK, following its exit from the EU, in existing and proposed international regimes involving European Union (EU) law.</description><pubDate>Tue, 21 May 2019 10:20:00 Z</pubDate></item><item><guid isPermaLink="false">3e6e3c6a-f302-4db3-90e4-8288b2411a0d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/law-improve-accessibility-to-marketing-authorize</link><title>Law to improve accessibility to marketing authorisations for drugs could have some nasty side-effects</title><description>Precis: The Russian Ministry of Health has introduced a draft bill that clarifies the application process for marketing authorisations for a drug. There is concern that the new accessibility could lead to infringement when authorisation is sought for generic drugs. However, a proposed unified registry could prevent this.</description><pubDate>Tue, 16 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ed03cb37-b44d-441b-9152-be8a7988bc85</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/intellectual-property-enforcement-guidelines</link><title>Intellectual Property Enforcement Guidelines: Settlements of Proceedings under the PM(NOC) Regulations</title><description>On March 13, 2019 the Competition Bureau introduced its new Intellectual Property Enforcement Guidelines, which seek to increase transparency regarding the Bureau&#x27;s application of the Competition Act as it relates to the assertion of IP rights.</description><pubDate>Wed, 03 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f3c851f6-6535-45dd-b804-a8cb0974c13e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2019/winning-judgment-for-tq-delta-reaffirms-expertise</link><title>Gowling WLG reaffirms its patent expertise with a winning judgment for TQ Delta</title><description>Gowling WLG&#x27;s award-winning Patent team has gained recognition in the market for a significant patent win for client TQ Delta LLC.</description><pubDate>Wed, 03 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">53a2a91b-e82f-4de9-ade4-c239e72c2fba</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/uk-supreme-court-explains-the-law-of-obviousness</link><title>UK Supreme Court explains the law of obviousness</title><description>The UK Supreme Court has delivered an important judgment on the test of &#x27;obviousness&#x27; in patent law, and in particular for dosing regimen patents.</description><pubDate>Tue, 02 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a3d7f9ec-0d09-4340-95e6-8e2fdbb0e35b</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/benefits-of-industry-group-intervention</link><title>Benefits of industry group intervention in the Federal Court of Canada</title><description>A recent decision of the Federal Court provides useful guidance on the benefits that industry groups can bring to the proceeding in light of their unique perspectives.</description><pubDate>Mon, 25 Feb 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">acc42307-57c4-4cea-a8ed-e44c960b7ac2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/bad-faith-trademark-applications</link><title>Bad Faith Trademark Applications</title><description>Gowling WLG&#x27;s experts address the topic of &#x27;bad faith&#x27; applications in the field of trademarks; considering the significance of the problem; how such applications may be dealt with; and strategies for risk prevention, across multiple jurisdictions.</description><pubDate>Thu, 31 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">80015a71-8940-4ffd-b101-39d32b44a5b6</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2019/annual-review-of-the-2018-patent-cases</link><title>Annual Review of the 2018 Patent Cases</title><description>In January 2019, Gowling WLG&#x27;s co-head of global Intellectual Property (IP), Gordon Harris, delivered his much anticipated annual review of the year&#x27;s UK patent.</description><pubDate>Wed, 30 Jan 2019 12:24:00 Z</pubDate></item><item><guid isPermaLink="false">c99ea383-59fe-4120-8376-edcc99851823</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/changes-to-the-uk-s-trademarks-law</link><title>Changes to the UK&#x27;s Trademarks Law</title><description>The EU Trademarks Directive 2015 comes into force in the UK; bringing with it some key changes to the UK&#x27;s legal system governing the application, registration, enforcement and licensing of trademarks.</description><pubDate>Mon, 14 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">795b2598-6c6d-4d7c-b7ad-08bd2132f95e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/foreign-patent-holders-beware-when-writing</link><title>Foreign patent holders (and lawyers/patent agents): Beware when writing to Canadians</title><description>A number of changes to Canada&#x27;s intellectual property legislation came into force on Dec. 13, 2018. One of the changes to Canada&#x27;s Patent Act is a new subsection relating to written demands (a.k.a. cease and desist letters) in relation to patents - seemingly any patents, including foreign patents.</description><pubDate>Thu, 10 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1a7536cf-fc40-44df-8946-deec737aec3f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2019/canadian-patent-law-2018-year-in-review</link><title>Canadian patent law: 2018 year in review</title><description>Developments in Canadian patent law in 2018. Decisions of the Federal Court of Appeal and Federal Court will have a notable impact on patent law. Additionally, amendments to the Patent Act and the Patent Rules will impact prosecution and enforcement of patent rights in Canada for years to come.</description><pubDate>Mon, 07 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1460da15-d74d-4225-a921-13749147208f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/gsk-awarded-arrow-declaration-in-patent-dispute</link><title>GSK awarded &#x3C;em&#x3E;Arrow&#x3C;/em&#x3E; declaration in patent dispute with Vectura</title><description>Gowling WLG&#x27;s IP experts discuss GSK&#x27;s High Court patent dispute with Vectura.</description><pubDate>Thu, 13 Dec 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61dd4b4f-40d8-4a44-873e-5dcea8df678a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/another-step-towards-ratification-of-patent-law</link><title>One more step towards implementation of the Patent Law Treaty</title><description>On Dec. 1, 2018, the Canadian government published for public consultation an updated version of its proposed amendments to the Canadian Patent Rules.</description><pubDate>Mon, 03 Dec 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e94ea64a-fab4-471d-b50e-90952be171ef</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/uk-supreme-court-ruling-in-warner-lambert-case</link><title>UK Supreme Court confirms Warner-Lambert patent claims insufficient&#x2026;</title><description>The UK Supreme Court&#x27;s judgment in Warner-Lambert v Generics has, sadly, unsettled areas of patent law in the UK, while confirming the invalidity of key claims of Warner-Lambert&#x27;s patent.</description><pubDate>Wed, 21 Nov 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cbcc8bee-08fb-47bd-b52d-7a8d1e468ef3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/warner-lambert-pregabalin-patent-case</link><title>UK Supreme Court majority against Warner-Lambert in pregabalin patent case</title><description>Gowling WLG&#x27;s IP team provides a snap-shot commentary on the Supreme Court&#x27;s reasoning in the Warner-Lambert case.</description><pubDate>Wed, 14 Nov 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a31e4563-a11d-45d6-9bb9-a4c0b0c05045</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/first-reading-bill-c-86</link><title>A First reading of Bill C-86 introduces a number of amendments to the &#x3C;em&#x3E;Patent Act&#x3C;/em&#x3E;, &#x3C;em&#x3E;Copyright Act&#x3C;/em&#x3E; and &#x3C;em&#x3E;Trademarks Act&#x3C;/em&#x3E;</title><description>Bill C-86, the Budget Implementation Act (the Bill), received its first reading in the House of Commons on October 29, 2018.</description><pubDate>Thu, 01 Nov 2018 07:33:00 Z</pubDate></item><item><guid isPermaLink="false">78a1bf15-e891-4940-b2c3-6298d1865555</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/usmca-what-it-means-for-patents-and-pharmaceutical</link><title>The USMCA: What does it mean for patents and the pharmaceutical industry?</title><description>In a joint statement on Sept. 30, 2018, the United States and Canadian Governments announced that they reached an agreement, alongside Mexico, on a new, modernized trade agreement for the 21st century.</description><pubDate>Fri, 05 Oct 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9192fc3e-9cf1-4816-af33-fb69a99c05bc</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/the-intellectual-property-review-seventh-edition</link><title>The Intellectual Property Review, seventh edition</title><description>The Intellectual Property Review, seventh edition, has been published. Gowling WLG (Gordon Harris, Andrew Maggs, George Sevier and Ailsa Carter) authored the UK Chapter.</description><pubDate>Wed, 26 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fdccc7d2-561a-4015-9fd8-a863a1b043c8</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2018/uk-government-no-deal-brexit-guidance-for-ip</link><title>&#x27;If there&#x27;s no deal&#x27; Brexit IP guidance from UK Government</title><description>The UK Government has released guidance on the Brexit process for intellectual property in a no deal scenario. UK legislation will extract UK rights from existing EU-wide trademark and design registrations. The UK will continue to recognise existing unregistered Community design right and will create a new unregistered design right of equivalent scope. For the &#x22;immediate&#x22; term, the UK will also continue to recognise regional exhaustion (but the European Economic Area (EEA) will not recognise the UK within that system). The existing patent systems will largely be unaffected by Brexit. Please read on for our fuller summary of the highlights of the 24 September 2018 guidance.</description><pubDate>Tue, 25 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">374509b0-b45e-45f4-abfb-bf3d4029e17b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/one-year-anniversary-of-the-csp-regulations</link><title>One-year anniversary of the CSP Regulations</title><description>On Sept. 21, 2017, the Certificate of Supplementary Protection Regulations (CSP Regulations) came into force, providing for the first time the ability to obtain an extended period of patent protection for human and veterinary drugs in Canada.</description><pubDate>Mon, 17 Sep 2018 18:26:00 Z</pubDate></item><item><guid isPermaLink="false">bd5bf0ac-98aa-4b41-81d2-a216404d9683</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/new-automotive-technology-and-brexit</link><title>New automotive technology and Brexit</title><description>This short guide highlights key areas requiring action by companies in the UK&#x27;s automotive sector involved in the development of new technology: access to funding; access to skilled workers; potential divergence in legal and regulatory frameworks; intellectual property; and technical standards.</description><pubDate>Fri, 07 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fc1b794e-8742-4e21-b166-0dba3831b36e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/no-deal-brexit-implications-for-automotive-ip</link><title>No deal Brexit implications for automotive IP?</title><description>This article explores the implications of a no deal Brexit, for IP regimes supporting the UK automotive sector.</description><pubDate>Wed, 05 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">bf4ea228-b71b-4ec7-84ae-8f61d8d81000</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/rospatent-fee-based-extradited-examination</link><title>Rospatent re-launches fee-based expedited examination</title><description>On October 5, 2017 the Russian Patent and Trademark Office (Rospatent) officially announced that expedited examination will be available for all applications.</description><pubDate>Tue, 17 Jul 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">20c8dee9-b22d-45c2-9414-b58dffbe1727</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/challenges-facing-the-automotive-sector</link><title>Unprecedented challenges facing the automotive sector demand urgent re-evaluation of existing IP strategies</title><description>Research from our new report found that 86% of industry experts expect to see more litigation in the automotive sector.</description><pubDate>Tue, 10 Jul 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e3cb35e4-70d3-4801-aeab-8ee4bb33b420</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/shire-successfully-defends-canadian-vyvanse-paten</link><title>Shire Defends Canadian VYVANSE&#xAE; Patent against Apotex&#x27;s Impeachment Attacks</title><description>Apotex&#x27;s invalidity allegations regarding Shire&#x27;s Canadian Patent 2,527,646 covering the active ingredient in Shire&#x27;s ADHD medication VYVANSE&#xAE; have been rejected following a 17-day trial before Justice Fothergill of the Federal Court.</description><pubDate>Tue, 03 Jul 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2be3aff2-ee9e-4546-9827-5b6bcd9be15c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2018/shire-successfully-defends-against-apotex</link><title>Shire successfully defends Canadian VYVANSE&#xAE; patent against Apotex&#x27;s impeachment attacks</title><description>On June 29, 2018, the Federal Court, after a 17-day trial presided over by Justice Fothergill, issued its public judgment and reasons on a dispute involving Apotex&#x27;s invalidity allegations regarding Shire&#x27;s Canadian Patent 2,527,646 covering the active ingredient in Shire&#x27;s ADHD medication VYVANSE&#xAE;.</description><pubDate>Fri, 29 Jun 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6367a1a0-2a56-4f86-9980-e2e7ed7bbc43</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/how-to-shoot-for-arrow-relief</link><title>How to shoot for Arrow relief</title><description>The Court of Appeal has ruled that the discretion as to whether or not to award Arrow relief lies with the trial judge, for exercise in light of the facts and circumstances at the date of the trial.</description><pubDate>Thu, 28 Jun 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">bc30037c-88b5-4db3-86c9-715fa4e3fe87</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/alcon-puts-the-brakes-on-ap-racing</link><title>The Court of Appeal confirms that retrial is not permitted</title><description>Alcon has successfully resisted AP Racing&#x27;s appeal against an Intellectual Property Enterprise Court (IPEC) decision. The case concerns Alcon&#x27;s high performance brake caliper designs and technology.</description><pubDate>Wed, 27 Jun 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9041352c-ca53-4946-866f-37ce8cce1fcf</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/eu-commission-proposes-softening-of-spc-law</link><title>EU Commission proposes softening of SPC law to assist EU-based manufacturers</title><description>The European Commission has proposed a &#x27;targeted adjustment&#x27; to intellectual property law with a view to reducing the restrictions on EU-based manufacturers of pharmaceuticals seeking to compete in global markets.</description><pubDate>Wed, 30 May 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d2b4c92e-c894-4262-9303-fe4b2eec19bb</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/post-grant-patent-validity-challenges-canada-uk</link><title>Post-grant patent validity challenges in Canada and the UK</title><description>Most jurisdictions provide at least some procedures for challenging the validity of a granted patent.</description><pubDate>Tue, 01 May 2018 15:05:00 Z</pubDate></item><item><guid isPermaLink="false">7412da35-1593-48db-9c45-75c01d48845b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/canadian-government-launches-ip-strategy</link><title>Canadian government launches intellectual property strategy for innovators &#x26; small businesses</title><description>On April 25, the federal government launched a national Intellectual Property (IP) Strategy aimed at innovators and small businesses.</description><pubDate>Fri, 27 Apr 2018 14:32:00 Z</pubDate></item><item><guid isPermaLink="false">6f88356f-2228-49e1-a634-ef7addb1e365</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/uk-ratifies-the-upc-agreement</link><title>UK ratifies the UPC Agreement - what does this mean for the UPC? (Sssh - don&#x27;t mention Brexit&#x2026;)</title><description>On 26 April 2018 the UK completed its ratification of the UPC Agreement by depositing its instrument of ratification with the European Council.</description><pubDate>Fri, 27 Apr 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3972fa58-3cda-4fad-8991-53ae191eac28</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/patent-eligibility-natural-product-can-us</link><title>A tale of two countries: Patent eligibility requirements for natural products in Canada and the U.S.</title><description>Like any sector of the innovation economy, the life-sciences industry relies on sound patent policy to incentivize research and development.</description><pubDate>Wed, 28 Mar 2018 16:36:00 Z</pubDate></item><item><guid isPermaLink="false">8dd95e1e-f1df-43aa-9a5e-45045037a420</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/brexit-implications-for-ip-arrangements-agreed-so</link><title>Brexit implications for IP: arrangements agreed so far</title><description>The United Kingdom and the (remaining) EU have reached partial agreement on the text of a treaty that will govern the Brexit process. It provides broad clarity regarding arrangements for the transitioning of unitary EU rights in trademarks, designs and plant variety rights into UK rights.</description><pubDate>Tue, 20 Mar 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9e0b5bb6-c97c-4d8e-9965-f000116ec52d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/understanding-ip-across-multiple-jurisdictions</link><title>Understanding IP across multiple jurisdictions</title><description>Guides to understanding the differences between IP law in multiple jurisdictions.</description><pubDate>Tue, 27 Feb 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">924ccb11-100e-429f-ab69-67831f0b6a31</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/employee-inventor-compensation-annual-patents-re</link><title>Employee Inventor Compensation - Annual Patents Review 2017</title><description>This is the Employee Inventor Compensation chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 10:07:00 Z</pubDate></item><item><guid isPermaLink="false">623b5842-1397-4c2d-ac3a-406dd44fc38f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/competition-law-annual-patents-review-2017</link><title>Competition Law, Settlement and Licensing - Annual Patents Review 2017</title><description>This is the Competition Law, Settlement and Licensing chapter of Gordon Harris&#x27; Annual Patents Review 2017.</description><pubDate>Thu, 15 Feb 2018 10:06:00 Z</pubDate></item><item><guid isPermaLink="false">3f718a74-3f0b-42bf-9c03-2b5c21971e36</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/validity-annual-patents-review-2017</link><title>Validity - Annual Patents Review 2017</title><description>This is the Validity chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 10:04:00 Z</pubDate></item><item><guid isPermaLink="false">c9802ca5-1344-45c0-a9c5-6d5ce14974a2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/infringement-annual-patents-review-2017</link><title>Infringement - Annual Patents Review 2017</title><description>This is the Infringement chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 10:03:00 Z</pubDate></item><item><guid isPermaLink="false">a022e6c0-ae3b-4b4a-8bf2-d71e385ad9a1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/annual-patents-review-2017-overview</link><title>Annual Patents Review 2017 - Overview</title><description>Gowling WLG&#x27;s UK intellectual property (IP) team bring you their annual patent review for 2017.</description><pubDate>Thu, 15 Feb 2018 09:57:00 Z</pubDate></item><item><guid isPermaLink="false">be60fd93-4062-4c5f-9460-70c2858e2242</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/technical-matters-annual-patents-review-2017</link><title>Technical Matters and Procedure - Annual Patents Review 2017</title><description>This is the Technical Matters and Procedure&#xA0;chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 01:05:00 Z</pubDate></item><item><guid isPermaLink="false">07a2a365-3d36-479a-b456-d48657591f43</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/from-tpp-to-cptpp-suspensions-to-ip-provisions</link><title>From TPP to CPTPP: Suspensions to IP Provisions</title><description>On January 23, 2018, Canada and 10 other signatories of the now-defunct Trans-Pacific Partnership (TPP) concluded a series of negotiations in Tokyo concerning the planned &#x27;Comprehensive and Progressive Agreement for Trans-Pacific Partnership&#x27; (CPTPP).</description><pubDate>Wed, 07 Feb 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">36bca360-38a0-4e58-a19e-b1a2ac0a8832</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2018/top-10-differences-patent-litigation-canada-us</link><title>Top 10 differences in patent litigation in Canada and the U.S.</title><description>Patent owners are increasingly looking outside the United States in order to enforce their patent rights. Many would argue that the Inter Partes Review process and various US Supreme Court decisions have made enforcement of patent rights in the United States more challenging over at least the past five years.</description><pubDate>Mon, 22 Jan 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4e1fbdc7-ba9c-44b6-9a7d-afeeca75c675</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/uk-supreme-court-introduces-doctrine-of-equivalent</link><title>Actavis vs. Eli Lilly: UK Supreme Court introduces Doctrine of Equivalents in Patent Law</title><description>In a landmark decision, Actavis v Eli Lilly [2017] UKSC 48, the UK Supreme Court has re&#x2010;steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents, and expressly permiting recourse by the courts to the prosecution file in appropriate limited circumstances.</description><pubDate>Mon, 22 Jan 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">db6f463b-2f3e-4135-a8a8-743c72779351</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2018/canadian-patent-law-2017-year-in-review</link><title>Canadian patent law: 2017 year in review</title><description>This article summarizes these and other noteworthy decisions and developments in Canadian patent law from 2017.</description><pubDate>Wed, 03 Jan 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f03768ef-b2dc-4612-9795-ba4d7146038b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/the-skinny-on-skinny-labels</link><title>The skinny on skinny labels</title><description>In a recent decision of Federal Court (Bristol-Myers Squibb Canada v Apotex Inc., 2017 FC 1061), Justice Lafreni&#xE8;re dismissed the prohibition proceeding brought by Bristol-Myers Squibb Canada (BMS) against Apotex Inc. (Apotex) for a generic version of ABILIFY&#xAE;, which is indicated for several uses.</description><pubDate>Thu, 21 Dec 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e43e4704-8ed9-4195-9634-5aaaa81f416c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/podcasts/2017/design-protection-hindsight-giving-insight</link><title>London Design Festival: Design Protection - Hindsight giving insight</title><description>In this podcast, design lawyer John Coldham is joined by a panel of fellow experts, offering designers advice on protecting their creations.</description><pubDate>Fri, 03 Nov 2017 11:17:00 Z</pubDate></item><item><guid isPermaLink="false">57c74668-1c42-441a-8dd0-670d3cfa3d09</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/government-increases-official-fees-by-rospatent</link><title>Government increases official fees charged by Rospatent</title><description>As of October 6, 2017, administrative fees charged by the Russian Patent and Trademark Office (Rospatent) have been increased by Decree 1151. The decree has also introduced fees not previously charged by Rospatent.</description><pubDate>Wed, 01 Nov 2017 23:00:00 Z</pubDate></item><item><guid isPermaLink="false">6213a015-8910-42bb-aabc-056dbbd33d3b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/pmprb-decision-creates-uncertainty-for-patentees</link><title>PMPRB decision creates uncertainty for patentees</title><description>On September 27, 2017, a two-member Hearing Panel of the Patented Medicine Price Review Board (PMPRB) ruled that the ultra-rare disease drug Soliris&#xAE; (eculizumab), manufactured by Alexion Pharmaceuticals Inc. (Alexion), was excessively priced.</description><pubDate>Wed, 01 Nov 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">032cf7cb-52bd-4075-83b2-c2f716265d8f</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/defects-in-pre-patent-issue-process-do-not-render</link><title>Defects in pre-patent issue process do not render a patent void</title><description>In Apotex Inc. v Pfizer Inc. et al, 2017 FCA 201, the Federal Court of Appeal refused to void a patent based on an administrative error made during the prosecution of the patent application.</description><pubDate>Wed, 18 Oct 2017 10:57:00 Z</pubDate></item><item><guid isPermaLink="false">5eec1abd-22e1-415d-b0f9-262d9583ff3e</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/mind-the-actavis-v-eli-lilly-gap-please</link><title>Mind the Actavis v Eli Lilly gap please</title><description>Following the Supreme Court&#x27;s decision in Actavis v Lilly, is there a gap between the interpretation of a patent claim for validity purposes and its reach for infringement purposes? If so, what are the practical implications?</description><pubDate>Wed, 18 Oct 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4af2d49e-e7d2-4341-8313-96b673567389</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/uk-rewrites-its-law-prohibiting-threats-of-legal-p</link><title>UK rewrites its law prohibiting threats of legal proceedings for IP infringement</title><description>The Intellectual Property (Unjustified Threats) Act 2017 (the Act) entered into force on 1 October 2017, introducing changes to the law in the UK regarding threats of intellectual property proceedings.</description><pubDate>Mon, 02 Oct 2017 07:37:00 Z</pubDate></item><item><guid isPermaLink="false">1844555b-5246-4a0d-ac33-f89a2f4ac6f8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/draft-patent-rules-released-for-public-consultatio</link><title>Draft &#x3C;em&#x3E;Patent Rules&#x3C;/em&#x3E; released for public consultation: Overview of key changes</title><description>The Canadian Intellectual Property Office (CIPO) has released draft revisions to the Patent Rules for public consultation. The draft revisions propose to make extensive changes to the current Patent Rules.</description><pubDate>Tue, 01 Aug 2017 17:15:00 Z</pubDate></item><item><guid isPermaLink="false">9ae272b6-3880-48c4-8401-520928a65aa5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/certificates-of-supplementary-protection-canada-s</link><title>Certificates of supplementary protection: Canada&#x27;s new &#x3C;em&#x3E;sui generis&#x3C;/em&#x3E; patent term restoration regime</title><description>We previously reported on Bill C-30 (the Act to implement CETA) which made important changes to Canada&#x27;s intellectual property landscape reflecting its commitments under the Comprehensive Economic and Trade Agreement between Canada and the European Union (CETA).</description><pubDate>Mon, 24 Jul 2017 10:02:00 Z</pubDate></item><item><guid isPermaLink="false">946f2e77-8336-43c1-b9a2-1a95b92986e0</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/uk-supreme-court-introduces-doctrine-of-equivalent</link><title>UK Supreme Court introduces doctrine of equivalents in patent law in Actavis v Lilly</title><description>In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents.</description><pubDate>Thu, 13 Jul 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b39aeccb-665c-45f5-832b-8b30be34dabf</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/$644-million-patent-infringement-judgment-is-large</link><title>$644 million patent infringement judgment is largest in Canadian history</title><description>In its decision in The Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 637, the Federal Court of Canada has awarded the successful plaintiff (Dow Chemical) over $644,000,000, plus interest, as compensation for Nova Chemicals&#x27; patent infringement.</description><pubDate>Wed, 12 Jul 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0b8b5f09-7897-4b3d-87c5-3ed2eae0a176</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/promise-of-the-patent-doctrine</link><title>Supreme Court of Canada rejects the Promise of the Patent Doctrine</title><description>The Promise Doctrine required patentees to establish arguable statements of utility in the patent disclosure or risk losing their patents.</description><pubDate>Fri, 30 Jun 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aeacb763-1dde-43d8-a399-eb3dbf06f176</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/uk-parliament-continues-legislative-steps-needed-f</link><title>UK Parliament continues legislative steps needed for ratification of UPC Agreement</title><description>With the UK Parliament sitting again, following the drama of the June 2017 General Election, the Government is now continuing with the national legislative steps that need to be completed before the UK can ratify the Agreement on a Unified Patent Court (UPC Agreement).</description><pubDate>Tue, 27 Jun 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6ffc75c4-9ef8-45f4-b52b-1d420e491018</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/patent-exhaustion-in-canada-and-the-uk</link><title>Patent exhaustion in Canada and the UK</title><description>The doctrine of &#x27;patent exhaustion&#x27; provides that once a patentee sells one of its products, it can no longer exercise control over the specific product. In this regard, the patentee&#x27;s patent rights are said to &#x27;exhaust&#x27;.</description><pubDate>Mon, 12 Jun 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7a3ce23a-4961-4505-8939-6737bcf6a53a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/the-basics-of-patent-law-unified-patent-court</link><title>The basics of patent law: the Unified Patent Court and the Unitary Patent</title><description>Gowling WLG&#x27;s intellectual property experts explain the Unified Patent Court and Unitary Patent, as part of their series of articles titled &#x27;The basics of patent law&#x27;.</description><pubDate>Wed, 17 May 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">168bb5b5-625e-4ad5-a7aa-be2574554c71</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/what-the-supreme-court-of-canada-was-not-told-abou</link><title>What the Supreme Court of Canada was not told about patent utility</title><description>On November 8, 2016 the Supreme Court of Canada (SCC) heard an appeal by AstraZeneca regarding the validity of a patent covering its NEXIUM product.</description><pubDate>Thu, 11 May 2017 15:03:00 Z</pubDate></item><item><guid isPermaLink="false">84bf9f98-f152-463f-89e6-2ac84aa4d8da</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/russia-signs-up-to-international-design-registrati</link><title>Russia signs up to international design registration at long last</title><description>On April 3, 2017, President Putin signed a law ratifying the Geneva Act of the Hague Agreement Concerning the International Registration of Industrial Designs.</description><pubDate>Wed, 03 May 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8d12f41c-5186-4f5b-8a29-bba98355a419</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/basics-of-patent-law-assignment-and-licensing</link><title>The basics of patent law - assignment and licensing</title><description>Gowling WLG&#x27;s intellectual property experts explain assignment and licensing in a series of articles titled &#x27;The basics of patent law&#x27;.</description><pubDate>Wed, 19 Apr 2017 03:34:00 Z</pubDate></item><item><guid isPermaLink="false">fec5f2cb-0507-4e64-9bf4-56c76d3e6013</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/the-basics-of-patent-law-remedies-and-costs</link><title>The basics of patent law - remedies and costs</title><description>Gowling WLG&#x27;s intellectual property (IP) experts discuss remedies available in the UK, as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 12 Apr 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7227c025-992e-4ae3-8b8c-f283d33f3cf7</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/procedure-trial-appeal-and-settlement</link><title>The basics of patent law - procedure, trial, appeal and settlement</title><description>Gowling WLG&#x27;s intellectual property experts discuss litigation procedure, trial, appeal and settlement, as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 05 Apr 2017 06:05:00 Z</pubDate></item><item><guid isPermaLink="false">80f0ac78-2595-4419-b077-2b5adcdde5fb</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/revocation-non-infringement-and-clearing-the-way</link><title>The basics of patent law - revocation, non-infringement and clearing the way</title><description>Our IP experts discuss challenges to validity, revocation actions, non-infringement and other procedures to remove the effect of an IP right.</description><pubDate>Thu, 30 Mar 2017 12:09:00 Z</pubDate></item><item><guid isPermaLink="false">465029cc-1d62-4639-bb81-dcd6ff55eaf2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/evidence-for-establishing-sound-prediction-and-the</link><title>Evidence for establishing sound prediction and the use of trial and error experimentation to establish an enabling disclosure</title><description>The Federal Court of Appeal&#x27;s (FCA) recent decision in Teva v. Leo Pharma addresses important issues related to the doctrines of sound prediction and sufficiency.</description><pubDate>Thu, 30 Mar 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">dd4a9768-c1c6-4c8c-b454-c66951e20dd3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/the-basics-of-patent-law-infringement</link><title>The basics of patent law - infringement and related actions</title><description>Gowling WLG&#x27;s intellectual property experts discuss infringement and related actions as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 22 Mar 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8e527f98-e34e-4df6-a27c-fe07bf9079da</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/the-basics-of-patent-law-initiating-proceedings</link><title>The basics of patent law - initiating proceedings in the UK</title><description>Gowling WLG&#x27;s intellectual property experts discuss initiating proceedings as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 15 Mar 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0a269b13-ab15-454b-ae35-0e1f39822b5e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/types-of-ip-protection-for-inventions</link><title>Types of intellectual property protection for inventions and granting procedure</title><description>Gowling WLG&#x27;s intellectual property experts explore the types of intellectual property protection for inventions and granting procedure as part of their series called &#x27;The basics of patent law&#x27;.</description><pubDate>Wed, 08 Mar 2017 05:43:00 Z</pubDate></item><item><guid isPermaLink="false">209ee4ca-28ba-4771-90c2-afabb462eee5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/new-trade-mark-and-patent-fees-in-singapore</link><title>Your guide to new trade mark and patent fees in Singapore</title><description>The Trade Mark and Patent Registries of the Intellectual Property Office of Singapore (IPOS) has announced a series of fee revisions that will take effect from 1 April 2017.</description><pubDate>Mon, 20 Feb 2017 03:52:00 Z</pubDate></item><item><guid isPermaLink="false">52a2bba2-8dec-4a36-9dae-1f787b91a78d</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/annual-patent-review-2016</link><title>Annual patent review 2016</title><description>2016 was another a bumper year for patent decisions from the UK IP courts.</description><pubDate>Wed, 25 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">013cec61-119d-4e88-864d-2120beb345c8</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/high-stakes-patent-action-turned-damp-squib</link><title>&#x22;High stakes&#x22; patent action turned &#x22;damp squib&#x22;</title><description>In Mediatube Corp. v. Bell Canada, 2017 FC 6, the Federal Court of Canada has rendered a patent infringement trial decision in a case involving an alleged non-practicing entity.</description><pubDate>Mon, 23 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7a8bb04a-c708-449e-8f3d-4bd89e4cdf55</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2017/canada-adopts-six-new-industrial-design-practices</link><title>Canada adopts six new industrial design practices to improve service and align with international norms</title><description>The Canadian Intellectual Property Office (CIPO) released six new practice changes in relation to industrial designs on January 16, 2017. These practices are effective immediately and are being implemented, at least in part, to improve service and adopt practices or provide benefits available from other jurisdictions.</description><pubDate>Thu, 19 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2600f646-fab8-4725-a262-f2b2c3feecd1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2017/canadian-patent-law-2016-year-in-review</link><title>Canadian patent law: 2016 year in review</title><description>This article summarizes noteworthy Canadian patent law decisions and developments from 2016.</description><pubDate>Wed, 04 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2b7bff2f-20ed-4405-8483-59dcf6b4b950</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/uk-signals-intent-to-remain-in-the-new-upc-system</link><title>UK signals intent to remain in the new Unified Patent Court system</title><description>The United Kingdom&#x27;s Minister for Intellectual Property, Baroness Neville-Rolfe, has announced that the government is proceeding with preparations to ratify the Unified Patent Court Agreement (UPC Agreement).</description><pubDate>Wed, 30 Nov 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7257a67a-3593-48dd-86d7-1ff4ad2cfb15</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/monetary-consequences-for-falsely-alleging-patent</link><title>Monetary consequences for falsely alleging patent infringement</title><description>The Federal Court released a decision on Nov. 17, 2016 regarding two patent actions that were heard together.</description><pubDate>Mon, 21 Nov 2016 14:25:00 Z</pubDate></item><item><guid isPermaLink="false">664dee91-1cc6-4b19-89b9-9abaa0a176ba</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/challenge-to-patentee-s-right-to-elect-between-dam</link><title>Patentee&#x27;s choice, patent infringement</title><description>Which party has the right to choose the patentee&#x27;s remedy after a successful action for patent infringement?</description><pubDate>Thu, 10 Nov 2016 16:26:00 Z</pubDate></item><item><guid isPermaLink="false">f91947db-60d9-4430-b0b5-16d9f760836d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/changes-to-ip-rights-on-the-horizon-canada-introd</link><title>Changes to IP rights on the horizon: Canada introduces legislation to implement CETA</title><description>We previously reported on important changes the recently signed Comprehensive Economic and Trade Agreement between Canada and the European Union (CETA) requires Canada to make to its Patent Act and Trade-marks Act.</description><pubDate>Fri, 04 Nov 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d10ddd60-6bb9-4b12-a8e0-e1fcf7116465</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/federal-court-of-appeal-grants-minister-of-health</link><title>Federal Court of Appeal grants minister of health the right to be wrong</title><description>In a decision dated October 12, 2016, the Federal Court of Appeal upheld two decisions of the minister of health to issue Notice of Compliances to generic drug manufacturers without addressing the requirements of the Patented Medicines (Notice of Compliance) Regulations.</description><pubDate>Mon, 24 Oct 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3695930a-0112-43b2-93bc-ac039e3e9b0f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/patent-survives-anticipation-attack-based-on-use-i</link><title>Patent survives anticipation attack based on use in phase III clinical trial</title><description>On September 7, 2016, the Federal Court found that Apotex and Cobalt infringed three claims of Bayer&#x27;s Canadian Letters Patent No. 2,382,426. The Court also found those claims to be valid.</description><pubDate>Thu, 22 Sep 2016 11:28:00 Z</pubDate></item><item><guid isPermaLink="false">fbd35eb8-958c-4243-a1d5-3859e638f087</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/can-post-brexit-uk-remain-involved-in-the-up-and-u</link><title>Can post-Brexit UK remain involved in the UP and UPC system?</title><description>An Opinion, by English barristers Richard Gordon KC and Tom Pascoe, has been published considering the effect of Brexit (i.e. departure from the EU) upon the Unitary Patent (UP) Regulation and the Unified Patent Court (UPC) Agreement. Can the UK remain involved in the UP and UPC system?</description><pubDate>Fri, 16 Sep 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">76d146e1-717b-4839-b03a-683b6d33aa40</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/eli-lilly-s-erectile-dysfunction-patent-stands-up</link><title>Eli Lilly&#x27;s erectile dysfunction patent stands up to scrutiny</title><description>The English High Court (Patents Court) has ruled in a patent dispute concerned with the treatment of erectile dysfunction. Actavis and Mylan had commenced &#x22;clear the way&#x22; litigation by seeking to revoke Eli Lilly&#x27;s patent in order to launch generic versions of its CIALIS medicine upon expiry of the relevant SPC protection (November 2017).</description><pubDate>Thu, 01 Sep 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e9c81a5f-b37f-4387-a8e3-cb74723c11a5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/genentech-herceptin-formulation-patents-invalid</link><title>Court of Appeal confirms Genentech Herceptin formulation patents invalid</title><description>The Court of Appeal has confirmed that two Genentech patents concerning lyophilised formulations of trastuzumab (the active ingredient in Herceptin) are invalid for obviousness.</description><pubDate>Tue, 30 Aug 2016 08:28:00 Z</pubDate></item><item><guid isPermaLink="false">51b1ed66-ea22-4be8-adf6-99fc2d0f5bb5</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/english-patents-court-rules-patent-not-infringed-f</link><title>English Patents Court rules patent not infringed four months after claim filed</title><description>The English High Court (Patents Court) is a world-leading forum for efficient, high quality resolution of patent disputes. Demonstrating again the benefits of the court&#x27;s flexible and adaptable procedure, Mr Justice Arnold has delivered a full first instance judgment in a patent infringement case regarding therapeutic patches less than four and a half months after the claim was filed. This is less time than is needed to obtain preliminary relief in many jurisdictions.</description><pubDate>Thu, 14 Jul 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ddec7782-9795-4326-9cfc-9efeb7f285c1</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/business-as-usual-for-upc-says-chair</link><title>Business as usual for UPC, says chair</title><description>Following the result of last month&#x27;s UK referendum to leave the EU, the Unified Patent Court&#x27;s (UPC) Preparatory Committee has said that preparation for the regime will continue as planned.</description><pubDate>Tue, 05 Jul 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c8bf5ac5-a10f-48ef-98b6-7c58b15bb9ea</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/changes-to-the-profession-patent-and-trademark-ag</link><title>Patent and trademark agent privilege new governance framework</title><description>On June 24, 2016, by way of statutory amendment, the age-old common law concept of privilege between lawyers and their clients was extended to certain communications between patent and trademark agents (collectively &#x27;agents&#x27;) and their clients.</description><pubDate>Mon, 04 Jul 2016 14:54:00 Z</pubDate></item><item><guid isPermaLink="false">b2025d58-cbe9-414e-9b3a-9ddbf3cba468</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/what-brexit-means-for-the-patents-ecosystem-upc</link><title>Brexit - what the UK&#x27;s vote Leave means for the patents ecosystem and UPC</title><description>On 23 June 2016, in a national referendum, the population of the UK by a narrow majority (52%) voted to leave the European Union (EU).</description><pubDate>Thu, 30 Jun 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9686da05-c5d6-4adf-a064-7d169f38906f</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/brexit-what-next-for-intellectual-property</link><title>Brexit - what next for intellectual property?</title><description>The UK has voted to leave the EU. What next?</description><pubDate>Fri, 24 Jun 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d9dd2117-fb78-4b7c-8f8d-8b6218403f94</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/patentability-of-methods-of-medical-treatment-in-c</link><title>Patentability of methods of medical treatment in Canada</title><description>A method of medical treatment is not patentable in Canada. This rule arises out of a concern that granting a monopoly over a method of medically treating a patient could interfere with physicians&#x2019; skill and judgment when treating patients.</description><pubDate>Fri, 17 Jun 2016 09:39:00 Z</pubDate></item><item><guid isPermaLink="false">0dac3b13-8b28-4c9a-8926-178bb0bf07f4</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/post-amazon-com-how-the-canadian-patent-appeal-bo</link><title>Post Amazon.com: How the Canadian Patent Appeal Board has dealt with patent-eligibility of computer-implemented subject matter</title><description>An important consideration for every patentee is that each country&#x2019;s patent system has uniquely evolved to effectively deal with limits of patentable subject matter. For example, the patent systems of Canada, the United States and Europe continue to grapple with striking the necessary balance that leaves any underlying building blocks of an invention &#x2013; such as scientific principles, abstract ideas and laws of nature &#x2013; accessible to all, but extends patent protection to new, useful and innovative technical applications of these building blocks.</description><pubDate>Wed, 15 Jun 2016 15:36:00 Z</pubDate></item><item><guid isPermaLink="false">621d220c-d2d1-482c-9eed-d958ae24f397</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/federal-court-of-appeal-affirms-application-of-pri</link><title>Federal Court of Appeal affirms application of principles of causation, burden of proof and laws of evidence to section 8 proceedings</title><pubDate>Mon, 06 Jun 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">02a3991f-0422-4006-a04f-3c57108578b3</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/federal-court-releases-updated-guidelines-to-gover</link><title>Federal Court releases updated guidelines to govern proceedings under the &#x3C;em&#x3E;PM(NOC) Regulations&#x3C;/em&#x3E;</title><pubDate>Wed, 25 May 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a259ad96-4568-4dec-8e8a-c0ecc8c6258f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/what-other-products-federal-court-orders-generi</link><title>What &#x201C;other products&#x201D;? Federal Court orders generic to particularize damages claim</title><description>Unlike other actions, fulsome particulars of generic pharmaceutical damages claims (under section 8 of the Patented Medicines (Notice of Compliance) Regulations) have not always been thought to be necessary. It had been suggested that information in the possession of defendants might define the scope of such claims.</description><pubDate>Wed, 25 May 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">79d03716-c212-4be1-88d1-de9b755cc341</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/crowded-prior-art-and-narrow-drawings-lead-to-non</link><title>Crowded prior art and narrow drawings lead to non-infringement of industrial design</title><description>Industrial design registrations (or design patents as they are referred to in some jurisdictions) are attractive for a number of reasons, including their low cost and often easy prosecution before examiners.</description><pubDate>Thu, 19 May 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0b42631b-cd4b-437f-b3a4-a5d55d36522f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/demand-letters-are-now-mandatory-in-russia</link><title>Demand letters are now mandatory in Russia</title><description>For the last 20 years, at least, there were no legal conditions that had to be met prior to filing a trademark or patent infringement lawsuit in Russia.</description><pubDate>Thu, 28 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7f2953bb-56e1-443a-88fa-70ca6891e760</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/eli-lilly-s-cialis-patent-withstands-double-paten</link><title>Eli Lilly&#x2019;s Cialis&#xAE; patent withstands double patenting and utility challenges on appeal</title><description>The Federal Court of Appeal has provided guidance on the law of obviousness-type double patenting in dismissing Mylan&#x2019;s appeal pertaining to Eli Lilly&#x2019;s Canadian Patent.</description><pubDate>Tue, 26 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3e6d2272-af35-45a0-b8d3-19583a0b6e4f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/patent-owner-s-entitlement-to-permanent-injunction</link><title>Patent owner&#x27;s entitlement to permanent injunction in Canada confirmed</title><description>In Uponor AB v. Heatlink Group Inc. et al., 2016 FC 320 (Uponor), the Federal Court of Canada awarded a permanent injunction after a finding that the asserted patent was valid and infringed, notwithstanding that the plaintiff did not practise the claimed invention.</description><pubDate>Thu, 21 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">187dc7b4-2233-46a4-8f05-ee77868b107c</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/guidelines-from-competition-bureau-pm-noc-reg</link><title>Competition Bureau releases guidelines in respect of settlements under the &#x3C;em&#x3E;PM(NOC) Regulations&#x3C;/em&#x3E;</title><description>On March 31, 2016, the Competition Bureau released its updated Intellectual Property Enforcement Guidelines.</description><pubDate>Fri, 08 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">351a8fc1-b4aa-4852-808c-f8f9769faec8</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/paes-and-seps-patent-enforcement</link><title>PAEs and SEPs: When is patent enforcement anti-competitive?</title><description>In 2015, submissions were invited on draft Intellectual Property Enforcement Guidelines. As a result of the consultation process, the Bureau has updated and finalized the IPEGs.</description><pubDate>Fri, 08 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6366f05b-1d1d-40f2-ae75-a59096a378cf</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/approvability-of-generic-noc-satisfies-imminence-c</link><title>Approvability of generic NOC satisfies imminence criteria in &#x3C;em&#x3E;quia timet &#x3C;/em&#x3E;proceedings</title><description>The Federal Court in Gilead Sciences Inc v Teva Canada Limited, 2016 FC 336 has clarified the law with respect to the imminence requirement of future patent infringement claims.</description><pubDate>Thu, 07 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">472d43f0-d14a-4782-b6e2-588c474ebc5b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/upc-scenario-3-a-standards-case-from-the-defendan</link><title>UPC scenario 3: A standards case from the defendant&#x27;s perspective</title><description>Our latest Unified Patent Court (UPC) scenario looks at a case involving a standard-essential patent. Michael Carter, Nick Cunningham and David Barron consider a defendant&#x27;s options in the new court system.</description><pubDate>Fri, 01 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a2506831-4055-4348-a11e-ca01d94e89bb</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/the-final-word-on-the-claim-for-innovator-profits</link><title>The final word on the claim for innovator profits following PM(NOC) litigation?</title><description>Generic pharmaceutical companies have long sought the disgorgement of innovator profits following litigation under the Patented Medicines (Notice of Compliance) Regulations (the &#x201C;Regulations&#x201D;). On January 14, 2016 the Supreme Court of Canada (SCC), once again, denied leave after Apotex appealed a decision of the Court of Appeal for Ontario (OCA) which upheld Eli Lilly&#x2019;s motion to strike these claims.</description><pubDate>Thu, 31 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">473d5c1d-afb4-41fa-a45a-1ee0822ced78</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/technology-commercialization-forecast-heavy-clou</link><title>Technology commercialization forecast: &#x22;Heavy clouds with developing sunny breaks&#x22; - the emergence of &#x22;Patent Box&#x22; tax incentives in Canada</title><description>The Conference Board of Canada regularly publishes a &#x27;Report Card on How Canada Performs&#x27; in a number of sectors including, the economy, environment, innovation and health among others.</description><pubDate>Mon, 28 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e14f3905-82c5-4f8c-aefd-62cede2b16aa</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/federal-court-deviates-from-established-tests-for</link><title>Federal Court deviates from established tests for patent listing &#x2014; &#x3C;em&#x3E;Gilead Sciences, Inc. v. Canada (Health)&#x3C;/em&#x3E;</title><description>In the decision summarized below, Apotex successfully obtained a dismissal of Gilead&#x2019;s application for a prohibition order in respect of Canadian Patent 2,261,619 on the basis of improper listing on the Patent Register.</description><pubDate>Tue, 22 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9c0e7549-9f4d-42eb-87b0-657f18f435f4</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/what-you-need-to-know-about-brand-perception-and-t</link><title>What you need to know about brand perception and trademark applications</title><description>Brand perception has always been important to businesses. Now that social media has become one of the primary ways people access news, brand owners must be aware of how they are perceived across the different platforms that they use to manage their identities.</description><pubDate>Fri, 11 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">73a52988-d8e5-460f-9c8c-08f949bf9523</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/supreme-court-of-canada-to-consider-law-of-utility</link><title>Supreme Court of Canada to consider law of utility in Esomeprazole appeal</title><description>The Supreme Court of Canada has again acknowledged the need to consider the law of utility in Canada by granting Astrazeneca leave to appeal in Esomeprazole. At issue will be the validity of Canadian Patent 2,139,653 (&#x22;653 Patent&#x201D;) covering Astrazeneca&#x2019;s NEXIUM&#xAE; product, which has previously been declared invalid by Rennie J., as confirmed by the Federal Court of Appeal (&#x201C;FCA&#x201D;).</description><pubDate>Fri, 11 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1a45a968-156f-4e2e-b298-7b0d4331b4b9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/ceta-and-canadian-ip-law-possible-changes-ahead</link><title>CETA and Canadian IP law: Possible changes ahead?</title><description>In 2013, an agreement in principle was reached between Canada and the European Union - the Canada-European Union Comprehensive Economic and Trade Agreement (&#x201C;CETA&#x201D;).&#xA0; An official text was released on September 26, 2014, subject to legal review. &#xA0;On February 29, 2016, the federal government announced that a legal review of the English text of CETA is now complete, and published the text of the final agreement.&#xA0; International Trade Minister Chrystia Freeland has said she hopes the deal will be ratified later this year and come into force some time in 2017.</description><pubDate>Thu, 03 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8b92878f-3ad1-4607-89aa-328d22006b08</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/annual-patent-review-2015</link><title>Annual patent review 2015</title><description>2015 was a bumper year for patent decisions from the UK IP courts. Here Gordon Harris shares his comprehensive commentary of the key developments, in his annual review of the year&#x27;s patent cases.</description><pubDate>Tue, 09 Feb 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">31439126-7796-484b-a6c6-6a9b3a47b6ef</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/canadian-patent-law-2015-year-in-review</link><title>Canadian patent law: 2015 year in review</title><description>Canadian patent law: 2015 year in review</description><pubDate>Tue, 12 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">87a7a7ba-6cff-4de4-8b2f-cb569bd4e951</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/patent-enforcement-through-the-courts-in-canada</link><title>Patent enforcement through the courts in Canada</title><description>The Federal Court has in-depth knowledge of the substantive and procedural aspects of patent litigation. It has exclusive jurisdiction to hear cases regarding conflicting patent applications and the impeachment of a patent.</description><pubDate>Mon, 11 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ea105edc-92eb-4d95-9b02-041cb315f8cd</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2016/patentability-in-canada</link><title>Patentability in Canada</title><description>What are the criteria for patentability in your jurisdiction? In Canada, in order to be patentable an invention must be novel, useful and unobvious.</description><pubDate>Mon, 11 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b8a55995-46f9-4d13-9f2a-f34f8ea4e967</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2016/patents-in-canada</link><title>Patents in Canada</title><description>What are the criteria for patentability in your jurisdiction?</description><pubDate>Mon, 11 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">92da0c16-c714-4beb-9099-f1828c08248a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/pharmaceutical-data-protection-in-canada-the-late</link><title>Pharmaceutical data protection in Canada: The latest word from Photocure</title><description>In the recent Photocure decision the Federal Court has once again sided with Canada&#x27;s Minister of Health in denying data protection for a new medicinal ingredient.</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1624d386-ee30-4182-9f81-e5006fcc9151</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/bc-court-of-appeal-dismisses-proposed-consumer-cla</link><title>BC Court of Appeal dismisses proposed consumer class action for invalid pharmaceutical patent</title><description>On Dec. 8, 2015, the British Columbia Court of Appeal dismissed a proposed class action by consumers against Pfizer Canada Inc. in connection with Pfizer&#x2019;s now invalid patent which covered its VIAGRA&#xAE; product.</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cb11bf0b-bef0-4259-becb-afc9c25774c9</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/company-just-received-a-cease-and-desist-part-one</link><title>So, your company just received a cease and desist letter... (Part 1)</title><description>The first questions that typically come to mind in such events are: Do you have to respond to the letter, particularly if you don&#x27;t know anything about the sender? What are your options for a response? And what steps should you take in formulating a response to such a letter?</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8ac0816b-dced-453c-8680-60ffbe0d44a2</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/company-just-received-a-cease-and-desist-part-two</link><title>So, your company just received a cease and desist letter... (Part 2)</title><description>Part 1 of this article summarized the steps that should be taken if your company receives a cease and desist letter that alleges patent infringement.</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">67392e11-eaba-46fa-87f8-a4ad46a00ffa</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/the-tpp-rights-for-patent-holders-in-canada</link><title>The TPP - New rights for pharmaceutical patent holders in Canada</title><description>The Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the technical summary of negotiated outcomes posted on the Department of Foreign Affairs and Development Canada&#x2019;s website following conclusion of the agreement.</description><pubDate>Thu, 12 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">208fb197-b9b5-46e0-8332-0873b0ca496f</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/federal-court-grants-leo-pharma-s-application-for</link><title>Federal Court grants Leo Pharma&#x27;s application for a prohibition order in respect of DOVOBET&#xAE;</title><description>On Nov. 18, 2015, Justice Locke granted Leo Pharma&#x2019;s application to prohibit the minister of health from approving Teva&#x2019;s version of Leo Pharma&#x2019;s patented DOVOBET&#xAE; product until after expiry of Canadian Patent 2,370,565 (the &#x201C;565 Patent&#x201D;).</description><pubDate>Sun, 01 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ae33f3a-e348-483a-b812-313711b6aad1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/canada-china-patent-prosecution-highway-program-be</link><title>Canada/China patent prosecution highway program benefits</title><description>As previously reported the CIPO and the SIPO entered into a PPH pilot project agreement that was scheduled to last from September 1, 2013 to August 31, 2015.</description><pubDate>Sun, 01 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6acc3fcf-7838-4838-b0d7-9ad513268199</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/federal-court-of-appeal-finds-that-pmprb-extends-t</link><title>Federal Court of Appeal finds that PMPRB extends to generics</title><description>On Nov. 6, 2015, the Federal Court of Appeal issued a rare decision relating to Canada&#x27;s pricing control regime for patented medicines administered by the Patented Medicine Prices Review Board (&#x22;PMPRB&#x22;).</description><pubDate>Sun, 01 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1cc7f069-5c52-4279-9bc5-1ca94056ec3e</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/you-and-the-unified-patent-court-survey-findings</link><title>You and the Unified Patent Court - survey findings</title><description>Our IP team surveyed patent attorneys and solicitors in private practice and in-house, seeking views on the UP and UPC - Will it work? Will it change anything? And is it really necessary?</description><pubDate>Thu, 15 Oct 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4769e6ac-a17d-4fbf-b9d7-186606c9c5dd</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/the-trans-pacific-partnership-changes-for-patents</link><title>The Trans-Pacific Partnership: Changes for patents and pharmaceuticals?</title><description>Changes may be on the horizon for Canada&#x27;s legal and regulatory regime for patents and pharmaceuticals.</description><pubDate>Thu, 01 Oct 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">928847cb-5813-4a32-a550-b91c1a1aa8b7</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/federal-court-of-appeal-comments-on-standard-of-re</link><title>Federal Court of Appeal comments on standard of review and expert evidence in patent infringement action</title><description>On Aug. 18, 2015, the Federal Court of Appeal dismissed two appeals by ABB Technology AG, ABB Inc., and ABB AG (collectively, ABB) in the context of a patent infringementdispute against Hyundai Heavy Industries Co, Ltd (HHI) related to gas-insulated electrical switchgear assemblies used in electrical power transmission.</description><pubDate>Tue, 01 Sep 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">09dc2e4c-8ac3-4d3a-892e-c5b37e7a0043</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/ontario-superior-court-refuses-to-strike-generic-s</link><title>Ontario Superior Court refuses to strike generic&#x27;s damages claim against pharmaceutical innovator based on 400-year-old statute</title><pubDate>Tue, 01 Sep 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e861f9d0-76f9-4fe2-8f4b-0b217e3fa9bd</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2015/federal-court-of-appeal-reinterprets-product-speci</link><title>Federal Court of Appeal reinterprets product specificity requirements</title><description>On July 17, 2015, the Federal Court of Appeal set aside a judgment of the Federal Court that upheld Health Canada&#x2019;s refusal to list Canadian Patent 2,379,329 owned by Eli Lilly Canada Inc. on the Patent Register maintained under the PM(NOC) Regulations.</description><pubDate>Fri, 17 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cbe6e35b-cb7e-4476-8575-987e45e80c08</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/federal-court-grants-accounting-of-profits-and-add</link><title>Federal Court grants accounting of profits and addresses NIA &#x22;Non-Infringing Alternative&#x22;</title><description>The Federal Court recently released a decision accounting for an infringer&#x27;s profits in a pharmaceutical matter.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f01c7f1d-8aa4-4937-a832-27ffba1c772b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/federal-court-grants-interlocutory-stay-in-ip-disp</link><title>Federal Court grants interlocutory stay in IP dispute</title><description>On June 12, 2015, the Federal Court issued an interlocutory stay in the context of a data protection application in Horizon Pharma plc v The Minister of Health et al, 2015 FC 744.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">349edad2-5b3d-47b7-9609-987744276521</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/fca-does-not-address-trial-judge-s-finding-that-th</link><title>FCA does not address trial judge&#x27;s finding that there is no heightened disclosure requirement in cases of sound prediction</title><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fe8f8652-e0b9-4693-bbac-1575834ae85b</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/fca-imposes-could-and-would-test-to-assess-non-i</link><title>FCA imposes &#x22;could and would&#x22; test to assess non-infringing alternative</title><description>The Federal Court of Appeal has released its reasons in the appeal of Justice Snider&#x2019;s lovastatin damages decision.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aa34c578-ee8b-4ab9-b7c9-f95b20071eec</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/federal-court-of-appeal-reinterprets-product-speci</link><title>Federal Court of Appeal reinterprets product specificity requirements: Patent listing is determined by patent claims construction and not a word match</title><description>On July 17, 2015, the Federal Court of Appeal set aside a judgment of the Federal Court that upheld Health Canada&#x2019;s refusal to list Canadian Patent 2,379,329 (the &#x2018;329 patent) owned by Eli Lilly Canada Inc. on the Patent Register maintained under the PM(NOC) Regulations.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0decafe4-fb81-4e07-83fe-0e8e7808010c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2015/federal-court-affirms-principle-of-claim-different</link><title>Federal Court affirms principle of claim differentiation in evaluating utility</title><description>Novartis Pharmaceuticals Canada Inc. v. Teva Canada Ltd. and Minister of Health and Novartis AG, 2015 FC 770</description><pubDate>Fri, 19 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a0c76b26-fcd6-42aa-9876-3dcb44614178</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/canadian-competition-bureau-issues-draft-update-of</link><title>Canadian Competition Bureau issues draft update of Intellectual Property Enforcement Guidelines</title><description>On June 9, 2015, the Canadian Competition Bureau issued a draft update of its Intellectual Property Enforcement Guidelines (IPEGs) for public consultation.</description><pubDate>Mon, 01 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f01d2d13-8619-476d-bd58-a8d43e9bc33c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/ip-ownership-for-r-d-companies-cautionary-tales-a</link><title>IP ownership for R&#x26;D companies: Cautionary tales and best practices</title><description>In this presentation, Selena Kim discusses how companies engaged in R&#x26;D can successfully secure title to their intellectual property.</description><pubDate>Mon, 01 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5a990cd2-3e4c-4d93-8921-bf9ad6eb2c00</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/fca-confirms-that-no-disclosure-of-factual-basis-o</link><title>FCA confirms that no disclosure of factual basis or line of reasoning is required for sound prediction when they would be self-evident to the skilled person</title><pubDate>Mon, 01 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ddb201e2-61ac-474f-88c2-2876e4b5bc55</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/industry-canada-seeks-comment-on-proposed-changes</link><title>Industry Canada seeks comment on proposed changes to listing requirements under the PM(NOC) Regulations</title><description>On May 2, 2015, the Governor in Council issued proposed amendments to sections 2, 3, and 4 of the Patented Medicines (Notice of Compliance) Regulations. These amendments specifically address the eligibility of listing patent claims that may not include all medicinal ingredients referred to in the approved drug product for which listing was sought on the Patent Register.</description><pubDate>Fri, 01 May 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">727c22b8-c0a6-4435-add3-e24b6dca00d4</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/cipo-revised-guidance-on-methods-of-treatment</link><title>CIPO issues revised examination guidance on methods of medical treatment and dosage regimens</title><description>The Canadian Intellectual Property Office (CIPO) has now released Practice Notice PN 2015-01, which relates to examination of medical treatment claims.</description><pubDate>Sun, 01 Mar 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ef678a05-57c5-4f45-baf9-bae4fb663d74</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/re-examination-a-viable-alternative-in-canada</link><title>Re-examination: A viable alternative in Canada</title><description>The Federal Court of Appeal recently upheld the dismissal of an appeal from a decision of a Patent Re-examination Board thus establishing that re-examination may be a viable alternative to challenge the validity of a Canadian patent.</description><pubDate>Sun, 01 Mar 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d7439779-d6a1-434f-9feb-9b8521f128ea</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/annual-patent-review-2014</link><title>Annual patent review 2014</title><description>2014 was an interesting year in the world of patents in the UK, with some important developments:</description><pubDate>Thu, 12 Feb 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3442adc3-2646-4317-a882-842731c4410a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2015/canadian-patent-law-2014-year-in-review</link><title>Canadian patent law: 2014 year in review</title><description>Canadian patent law: 2014 year in review</description><pubDate>Sun, 01 Feb 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e1feddc0-78fe-411b-b7ba-b01287ff946f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/client-work/2015/federal-court-awards-eli-lilly-106-million-in-pat</link><title>Federal Court awards Eli Lilly $106 million in patent damages</title><description>On January 23, 2015, the Federal Court released its decision regarding the quantum of damages recoverable by Eli Lilly in an action relating to Apotex&#x2019;s infringement of patents related to the manufacture of the antibiotic cefaclor.</description><pubDate>Fri, 23 Jan 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8b7e81ce-2cb5-475d-9fbb-957a1f68d5ba</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/federal-court-determines-minister-s-decisions-gran</link><title>Federal Court determines minister&#x27;s decisions granting NOCs based on administrative ANDSs cross-referencing licensed generics without requiring NOAs are wrong</title><description>On Dec. 19, 2014, the Federal Court set aside a decision of the Minister of Health granting a Notice of Compliance (NOC) to Teva authorizing the sale of its product that referred to Pfizer&#x2019;s Aromasin&#xAE;.</description><pubDate>Thu, 01 Jan 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b30ead23-9582-4fd4-b44a-2c9caf52a0b3</guid><link>https://gowlingwlg.com/en-cn/insights-resources/articles/2015/federal-court-rejects-nia-defence-and-awards-compo</link><title>Federal Court rejects NIA defence and awards compound interest on patent damages</title><description>On Jan. 23, 2015, the Federal Court released its decision regarding the quantum of damages recoverable by Eli Lilly (Lilly) in an action relating to Apotex&#x27;s infringement of patents related to the manufacture of the antibiotic cefaclor.</description><pubDate>Thu, 01 Jan 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0325f1d5-749d-4b1c-a016-470b60530535</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/unitary-patent-likely-to-pass-its-spanish-test</link><title>Unitary Patent likely to pass its Spanish test</title><description>In welcome news for supporters of the Unitary Patent, Advocate General Bot has proposed that the Court of Justice should dismiss both of Spain&#x27;s applications for the annulment of EU Regulations relating to the Unitary Patent package.</description><pubDate>Thu, 20 Nov 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fdc25965-ee97-44a0-a85a-fb9476d742b9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/canada-prepares-for-hague-agreement-on-internation</link><title>Canada prepares for Hague Agreement on international industrial design registrations</title><description>The Industrial Design Act (the Design Act) is due for an update.</description><pubDate>Mon, 03 Nov 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">bb39ebd1-0ff1-43f9-8b5c-a7d285874863</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/canada-prepares-for-patent-law-treaty</link><title>Canada prepares for Patent Law Treaty</title><description>The Canadian Patent Act (the Patent Act) is undergoing amendment courtesy of Bill C-43, known as the Economic Action Plan 2014 Act, No. 2 tabled in the House of Commons on Oct. 23, 2014.</description><pubDate>Sat, 01 Nov 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9d74a289-af03-484b-9a0e-5564cc03f39b</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/leaving-their-mark</link><title>Leaving their mark</title><description>Over the past year, Canadian Federal Courts left their juristic mark on patent law. This article highlights recent patent decisions addressing the idiosyncratic Canadian concepts of &#x201C;promise of the patent,&#x201D; &#x201C;sound prediction,&#x201D; our treatment of methods for medical treatment, and our evolving management of remedies in patent cases. Canadian patent drafting and prosecution tips are also highlighted.</description><pubDate>Mon, 29 Sep 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3007bff9-874c-4491-8a29-facfe8d3727d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/patentability-of-computer-implemented-inventions</link><title>Patentability of computer-implemented inventions: how Canada compares to the United States in view of &#x3C;em&#x3E;Alice Corp&#x3C;/em&#x3E;</title><description>Every patentee must understand that each patent system has evolved a unique way in which to effectively deal with the limits of patentable subject matter.</description><pubDate>Fri, 04 Jul 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">57667228-a3c1-4712-9a58-91ee29ec7bf7</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/permanent-injunction-granted-despite-patentee-not</link><title>Permanent injunction granted despite patentee not having a product that practiced the claims of the patent</title><description>On May 22, 2014, the Federal Court of Canada issued an injunction curtailing Janssen Inc.&#x2019;s marketing of its drug ustekinumab (STELARA&#xAE;) in ongoing patent litigation with AbbVie Corporation and related companies. The Court had previously found that certain claims of the patent in issue were both valid and infringed.</description><pubDate>Wed, 18 Jun 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4be470df-d38a-445f-8ce2-d42858020c30</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/experimental-testing-in-patent-actions</link><title>Experimental testing in patent actions: Federal Court issues notice to the profession</title><description>Experimental testing and patent infringement actions: they often go hand-in-hand. With respect to providing notice to other parties of experimental testing, the patent litigation bar has been working under a salutary, unofficial rule since at least the 1960s.</description><pubDate>Thu, 17 Apr 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ce892c1a-9c70-421d-ac89-79670a7e953a</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/patents-year-in-review-2013</link><title>Patents year in review 2013</title><description>This article summarizes noteworthy Canadian patent law decisions and developments from 2013.</description><pubDate>Mon, 10 Feb 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d32258c0-6e41-4328-8f62-d6a3c5129d47</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2014/canadian-parliament-tables-five-ip-related-treatie</link><title>A table-full of treaties: Canadian parliament tables five IP-related treaties</title><description>On January 27, 2014, the Parliament of Canada laid upon the Table copies of five international treaties related to intellectual property.</description><pubDate>Fri, 31 Jan 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">41b2c4dc-88f9-4c88-a05b-476bc1a5498c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2013/court-grants-largest-patent-infringement-damages-a</link><title>Court grants largest patent infringement damages award in Canadian history</title><description>On July 16, 2013, the Federal Court released its decision granting the largest award of damages for patent infringement in Canadian history. In Merck &#x26; Co., Inc. v. Apotex Inc. (2013 FC 751) (&#x201C;Merck&#x201D;), Justice Snider found that Merck is entitled to over $119 million in damages, plus interest, for Apotex&#x2019;s infringement of Merck&#x2019;s patent for the anti-cholesterol drug lovastatin.</description><pubDate>Thu, 18 Jul 2013 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8db8430f-d3d3-4a4c-92f6-258946126c27</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2013/everything-you-wanted-to-know-about-software-and-b</link><title>Everything you wanted to know about Software and Business Method Patents but were afraid to ask</title><pubDate>Fri, 15 Feb 2013 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0120a6ce-b7ab-4f72-9800-0a6347a4eae9</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2013/patents-year-in-review-2012</link><title>Patents Year in Review 2012</title><description>This article summarizes the most noteworthy Canadian patent law decisions of 2012.</description><pubDate>Fri, 08 Feb 2013 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2152c60e-f722-4491-9111-2bbe6db0787d</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2012/supreme-court-of-canada-addresses-sufficiency-of-p</link><title>Supreme Court of Canada addresses sufficiency of patent disclosure</title><description>The Supreme Court of Canada has unanimously overturned decisions of the Federal Court and Federal Court of Appeal, and held, in the context of proceedings under the Patented Medicines (Notice of Compliance) Regulations [PM(NOC) Regulations], that Pfizer&#x2019;s Canadian Patent No. 2,163,446 for the use of VIAGRA (sildenafil) was void.</description><pubDate>Fri, 09 Nov 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1246de30-7d19-4dcd-a141-3dda827e61f4</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2012/navigating-the-patent-process-four-hot-tips-for-s</link><title>Navigating the Patent Process: Four Hot Tips for Startups</title><pubDate>Thu, 12 Jul 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d57dee08-1135-42fc-9cd9-3d7a459a3a37</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2012/punitive-damages-award-in-canada-due-to-implied-kn</link><title>Punitive damages award in Canada due to implied knowledge of infringed patent</title><description>Historically, Canadian courts rarely award punitive damages in patent infringement actions, making the recent award of punitive damages by the Federal Court of Canada in Eurocopter v. Bell Helicopter 2012 FC 113 particularly notable.</description><pubDate>Thu, 05 Apr 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cc7283a9-f5af-471e-be5b-20d6a3f25363</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2012/amazon-com-s-canadian-one-click-patent-on-the-th</link><title>Amazon.com&#x27;s Canadian &#x22;one-click&#x22; patent on the threshold of issuance</title><pubDate>Tue, 03 Jan 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d2278171-cc4f-46fd-828c-d6fb76e75311</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/business-method-patents-how-prepared-are-you</link><title>Business method patents: How prepared are you?</title><pubDate>Tue, 06 Dec 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">358757f8-c42f-440b-8635-be355c915261</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/ramifications-of-the-amazon-appeal-decision-on-doi</link><title>Surely business methods are prohibited in Canada? Ramifications of the Amazon appeal decision on doing business (methods) in Canada</title><description>A typical business method patent contains claims to innovative, computer-implemented technology related to the practice, administration, or management of an enterprise, usually involving the processing of data specific to enterprise operations. Industries potentially subject to business methods can include e-commerce, advertising, loyalty and reward programs, insurance and banking and other financial services. In some countries, business method patents are recognised as important assets for small, medium and large corporations.</description><pubDate>Mon, 05 Dec 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">421a47d6-955a-4b15-9498-484630b1f81f</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/business-method-as-essential-element-of-valid-pate</link><title>Business method as essential element of valid patent claim: Amazon one-click decision, a Canadian prosecution perspective</title><description>On November 24, 2011, the Canadian Federal Court of Appeal released a vital decision quashing the Commissioner of Patents&#x27; stated &#x27;tradition&#x27; of excluding business methods from patentability.</description><pubDate>Fri, 25 Nov 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d6c0a6bd-3b45-4d2d-8ec2-c448b405d728</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/top-ten-tips-for-dealing-with-business-method-pate</link><title>Top ten tips for dealing with business method patents in Canada</title><description>Will Canada Become a Haven for Non-Practicing Entities to Litigate Their Claims? This list of top ten issues will canvass the law of business method patents in Canada and will consider the impact of the recent Amazon case on your business.</description><pubDate>Tue, 13 Sep 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3ced0b97-4c23-499c-baac-2bf272a6bb76</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/patents-are-like-a-swiss-army-knife-know-to-use-t</link><title>Patents are like a Swiss Army Knife: Know to use them</title><description>Grant W.C. Tisdall&#x27;s presentation, &#x22;Patents are like a Swiss army knife: Know how to use them&#x22;, discusses tools and strategies for patent portfolio development, including how to best leverage both the certainty and uncertainty that patents and patent applications provide and what business considerations are important in selecting which technology to patent.</description><pubDate>Thu, 30 Jun 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">81efa921-08fb-4a6a-bb4c-395edf910a7c</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/cipo-accelerated-examination-provision-green-tech</link><title>Canadian Intellectual Property Office (CIPO) Introduces Accelerated Examination Provision for Green Technologies and Modifies Existing Rules</title><description>In the Rules Amending the Patent Rules (SOR/2011-61), which came into force on March 3, 2011, CIPO has introduced changes that modify the sections of the Patent Rules which deal with accelerated examination. In particular, there is a new provision regarding the accelerated examination of &#x22;green&#x22; technologies, and a new restriction affecting the accelerated examination of certain cases that becomes effective after April 30, 2011.</description><pubDate>Mon, 21 Mar 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ad51bf0f-b572-4a11-aa34-86303bf121a1</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/intellectual-property-protecting-what-s-yours</link><title>Intellectual property: Protecting what&#x27;s yours</title><description>This presentation was given on February 16, 2011 at the RIC/OCETA breakfast session, &#x22;Growing Your Business - Intellectual Properly - Protecting What&#x27;s Yours.&#x201D;</description><pubDate>Mon, 28 Feb 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">28e9683d-e607-4f24-8b6c-2e0a7b11a924</guid><link>https://gowlingwlg.com/en-CN/insights-resources/articles/2011/developments-in-canadian-patent-law-2010</link><title>Key Developments in Canadian Patent Law in 2010</title><description>Over the past year, patent law in Canada has continued to evolve in significant ways. This review discusses seven key developments based on recent Canadian judgments, as well as amendments to the Federal Courts Rules and the Patent Rules.</description><pubDate>Mon, 24 Jan 2011 00:00:00 Z</pubDate></item></channel></rss>